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PUBLICATION DISSERTATION OPTION 
The body of the dissertation has been compiled in the format of peer reviewed 
journals for eventual publication.  The main body has been divided into six papers in the 
following order.  The first paper, “Preliminary Evaluation of Bioactive Borate Glass 
Fiber Scaffolds for Mammalian Tissue Regeneration,” was written for publication in the 
Journal of Biomedical Materials Research Part B Applied Biomaterials, and consumes 
pages 15 to 57.  The second paper, “Potential Toxicity of Bioactive Borate Glasses In-
Vitro and In-Vivo,” was written to Acta Biomaterialia and consumes pages 58 to 99.  The 
third paper, “Angiogenic Bioactive Borate Glasses,” was written to Acta Biomaterialia 
and consumes pages 100 to 144.  The fourth paper, “Bone Growth on Bioactive Borate 
Glass Scaffolds,” was written for submission to the Acta Biomaterialia and consumes 
pages 145 to 185.  The fifth paper, “Conversion of Bioactive Borate Glasses In-Vivo,” 
was written for submission in Acta Biomaterialia and consumes pages 186 to 247.  The 
sixth paper, “Bioactive Borate Glass Fibers for the Treatment of Wounds” was written for 
submission to Journal of Biomedical Materials Research Part B Applied Biomaterials 
and consumes pages 248 to 273.   
Three papers not included in the main body of the dissertation are given in the 
appendix.  The first paper, “Bioactive Glass Scaffolds for Soft Tissue Engineering,” was 
written to provide supplemental information.  The second paper, “Comparison of Self-
Bonded Three Dimensional Bioactive Glass Fiber Scaffolds After In-Vivo Implantation 
in Rats,” was accepted for publication in the proceedings of the Pacific Rim 8 Conference 
(June 2009, Vancouver Canada).  The third paper, “Conversion Kinetics of Silicate, 
Borosilicate, and Borate Bioactive Glasses to Hydroxyapatite,” was published in the 
  
iv 
European Journal of Glass Science and Technology B - Physics and Chemistry of 

























The main objectives of this dissertation were to evaluate bioactive borate glass 
scaffolds for hard and soft tissue applications and determine the potential toxicity of the 
borate glasses on the adjacent and systemic tissues.  Porous randomly oriented fiber 
scaffolds composed of bioactive borate glass were implanted in subcutaneous soft tissue 
sites and in calvaria defects of laboratory rats and no signs of toxicity (necrotic tissue, 
increase in macrophages or other immune cells) were detected in any of the adjacent 
tissues (hard or soft).  Systemic organs (kidney and liver) of laboratory rats implanted 
with bioactive borate scaffolds were analyzed for possible systemic toxicity and no 
adverse effects were found beyond normal incidental changes.  Bone was found to grow 
statistically better (p<0.05) in bioactive borate glass scaffolds when compared to similar 
scaffolds composed of borosilicate and silicate based bioactive glasses.  For the first time, 
elements were added to a bioactive glass for the purposes of promoting angiogenesis.  
The elements copper and zinc were shown to significantly increase the number of blood 
vessels (p<0.05) present in the soft tissue inside bioactive borate glass scaffolds when 
compared to the un-doped scaffolds.  Bioactive borate glass fibers were also 
demonstrated as a new material that may be useful in the treatment of chronic wounds.  A 
full thickness cutaneous defect (15mm diameter) on the back of a laboratory rats were 
healed in similar time (18 days), but with a higher quality scar than the control (un-
treated wound).  The results from the full thickness cutaneous defect opens the door for 
new potential uses of bioactive borate glass fibers such as the treatment of chronic 
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1. PURPOSE OF DISSERTATION 
The purpose of this dissertation was to evaluate bioactive borate glass scaffold 
composed of randomly oriented glass fibers in-vivo to determine potential toxicity in 
adjacent and systemic tissues, compare borate glasses to silicate based bioactive glasses 
such as 45S5 and 13-93 as a bone repair material, improve the angiogenic propetties of 
bioactive glass, study the reaction of the borate glasses in-vivo, and experiment with 
using bioactive borate glass as a soft tissue wound healing material. 
Borate glasses react considerably faster than silicate glasses when in the presence 
of body fluids or an aqueous solution such as simulated body fluid. The increased 
reaction rate is thought to be an advantage in that the glass converts to hydroxyapatite 
faster, and can then be remodeled by the body sooner for complete removal of the 
implant material. Unfortunately, the scientific community has limited interest in borate 
glasses because of poor performance by static in-vitro cell culture. Borate glasses are 
thought to be toxic to cells and adjacent tissue due to the fast release of alkali and 
localized alterations in pH. The present work uses animal models and histological 
evaluations of adjacent and systemic tissues along with indirect toxicity measurements 
such as bone growth to evaluate borate glass toxicity. 
Angiogenesis (blood vessel formation) is another critical aspect of this research in 
that scaffolds, particularly larger load bearing scaffolds made from metal and/or ceramics 
do not stimulate blood vessel formation and therefore do not promote tissue growth. 
Borate glasses react fast and may be used as a delivery vehicle for ions that can promote 




2.1. TISSUE ENGINEERING WITH BIOACTIVE GLASS 
Tissue engineering is the process of using materials (natural or synthetic) to 
mimic or replace the natural function of damaged or diseased tissue. Devices composed 
of plastic, metal, glass and ceramics, along with donor tissues are used to treat or replace 
almost any part of the body. One subset of materials used for tissue engineering are 
silicate based bioactive glasses such as 45S5 (wt%, 45% Si02, 24.5% Na20, 24.5% CaO, 
6% P20 5) as they have been known to bond to bone and soft tissue for almost 40 years 1. 
Bioactive glasses are useful materials for tissue engineering due to the high degree of 
biocompatibility with the body. 
Bioactive glasses and glass-ceramics have been used in clinical applications 
including periodontal repair 2, inner ear replacement 3, and filler for bone cement 4•5 to 
name a few. Three dimensional scaffolds composed ofbioactive glasses in a variety of 
microstructures have recently been under investigation for bone defects for load bearing 
and non-load bearing applications 6' 10. 
Soft tissue fi·om several mammalian species has been known to bond to 45S5 and 
similar silicate based bioactive glasses for decades 11 . The emphasis in the past has been 
placed primarily on bioactive glasses bonding to bone, so the soft tissue analysis was 
usually based on bond interface with the glass, or if the tissue merely grew adjacent to the 
I 'h b d' 1112 g ass w1t no on mg · . 
Researchers have started to look into the possible angiogenic effects ofbioactive 
glasses such as 45S5 coated with vascular endothelial growth factor (VEGF) for 
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increasing the vascular network inside of a scaffold 13• Further study on 45S5 as a 
proangiogenic material has demonstrated that it is angiogenic in low concentrations and 
has been hypothesized to up regulate VEGF production fi·om the soluble reaction 
products when co-cultured with human microvascular endothelial cells in-vitro 14• These 
angiogenic findings on bioactive glasses such as 45S5 make them interesting materials 
for soft tissue engineering applications as they are relatively unexplored for soft tissue 
applications such as wound care. 
Silicate based bioactive glasses however have been shown to react relatively 
slowly in-vivo taking months to years to fully react to hydroxyapatite (HA) 15• The rate at 
which silicate bioactive glasses convert to HA (stoichiometric composition is 
Ca10(P04)6(0H)2) and is relatively slow, on the order of months to years depending on 
the size of the bioactive glass particle and the glass composition 16 • Due to this slow 
reaction rate, faster reacting bioactive glasses containing boron have been developed with 
significantly faster reaction rates than silicate glasses 17 . Borate based bioactive glasses 
submerged in phosphate solutions convert to HA similar to silicate based bioactive 
glasses, but at a much faster rate 17•18• 
2.2. PAST WORK ON BORATE CONTAINING GLASSES FOR IN-VIVO USE 
Borate based bioactive glasses have been studied for several in-vivo applications 
including, bone replacement, a treatment for osteoarthritis, and drug delivery systems19. 
Richard implanted patticles of a 45S5 borate analog (complete exchange of boron for 
silica) in rat femurs and the glass converted to hydroxyapatite at a significantly 
accelerated rate and bone grew in and attached to the glass particles 20 . Han 21 , 
Vanderspiegel 22 , Huang 19, and Fears 23 investigated the use of hydroxyapatite shells 
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converted fi·om borate based glasses to act as rate controlled drug delivery systems in the 
body. 
White 24 and Conzone 25•26 demonstrated the application of using irradiated borate 
based glass microspheres for treatment of osteoatthritis and other in-vivo radiotherapies. 
The borate glasses degraded without radiation leakage as the glasses converted to 
chemically durable rare eatth phosphate materials. Zhao et al implanted similar 
dysprosium lithium borate glasses in rat livers and repmted no toxicity after two weeks 
in-vivo 27• 
Jai et al. 28 made pellets composed of borate glass particles ( <50J1m) mixed with 
four and eight weight percent teicoplanin for the treatment of osteomyelitis. The pellets 
released approximately 80% of the teicoplanin within 15 days in-vitro, and the 
compressive strength decreased fi·om 22 MPa to about 12 MPa after six days in PBS 
solution. The in-vivo results from New Zealand White rabbits were comparable to what 
was seen in-vitro, as the teicoplanin released in a controlled manner and the implants had 
sufficient load bearing strength. No toxic effects were seen in the adjacent bone from the 
borate glass as the glass converted to HA and suppmted the growth of new bone into the 
scaffolds. 
Liu et al. 29 treated osteomyelitis in the tibia of New Zealand White rabbits with a 
scaffold consisting of borate glass particles and a polymer binder loaded with 
Vancomycin. After eight weeks in-vivo, no observable tissue damage or inhibition of 
bone growth was present at the implant sites. Approximately 80% of the osteomyelitis 
infected tibia tested negative for the infection after eight weeks. The outer perimeter of 
the scaffolds had visible vascular growth that was claimed to have been participating in 
the bone regeneration. 
8ioactive silicate glasses, such as 45S5, have been modified with up to 3wt% 
8 20 3 with positive results IJ.Jo. Particles of 45S5 with 2wt% added 8 20 3 had 
significantly increased the amount of bone present after 15 days post-implantation in the 
intramedullary canal of a rat tibia, and the Ca/P ratio surrounding the boron doped 
particles was significantly higher than 45S5 glass particles30• Similar results were 
repotted for a series of silicate glasses with up to 3wt% 8 20 3 added. Direct bone 
bonding of the surface of the glass particles and rabbit bone was present, and a well 
defined calcium phosphate layer was reported at the surface of the particles after eight 
weeks11 • 
2.3. BORATE GLASSES SUIT ABLE FOR MAKING SCAFFOLDS 
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The borate glass studied by Richard 20 was successful for growing bone and 
reacting to form hydroxyapatite in-vivo. Huang, through in-vitro weight loss 
experiments, showed that this glass could react significantly faster than the well known 
and widely studied silicate based 45S5 glass17 • Jung showed that the reaction kinetics of 
the borate glass was approximately five times greater than that of the silicate glass 18 . The 
borate glass reacted in a controllable and continuous manner until complete reaction of 
the glass, while the silicate based 45S5 reaches a point where the mechanism of the 
hydroxyapatite conversion reaction changes and the reaction kinetics decrease 
significantly 17,1 8• The borate based 45S5 glass crystallizes easily upon heating and 
cannot be heat treated to form a three dimensional scaffold without crystallizing. The 
borate analog of 45S5 was therefore deemed unusable as a scaffold material. Therefore, 
a new material had to be found that was more suitable for thermal processing. 
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Another bioactive glass known as 13-93 is a silicate based glass containing 
53wt% Si02 along with materials such as MgO and K20 that allows for glass fibers to be 
pulled and can be heat treated to make three dimensional scaffolds 6•9•31 • The 13-93 glass 
was modified similarly to the 45S5 glass where all the silica was replaced by boron17•32, 
and this glass is now known as 13-9383 (wt%, 53%820 3, 20% CaO, 12% K20, 6% 
Na20, 5% MgO, and 4% P20 5). The 13-9383 glass exhibits reaction kinetics similar to 
the 45S5 analog glass 33 , and, can be easily pulled into glass fibers. It can be heat treated 
to form a three dimensional porous scaffold 33 . 
2.4. SOURCES OF BORON, MAMMALIAN INTERACTION, AND INTAKE 
Boron is an element that most humans ingest on a daily basis. Fruits, vegetables, 
and nuts are humans' greatest source for boron 34-36, as boron is a trace element required 
for cell wall formation in most plants 34• Ground water has relatively little boron as 
determined by the World Health Organization, as the range of boron in water is typically 
between 0.1 and 0.3mg/L, however, this depends on the water source 34• Ingestion of 
boron usually takes place as boric acid, either fi·om water or food sources, and meat and 
dairy products tend to be poor sources of boron 34• Boron can be inhaled; however, this is 
not a significant source of intake, except for people that work in borosilicate glass 
production or other industrial process that involves large amounts of airborne borate 
materials 34 '36. Absorption of boron through the skin is also limited unless there is an 
open wound or severely abraded section of skin, then boric acid will enter the body 36•37• 
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Humans and animals metabolize boron, or boric acid, similarly 34 . Typically, 
greater than 90% of ingested boric acid is excreted through urine, and this takes place 
relatively quickly, usually in the first 96 hours after ingestion 34·36 . Boric acid distributes 
equally throughout most soft tissues, however, boron when administered at a dose of 
9000ppm boric acid to male Fischer rats, has been repmted to accumulate up to 
approximately 20 times normal levels in bone 38 . 
Little is known about the interactions boron has with humans. Few human studies 
about boron exist, but boron is a known trace element that is present in human cadaver 
bones 3941 . Several investigators have suspected boron as an essential trace element to 
bone fimctionality and/or metabolism; however, this has not yet been proven 4246. No 
data has been repmted linking boron to cancer in humans 36, and no animal experiments 
have adequately addressed any potential link 36 . An estimated value of0.2mg/kg-day of 
boron has been established fi·om data of several animal studies as maximum average 
lifetime ingestion; however, this number is not based off of human data 36 . Animal 
models comparing ingested boric acid in rats versus control rats has determined a 
benchmark dose level (BMDL) of 55mg/kg/day of boric acid. This means that 
55mg/kg/day of boric acid correspond to the level of boric acid required to induce an 
adverse response as compared to the control animals 35 . 
2.5. THE NEED FOR IMPROVED ANGIOGENESIS IN TISSUE ENGINEERING 
SCAFFOLDS AND WOUND CARE 
Angiogenesis is the process by which blood vessels are formed in the body. 
Wounds need sustained blood flow to deliver nutrients and growth factors needed for 
. f . I . h d 47 48 Th . repair o t1ssues a ong Wit a means to remove waste pro ucts · . e maximum 
distance tissue can survive is approximately I 00 to 200fim from a blood vessel, so new 
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blood vessel formation is necessary for wounds to heal 47 . Specific to placing artificial 
materials such as bioactive glass scaffolds in the body, tissues cannot grow into and fill 
the scaffold until a network of blood vessels have first penetrated the scaffold or at least 
are promoted to penetrate the scaffold as surrounding tissues infiltrate. The importance 
of vascularization on wound healing is significant and should not be ignored 47 . Vascular 
endothelial growth factor has been isolated as one of the most important signals for 
wound healing. Several growth factors natural to the body have been identified as 
impottant to wound healing, however, none are as prevalent or have the long-term 
stimulatory effects for vascular growth as VEGF 48• 
Bone is a vascular material and among its obvious structural function, red blood 
cells are produced inside the marrow cavity of bone. Bone cells require a relatively high 
oxygen supply for growth and natural function, as all osteocytes are located within 
200J.im of a blood capillary 49• Scaffolds are important for growth of damaged bone 
because bones grow entirely by apposition 49• Bone needs a preexisting surface in which 
osteocytes can attach and form a calcified bone matrix 49• Several methods of improving 
vascularization of engineered scaffolds are currently under investigation including 
growth factors, the addition of trace elements, co-culturing of cells on the scaffold, and 
in-vivo prevascularization. 
Rouwkema repotted that bone growth could be enhanced simply by co-culturing 
endothelial cells (the cells that line blood vessels) with mesenchymal stem cells to form 
vessels at the same time as bone47 • Another method Rouwkema repotted was to do a 
procedure called in-vivo prevascularization. A scaffold is placed it in the vicinity of an 
artery or a vascular tissue such as muscle of the patient long enough for the attery or 
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vascular tissue to penetrate the scaffold, then the scaffold is surgically removed and 
placed in the bone defect site47• This implies that if a vascular network is in place when 
bone growth is initiated, then the bone can grow faster due to the increased oxygen and 
nutrients being supplied. 
Previous work completed by multiple researchers has confirmed that cettain 
elements such as copper and tin may be beneficial for the promotion of angiogenesis 48•50. 
53
• Copper ions released in the vicinity of engineered scaffolds, usually in the form of a 
copper sulfate salt, have increased vascularization in calcium phosphate 53 and 
hyaluronan-based hydrogel 54 scaffolds. A major benefit of copper ion release for 
increasing vascular density is that it is a much more cost effective method as opposed to 
attachment of expensive growth factors like VEGF 47• 
2.6. POTENTIAL BENEFITS OF DOPING BIOACTIVE GLASS WITH 
BIOLOGICAL TRACE ELEMENTS 
Several elements at physiological levels are used to trigger or control reactions in 
the body that are required for living. Trace elements such as zinc, boron, strontium, 
copper, and iron have been studied for specific biological responses and are all elements 
found in human cadaver bone 41 . Endothelial cell migration has been stimulated by 
copper ions 55 and the presence of copper is required for blood vessel formation 
(angiogenesis) 56• Zinc is a cofactor responsible for keratinocyte migration during wound 
healing which promotes re-epithelialization and improves epithelial cell apoptosis 57 • 
Zinc oxide is also useful in decreasing blood clotting time 58 . Boron, in the form of boric 
acid (I to I OmM concentrations), significantly increased mRNA uptake of human 
placental cells similar to what would be expected if a growth factor were present 59• 
Strontium, >99% located in the skeleton 60, has been shown to have severe implications 
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on bone mineralization. Finally, iron is part of several enzymes and is present in bone 
marrow and red blood cells 61 • The release of these ions from bioactive glass is 
hypothesized to locally promote these biological functions when released at physiological 
concentrations. 
2.7. SOFT TISSUE INTERACTIONS WITH BIOACTIVE BORATE GLASSES 
Borate based bioactive glasses have not been investigated for soft tissue use; 
however they have traits that make them attractive such as fast reaction rates 18, and 
controllable and continuous reaction to completion when in the presence of body fluids. 
The previously mentioned in-vivo animal data for bioactive borate glasses in bone repair 
indicated that immune response is likely to be minimal and bone bonded directly to the 
surface of the reacted borate glass particles 28•29•33 • The release of trace elements from a 
bioactive borate glass may further promote the formation of blood vessels in soft tissue 
and the calcium (a potential regulator in wound healing) might be beneficial to the 
treatment of wounds and stimulate the release of growth factors 62. 
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1.1 ABSTRACT 
After four weeks in rat subcutaneous tissue, scaffolds composed of randomly 
oriented, self-bonded bioactive glass fibers with an open and interconnected porosity of 
51 ± 2% were completely reacted to nanocrystalline carbonated hydroxyapatite (HA) and 
the interconnected pores had become significantly infiltrated with soft tissue.  The 
bioactive borate glass fibers reacted to form hollow HA channels that soft tissue and 
blood vessels infiltrated. Histological staining with both the PAS and VVG stains 
positively stained vessels from the 93B3 scaffolds. The PAS stain also positively stained 
macrophages which were sparsely present throughout the adjacent soft tissue; however, 
there was no negative immune reaction due to the presence of the reacted scaffold (HA).  
Fibers composed of bioactive borate glass could have future applications as blood vessel, 
bone, or other tissue guides, as porous scaffolds for hard and soft tissue regeneration, or 
for wound care of soft tissue.  
 
1.2    INTRODUCTION 
Boron is an element that most humans ingest on a daily basis from fruits, 
vegetables, and nuts 1-3.  Boron is a trace element required for cell wall formation in most 
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plants 1.  Ground water has a relatively low boron concentration as determined by a study 
done by the World Health Organization.  The boron concentration in water is typically 
between 0.1 and 0.3mg/L, but, this depends on the water source 1.  Ingestion of boron 
usually occurs as boric acid (BA), either from water or food sources. Meat and dairy 
products tend to be poor sources of boron 1.  Boron can be inhaled, but, this is not a 
significant source of intake, except for persons working in borosilicate glass production 
or other industrial environments where large amounts of airborne borate materials are 
produced 1-4.  Absorption of boron through the skin is also limited unless there is an open 
wound or severely abraded section of skin, then BA will enter the body 3,5.  
 Humans and animals metabolize boron, or boric acid, similarly 1.  Typically, 
greater than 90% of the ingested BA is excreted through urine, usually in ~96 hours after 
ingestion 1,3.  Boric acid distributes equally throughout most soft tissues, but, when boron 
was administered at a dose of 9000ppm BA to male Fisher rats, it was reported to 
accumulate up to approximately 20 times normal levels in bone 6.  
 Little is known about the interaction boron has in humans.  Few human studies 
about boron exist, but it is a known trace element that is present in human cadaver bones 
7-9.  Several investigators have suspected boron to be an essential trace element to bone 
functionality and/or metabolism, but, this has not yet been proven 10-14.  No data has been 
reported linking boron to cancer in humans 3, and no animal experiments have adequately 
addressed any potential link 3.  An estimated value of 0.2mg/kg-day of boron has been 
established from several animal studies as the maximum average lifetime ingestion, but, 
this number is not based on human data 3.  A study of airborne boron ingestion for 
humans working with borax (a mixture of three sodium tetraborate materials, Na2B4O7, 
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Na2B4O7-5H2O, and Na2B4O7-10H2O) found that the average boron consumption 27.90 
mg/day or 1.9mg/kg/day of BA, no progressive accumulation of boron was observed in 
the test subjects 4.   
Studies on the developmental toxicity of BA in mice (248 to 1003mg/kg/day), 
rabbits (62.5 to 250mg/kg/day), and rats (78 to 539mg/kg/day), found that there were 
measurable increases in the weight of the kidney and liver, and renal lesions were formed 
in mice 15.  These reported levels of BA were associated with lower fetal weights and 
higher fetal mortality in all species.  The occurrence of wavy ribs in rats was also 
observed, but this was attributed to significant decreases in fetal weight 15.  Animal 
models comparing ingested boric acid in rats versus control rats determined the 
benchmark dose level (BMDL) was 55mg/kg/day of BA.  This represents the amount of 
BA required to induce an adverse response as compared to the control animals 2.   
 Borate based bioactive glasses have been studied for several in-vivo applications 
including, bone replacement, a treatment for osteoarthritis, and drug delivery systems 16.  
Richard implanted particles of a borate glass in rat femurs and the glass converted to 
hydroxyapatite (HA) at a significantly higher rate than silicate glasses and bone grew and 
attached to the glass particles 17.  White 18 and Conzone 19,20 demonstrated the application 
of using radioactive borate glass microspheres for treating osteoarthritis and other in-vivo 
radiotherapies.  The radioactive borate glasses degraded without radiation leakage as the 
glasses converted to a chemically durable rare earth phosphate material that prevented the 
release of the radioisotope.  Han 21, Vanderspiegel 22, Huang 16, and Fears 23 investigated 
the use of hydroxyapatite shells converted from borate based glass microspheres to act as 
rate controlled drug delivery systems in the body.   
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 Jai et al. 24 used pellets composed of borate glass particles (<50µm) mixed with 
four and eight weight percent teicoplanin to treat osteomyelitis.  The pellets released 
approximately 80% of the teicoplanin within 15 days in-vitro, and the compressive 
strength decreased from 22 MPa to ~12 MPa after six days in phosphate buffered saline 
(PBS) solution.  The in-vivo results from New Zealand White rabbits were comparable to 
what was seen in-vitro, as the teicoplanin was released in a controlled manner and the 
implants had sufficient load bearing strength.  No toxic effects were seen in the bone 
adjacent to the borate glass as the glass converted to HA and supported the growth of new 
bone into the scaffolds. 
 Liu et al. 25 treated osteomyelitis in the tibia of New Zealand White rabbits with a 
scaffold consisting of borate glass particles and a polymer binder loaded with 
Vancomycin.  After eight weeks in-vivo, no observable tissue damage or inhibition of 
bone growth was detected at the implant sites.  Approximately 80% of the osteomyelitis 
infected tibia tested negative for the infection after eight weeks.  The outer perimeter of 
the scaffolds had visible vascular growth that was claimed to have participated in bone 
regeneration.    
 Bioactive silicate glasses, such as 45S5 (Table 1), have been modified with up to 
3wt% B2O3 with positive results in-vivo 26,27.  Particles of 45S5 with 2wt% added B2O3 
had increased the amount of bone present after 15 days post-implantation in the 
intramedullary canal of a rat tibia, and the Ca/P ratio of the bone surrounding the boron 
doped particles was significantly higher than the Ca/P ratio in the 45S5 glass particles 26.  
Direct bone bonding of the surface of the glass particles and rabbit bone was present, and 
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a well defined calcium phosphate layer was reported at the surface of the boron doped 
glass particles after eight weeks in-vivo 27. 
 Soft tissue from several mammalian species has been known to bond to 45S5 and 
similar silicate based bioactive glasses for decades 27.  The emphasis in the past has been 
primarily on bioactive glasses bonding to bone, so the soft tissue analysis was usually 
based on whether or not the tissue bonded with the glass, or if the tissue merely grew 
adjacent to the glass without forming a bond 27,28.   
More recently, researchers have looked into the possible angiogenic effects of 
bioactive glasses such as 45S5 coated with vascular endothelial growth factor (VEGF) for 
increasing the vascular network inside a scaffold 29.  Further study on 45S5 as a 
proagiogenic material has demonstrated that it is angiogenic in low concentrations and 
has been hypothesized to up regulate VEGF production from the soluble reaction 
products when co-cultured with human microvascular endothelial cells in-vitro 30.  These 
proangiogenic findings for silicate based bioactive glasses, such as 45S5, make them 
interesting materials for soft tissue engineering applications as they are relatively 
unexplored for soft tissue applications such as wound care. 
Borate based bioactive glasses have not been investigated for soft tissue use; but 
they have traits that make them attractive, such as higher reaction rates 31, and 
controllable and continuous reaction to completion when in the presence of body fluids.  
The previously mentioned in-vivo data for borate glasses in bone repair also indicate that 
immune response is likely to be minimal 24,25,32. 
 The borate glass studied by Richard known as 45S5B1 (Table 1) 17 successfully 
bonded to bone and reacted to form HA in-vivo.  Huang, used in-vitro weight loss 
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experiments to show that a 45S5B1 glass reacted significantly faster than the well known 
and widely studied silicate based 45S5 glass 33.  Jung et al analyzed the in-vitro weight 
loss data from Huang and found that the reaction kinetics of the 45S5B1 glass was 
approximately five times greater than that of the 45S5 31.  The 45S5B1 glass reacted in a 
controllable and continuous manner until the glass was completely reacted, while the 
45S5 silicate glass reached a point where the mechanism for HA conversion reaction 
changed and the reaction kinetics decreased significantly 31,33.  
Through preliminary experiments, the 45S5B1 glass crystallized easily upon 
heating and could not be heat treated to form a three dimensional porous scaffold without 
crystallizing. The 45S5B1 glass was therefore deemed unusable as a scaffold material 
and a new glass was needed that was more suitable for thermal processing.  
 Another bioactive glass known as 13-93 (Table 1) is a silicate based glass 
containing 53wt% SiO2 along with materials such as MgO and K2O that allow glass 
fibers to be pulled which can be heat treated to make three dimensional porous scaffolds 
without crystallization 34-36.  The 13-93 glass was modified similarly to the 45S5 glass by 
replacing all the SiO2 with B2O3 33,37.  This glass is hereafter referred to as 93B3 (Table 
1).  The 93B3 glass has reaction kinetics similar to the 45S5B1 glass 32, and, can be easily 
pulled into fibers and can be heat treated to form a three dimensional porous scaffold 32.   
 The purpose of the present work was to investigate 93B3 glass fiber scaffolds in a 
mammalian in-vivo environment to determine if these scaffolds would be useful in 




1.3.   MATERIALS AND METHODS 
1.3.1 Glass and Fiber Preparation 
 The bioactive 93B3 glass (Table 1) was melted at 1050oC in a furnace for one 
hour in a platinum crucible.  The glass batch was made using reagent grade chemicals of 
H3BO3, CaCO3, Na2CO3, MgCO3, NH4(H2PO4), and K2CO3.  Fibers in the range of 100 
to 300µm were hand pulled from the melt, collected, and broken into ~2 to 3mm lengths 
which were used to manufacture porous randomly oriented fiber scaffolds.    
1.3.2 Scaffold Preparation 
 Seventy milligrams of 93B3 glass fibers (weighed using a Sartorius model R200D 
(Sartorius Corporation, Edgewood, NY) balance accurate to ±0.1mg) were placed inside 
a cylindrical ceramic (mullite) mold.  The molds holding the randomly oriented glass 
fibers were placed into an oven preheated to 575oC, and heated for 45 minutes. After 
heating, the molds were removed from the oven and cooled to room temperature. The 
scaffolds, 7 ± 0.1 mm in diameter and 2 ± 0.2mm thick and were stored in a desiccator 
until used.  The scaffold shown in Fig 1 is representative of an as-made three dimensional 
scaffold composed of self-bonded, randomly oriented 93B3 fibers. 
1.3.3 Scaffold Porosity 
 The open, interconnected porosity of the scaffolds was measured using a liquid 
displacement technique.  The scaffolds were first weighed with a digital scale (Mettler 
Toledo XS105 ±0.00001g) to obtain a dry weight (M1), and then submerged in kerosene 
under vacuum for one hour to fill the open pores with kerosene.  The scaffold was 
weighed while suspended in kerosene (M2), and again while saturated with kerosene in 









MMPo  (1) 
The open porosity of the 93B3 scaffolds was measured prior to implantation into the rats, 
and the average open porosity calculated from 12 scaffolds by Eqn 1. was 51 ± 2%. 
1.3.4 Scaffold Sterilization and Implantation 
 Scaffolds of 93B3 were dry heat sterilized in a fused silica glass vial covered with 
aluminum foil by heating to 300oC in a small oven (Ney Vulcan 3-130) for four hours.  
Once cool, the scaffolds were ready for implantation. 
 Two rats were used for the in-vivo subcutaneous experiment were Fisher 344 rats 
(Fisher Scientific, St. Louis MO) between the age of 10 and 12 weeks.  The rats were 
anaesthetized with a mixture of isoflorine and oxygen and shaved to remove hair from the 
base of the neck to the base of the tail.  Loose hair was removed from the animal by 
washing first with iodine and then 70% ethanol prior to incisions.   
Figure 2 shows the location of the four implant sites, above each shoulder and 
above each hind leg, on the back of the rat.  A pocket ~15mm wide by 15mm long was 
made under the skin at each site for scaffold placement.  The image in Fig 3 shows a 
scaffold being inserted into subcutaneous tissue.  After implantation, the implant site was 
gently compressed to remove air, and the incision was sealed with super glue.  After all 
four scaffolds were implanted; the rat was marked by labeling the ear, injected with 0.2ml 
of penicillin, and placed on a heating pad and exposed to fresh air during recovery. 
1.3.5 X-Ray Diffraction 
 A 93B3 scaffold was x-rayed (Scintag XDS 2000 using Cu Kα radiation with a 
step scan mode with a 0.05o step) after four weeks in-vivo over the range of 10 to 70 
degrees 2θ to determine what crystalline phase(s), if any, were present.     
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1.3.6  Micro Raman  
 Micro Raman (LabRAM ARAMIS, Horiba Jobin Yvon) was used to analyze the 
reacted 93B3 fibers from scaffolds implanted for four weeks in rat subcutaneous tissue.  
A 50x objective was used to view the fibers, and the spectra were collected using a diode 
laser (785nm) with a collection time of five seconds.  LABSpec5 software was used to 
capture the image and analyze the peak positions.   
1.3.7 Scanning Electron Microscopy 
 An environmental scanning electron microscope ESEM (ESEM FEG XL30 from 
FEI, Hillsboro, OR (Formerly Philips)) was used to image the cross section of a 93B3 
scaffold implanted four weeks.  The scaffold was sectioned with a razor blade to expose 
the tissue and fibers located inside the scaffold.  The scaffold section was coated with 
approximately 100nm of Au/Pd to minimize charging effects.    
1.3.8 Scaffold Recovery, Fixation, and Dehydration 
 After four weeks, the scaffolds were excised for histological and SEM analysis.  
The animals were sacrificed in a sealed container filled with CO2.  The scaffolds were 
removed from the subcutaneous tissue and fixed in 5mL of 10% formalin solution (10:1 
formalin to scaffold volume ratio) for four days.  The scaffolds were then dehydrated 
with a series of ethanol solutions from 70% to 100% in a microwave tissue processor 
(EBSciences H2850 Microwave Processor).  The microwave was set to 70% power, the 
sample temperature was set to 37oC, and the microwave was operated for 2.5 minutes for 
each solution.  The scaffolds were in each solution for a minimum of 15 minutes 
(including time in the microwave).  
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1.3.9 Sample Preparation and Staining (Histology) 
 Dehydrated scaffolds were placed in a tissue processor (AutoTechnicon Model 
2A) filled with fluid paraffin mounting wax (Paraplast Tissue Embedding Medium, 
McCormick Scientific LLC) at 45oC for four hours to allow the wax to infiltrate the 
scaffold and tissue.  The scaffold was then mounted in a wax block for histological 
sectioning with a paraffin mounting system (Leica EG 1150H).  Sections, 18µm thick, 
were cut with a microtome (Leica RM 2235 microtome) with TBS Shur/sharp blades, 
(Triangle Biomedical Sciences, Durham NC) and floated on a water bath (Lipshaw 
Electric Tissue Float, model number 375, Detroit MI) (40oC) prior to mounting on a glass 
slide (Fisher Brand Superfrost microscope slides, St. Louis MO).  Three to four tissue 
sections were placed on a single slide, and dried overnight on a slide dryer (Fisher 
Scientific slide warmer, St. Louis MO).  The slides were stained with hematoxylin and 
eosin (H&E), periodic acid schiff (PAS), and Verhoeff’s Van Gieson (VVG) to identify 
soft tissues and verify the presence of blood vessels.  Stained slides were viewed with an 
optical microscope (Olympus BX50, Olympus Optical Co) at magnifications of 40, 200, 
and 400X.  Imaging software (DP Controller, Olympus Optical Co) was used to capture 
images. 
1.3.9.1 Hematoxylin and Eosin (H&E) Staining Protocol 
 H&E staining was completed in a Leica CV 5030 Autostainer XL.  The slides 
were immersed in 95% xylene, 5% ethanol for two minutes (two stations) and 100% 
xylene for two minutes (two stations) to remove the wax.  Each slide was dipped 15 times 
in distilled water, and immersed in hematoxylin stain for three minutes.  The slides were 
washed in a series of four distilled water stations, one minute each, followed by 15 dips 
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in acid alcohol and immersion in eosin stain for one minute.  The slides were then 
dewatered with a series of ethanol solutions, 80% for 30 seconds, 95% for one minute 
(two stations), and 100% ethanol for one minute (three stations).  The slides were 
immersed in xylene for one minute (three stations) prior to mounting with a coverslip. 
1.3.9.2 Periodic Acid Schiff (PAS) Staining Protocol 
 Prior to staining, slides were deparaffinized in xylene and hydrated in distilled 
water.  Sections were placed in 0.5% periodic acid solution for five minutes at room 
temperature and then washed with a series of three washes in distilled water.  Sections 
were then placed in the Schiff reagent for 15 minutes followed by two washes in 0.55% 
potassium metabisulfite to remove excess stain.  Sections were rinsed in tap water for 10 
minutes to develop color prior to a 30 second counter stain with 1% light green.  Sections 
were washed with tap water and then dehydrated in a 95% ethanol solution.  Xylene was 
used to remove all the alcohol prior to mounting with a synthetic resin.  After staining, 
blood vessels should be light blue, and red blood cells green. 
1.3.9.3 Verhoeff’s Van Gieson (VVG) Staining Protocol 
 Slides were deparaffinized in xylene and hydrated in distilled water.  Slides were 
immersed in Verhoeff’s stain for 20 seconds and then washed in a series of distilled water 
baths for one minute (three stations).  Sections were placed in 2% ferric chloride until 
elastic fibers were distinct and the background was colorless to light gray under 
microscopic view.  The sections were then rinsed in distilled water before immersion in 
sodium thiosulfate for one minute.  Sections were washed in tap water for five minutes 
prior to counterstaining in Van Gieson stain for one minute.  Sections were then 
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dehydrated in a series of ethanol solutions, cleared with xylene, and mounted with a 
coverslip.  
1.4.  RESULTS 
1.4.1  93B3 Scaffold Removal  
 Figure 4 shows a 93B3 scaffold after four weeks in-vivo before being removed 
from the subcutaneous tissue.  The area labeled SM is the skeletal muscle and the area 
labeled ST is the subcutaneous tissue.  Soft tissue had grown into the scaffold with 
vessels (black arrows) visibly penetrating the outer perimeter.  The originally transparent 
(colorless) 93B3 fibers became white and the scaffold was soft to the touch, which 
indicates that the fibers had reacted with body fluids to form amorphous calcium 
phosphate (ACP) or possibly a crystalline calcium phosphate such as HA. 
1.4.2 Backscattered SEM of a Sectioned 93B3 Scaffold After Four Weeks In-Vivo 
 The SEMBSE image in Fig 5 shows the cross section of a 93B3 scaffold after 
four weeks in-vivo.  The soft tissue is black, and the reacted fibers are a light gray.  
Several of the fibers were broken while cutting; but, many of the fibers that did not break 
are hollow as shown in Fig 5.   
A fiber from the 93B3 scaffold which had fully reacted is shown in Fig 6.  The 
image in Fig 6A shows the end of a reacted fiber, as the fiber is cut perpendicular to its 
longitudinal fiber axis.  The center of the fiber has a relatively rough surface and does not 
contain any original glass.  Figure 6B shows a higher magnification of the hollow core of 
the fiber where several nodules of calcium phosphate are present.  The nodules are 
magnified in Fig 6C, and are made of a porous network of nanocrystals.  Figure 6D is a 
magnified image of the nanocrystals in Fig 6C, and the needle-like structure is similar to 
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that of HA.  The crystals are approximately 50nm in length, and the overall structure is 
highly porous.     
1.4.3 X-Ray Diffraction of a 93B3 Scaffold after Four Weeks In-Vivo 
 The XRD pattern shown in Fig 7 is from a reacted 93B3 fiber scaffold after four 
weeks in-vivo.  The peaks present match those for HA (Ca10(PO4)6(OH)2) PDF card #72-
1243, a mineral similar to that found in the inorganic component of bone.  The broad 
peaks in the XRD pattern are due to the nano-sized crystals of hydroxyapatite, see Fig 
6D. 
1.4.4  Micro Raman of a Reacted 93B3 Fiber after Four Weeks In-vivo 
 A reacted 93B3 fiber analyzed by micro raman and the four spots analyzed across 
the fiber diameter are shown in Fig 8.  A white dashed line has been added to show the 
fiber perimeter more easily. The raman spectra are shown in Fig 9, position one is at the 
outer edge of the fiber and position four at the center of the reacted fiber.  The three 
peaks associated with HA (431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 
(CO32- v1) and 1076cm-1 PO43- v3) 38 are denoted by dashed lines.  The solid lines are due 
the mounting medium (PMMA) as indicated by the spectra at the top of Fig 9.   
 Positions three and four located toward the center of the fiber in Fig 8 have the 
highest intensities for the phosphate and carbonate peaks indicating a difference in the 
amount of each species distributed throughout the fiber.  The presence of a carbonate 
peak at 1065 to 1070cm-1 (CO32- v1) indicates that the fibers are carbonated, similar to 
natural bone.  The difference in the amount of phosphate and carbonate measured could 
be due to differences in the density of the reacted fiber. 
1.4.5 Histological and Vascular Assessment of Soft Tissue 
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 A cross sectioned 93B3 glass scaffold prior to implantation into soft tissue would 
look similar to that shown in Fig 10.  The fibers (dark gray) are randomly oriented, so the 
shape of the fibers (circular to elliptical), is dependant on the fiber orientation.  Several 
fibers are indicated with arrows, and the open space (porosity) in between the fibers 
(lighter color) is filled with a transparent epoxy.  The porosity in the scaffold is mostly 
interconnected and there are few, if any, closed pores.   
1.4.6  Hematoxylin and Eosin Stain (H&E) 
 The images of the 93B3 scaffold (four weeks in-vivo) stained with H&E in Fig 
11, look significantly different from that in Fig 10.  Soft tissue (purple) that has filled 
essentially all of the interconnected pores between the fibers, and the fibers (originally 
solid) have reacted with the body fluids and become hollow.  The tissue throughout the 
scaffold is healthy with no sign of any significant immune reaction or foreign body 
reaction like a walling off of the entire scaffold or the individual fibers.   
 Figure 12A shows that blood vessels are present in both the soft tissue between 
the fibers and in the soft tissue that had grown into what were the hollow cores of the 
reacted fibers.  The scaffold section in Fig 12A had fibers (F) that reacted and became 
hollow that subcutaneous tissue had grown inside.  There is an ordered line of red blood 
cells at the center of the image in Fig 12A indicating a small blood vessel ~10µm in 
diameter (white arrows).  The image in Fig 12B shows a larger blood vessel in the center 
of the image with significantly more red blood cells than in Fig 12A.  The vessel lining is 
denoted by the white arrows, is approximately 30 to 40µm in diameter and contains 
numerous red blood cells. 
 29 
 Figures 13A and 13B are images of H&E stained sections of a 93B3 scaffold that 
had been implanted in the rat for four weeks.  The two parallel purple regions marked (F) 
that run from the top left to bottom right of the image in Fig 13A are the outer edges of a 
reacted fiber, cut parallel to its longitudinal axis, to reveal a hollow core containing soft 
tissue (purple) and red blood cells (red dots) as indicated by the white arrow.  Another 
fiber shown at the center of Fig 13B, which was cut perpendicular to its longitudinal axis, 
contains both soft tissue and red blood cells (vertical arrows) in what appears to be a 
blood vessel.    
1.4.7  Verhoeff’s Van Gieson Stain (VVG) 
 The images in Fig 14A and 14B are from a sectioned 93B3 scaffold, implanted in 
rat subcutaneous tissue for four weeks, which was stained with VVG (Verhoeff’s Van 
Gieson) that stains specifically for elastic tissue, veins, arteries, and other vessels.  The 
cell nuclei and blood vessel lining (elastin) stains black, collagen or other connective 
tissue is pink, and red blood cells are yellow.   
The image in Fig 14A shows several reacted fibers (F) along with a circular 
shaped vessel in the center of the image (black arrow) and a black rim (elastin) filled with 
red blood cells (yellow dots).  The image in Fig 14B, stained positive for a vessel, white 
arrow at center, in the hollow void of a reacted fiber (F), and there is connective tissue 
(pink) surrounding a black elastin ring (vessel wall) which contains red blood cells 
(yellow dots).  A second vessel at the bottom center of Fig 14B, between two fibers, is 
shown by the black arrow.  As is apparent from Figs. 14A and 14B, the dark color of the 
nuclei can make it difficult to determine whether or not there was a positive stain for 
elastic lining.   
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1.4.8  Periodic Acid Schiff Stain (PAS) 
 The images in Fig 15A and 15B are images of sections from a 93B3 scaffold 
implanted four weeks in a rat that were stained with Periodic Acid Schiff (PAS).  The 
PAS stain bonds to glucose residue in tissue.  Glucose is present in muscle, liver, and red 
blood cells, but vessel lining is also stained due to the diffusion of glucose from the red 
blood cells to the surrounding tissue. Connective tissue is light green, red blood cells are 
bright green, vessel lining is blue, macrophages are yellow or brown, and HA stains 
purple.   
The vessels in Fig 15A are marked by arrows.  Several of the vessels contain the 
bright green labeled red blood cells.  There are also macrophages distributed throughout 
the section, as denoted by the black circles in the tissue surrounding the reacted fibers.  
Figure 15B shows a reacted fiber, cross sectioned perpendicular to its longitudinal axis, 
in the center of the image (dashed circle).  There is a vessel (blue circle) with red blood 
cells (bright green) present in the hollow fiber (F) void as indicated by the black arrow.   
1.5  DISCUSSION AND CONCLUSIONS 
 Upon removal of the 93B3 implanted scaffolds, soft tissue had penetrated deep 
into the scaffolds, and several blood vessels had grown adjacent to the scaffold surface as 
shown in Fig 13.  There was no visible inflammation or infection surrounding the 
scaffolds and there was no sign of fibrous tissue that is typically present surrounding an 
object which the body considers a foreign body.  This was an important indication that 
the scaffold was not being rejected by the animal.  The lack of inflammation surrounding 
the scaffold upon excision agrees with work done by Richard using 45S5B1 glass 
particles in contact with bone 17.  
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 The 93B3 scaffolds were no longer rigid when removed from the animals, as 
much of the original mechanical strength was lost when the glass converted to the porous 
HA.  The soft tissue that had bonded to the fibers as it grew into the scaffold was holding 
the reacted fibers together.  While a decrease in strength is not necessarily a desirable 
quality for bony defects, especially load bearing defects, the softening of the material 
may be an advantage for the treatment of soft tissue such as muscle and skin.   
The XRD patterns from the 93B3 scaffolds implanted for four weeks matched 
HA, PDF card # 72-1243.  The peaks are relatively broad due to the nano-sized crystals 
of HA shown in Fig 6D.  The needle-like nanocrystals of HA that formed in-vivo from 
the 93B3 glass look similar to those from a silicate glass soaked in simulated body fluid 
(SBF) for 30 days indicating that the borate glass reacts in a similar manner as the well 
known and commercially used bioactive glasses 27.  The HA is carbonated similar to 
natural bone as shown by the micro raman in Fig 9. 
The PAS stained sections in Figs 15A and 15B clearly show that blood vessels 
were present in both the open pores of the scaffold and inside the hollow core of reacted 
fibers.  Macrophages were also identified, but, they were in the soft tissue and not 
specifically surrounding any of the HA from the reacted glass.  The presence of 
macrophages in regenerating tissue is normal as they release growth factors required for 
tissue growth. 
The histological staining proved that soft tissue had significantly penetrated the 
93B3 scaffold in four weeks and had filled not only the open pores of the scaffold, but 
also the relatively large voids (50 to 150µm diameter) formed in the hollow fibers.  The 
relatively low chemical durability of the 93B3 glass releases calcium when in contact 
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with body fluids and reacts with phosphate present in the body fluids to form 
hydroxyapatite on the surface of the glass fiber.  This reaction continues until the glass 
fiber has fully degraded and released all of the calcium.  The amount of calcium in the 
glass determines the HA wall thickness that is formed when reacted with body fluids. 
The reacted fibers shown in Fig 5 and Fig 11 show that almost all of the fibers 
have become hollow, and most had soft tissue that had filled the hollow cavity.  How the 
soft tissue got inside the cavity is not well understood, but the tissue may have gained 
access when the 93B3 fibers formed HA, lost mechanical strength, and fractured from the 
regular movement and activities of the animal.  Regardless of how the tissue entered the 
hollow fiber cavities, both soft tissue and blood vessels were present.  The fact that blood 
vessels entered the hollow fibers and grew in the direction of the hollow cavity indicated 
that these hollow fibers may have use as vascular or other tissue guides.  Vessels were 
present in several of the hollow fibers and stained with either VVG or PAS for 
verification as shown in Figs 14, and 15.  
One example of a vessel growing a significant distance (several hundred microns) 
along the hollow core of a fiber is shown in Fig 16A and 16B.  The hollow fiber (F) of 
interest is the in the center of Fig 16A and has parallel dashed lines on either side of the 
vessel.  Many of the HA fibers were debonded from the slide during the staining process 
and appear as white ellipses or circles depending upon the fiber orientation, but, the soft 
tissue was well adhered to the glass slide.  Figure 16B is a magnified view of the reacted 
fiber in Fig 16A.  The black horizontal arrows point to the blue vessel lining travelling 
from one end of the fiber to the other.  The vessel has a diameter of about 20 to 30µm and 
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is approximately 700 to 800µm in length inside the hollow fiber.  The exact length of the 
vessel could not be determined due to the orientation of the fiber when it was cut. 
Boron, although not entirely understood, is hypothesized to play an important role 
in several developmental and biological functions.  If boron is removed from the diet of a 
developing animal such as a rat, there is a significant decrease in the animal’s size and 
the bones are not well developed 14.  Boron is in the diet of humans as it is found in most 
vegetables and nuts 1-3.  At low levels (1 to 20 mM BA) boron has been found to have a 
positive effect on mRNA uptake of human placental cells in-vitro, which means that the 
BA has a stimulatory effect on cell activity similar to a growth factor 39.  
Assuming the 93B3 glass fibers reacted (lost weight) similarly to the way other 
borate glasses have been shown to do in-vitro 33, and the fibers were fully reacted in four 
weeks, it is possible to estimate the BA concentration in the adjacent tissue (tissue inside 
scaffold).  In estimating the BA concentration, blood flow rates were used which were 
measurements of blood flow through rat adipose tissue 40.  The weight of the rats used in 
the present work was ~300g each.   
The following is a description and background information required for making 
the BA concentration calculations.  The 93B3 as-made scaffolds each weighed ~70mg 
prior to implantation.  From Table 1, each scaffold was 53wt% B2O3 which means that a 
93B3 scaffold contained 0.037 grams B2O3 or 0.066g BA (H3BO3), or 1.07E-3 moles of 
BA as that is the form boron takes in an aqueous environment such as body.  Assuming it 
took four weeks, or 28 days, for the fibers to completely react and the fibers lost weight 
(reacted) linearly over the time period, the BA release was 3.82E-5 moles per day.  
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The Benchmark Dose Limit (BMDL) for boric acid as determined from a series of 
animal experiments is 55mg/kg/day 2.  A single 93B3 scaffold contained enough boron to 
produce 66mg of BA when fully reacted, which divided equally over 28 days is 
2.36mg/day of BA.  When the weight of a rat (300g) is taken into account, the release of 
H3BO3 from a scaffold is 7.87mg/kg/day.  This simple calculation indicates that the 
concentration of BA in a single 300g rat should have been well below the BMDL.  A 
300g rat should be able to tolerate over seven times the mass of a single 93B3 scaffold 
(~500mg of glass) before any observable effect might be seen.  
The concentration of BA in the vicinity of the infiltrated soft tissue was estimated 
to determine the concentration of BA present.  The tissue inside the scaffold was 
estimated to be ~50mg just after the scaffold was removed by assuming complete 
reaction of the glass to HA (weight loss) and the weight of the scaffold and infiltrated 
tissue after removal from the subcutaneous tissue.  The fluid flow through the scaffold 
was assumed to be due to blood flow, so the highest average (0.4ml/min/gram of tissue) 
and lowest (0.1ml/min/gram of tissue) flow rates from published data for rat adipose 
tissue were used in determining the concentration range of BA in the tissue 40.  The 
highest flow rate was measured while the rats were active and feeding, while the lowest 
was when the animals were sleeping. 
Assuming the minimum flow rate for a 24 hour period, the amount of blood that 
would pass through the tissue in the scaffold was calculated to be 7.2ml.  This number 
was calculated from Eqn 2.   
 Vol. of blood = Blood flow rate*Mass of tissue*Time (2) 
The calculation for the minimum flow rate is shown below: 
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 (1440min/day)(0.1ml/min*g)(1 day) (0.05g) = 7.2ml or 0.0072L 
Taking the value calculated for the amount of BA released per day from a scaffold 
(3.82E-5 moles/day) and dividing it by 0.0072L, the average concentration for an entire 
day is 5.29mM BA. 
A similar calculation was made for the highest flow rate.  Assuming the highest 
blood flow rate for a 24 hour period, the amount of blood that would pass through the soft 
tissue was 28.8ml.  The four times greater volume of blood lead to a BA concentration 
that decreased by four times to the estimated concentration of 1.32mM BA.   
The two concentrations calculated represent the highest and lowest BA 
concentration would reach, with the actual value fluctuating depending on the activity of 
the rats.  The two calculated values have been compared to the in-vitro mRNA uptake 
data from human placental cells cultured with low levels of BA as shown in Fig 17.  The 
total mRNA (nmol) uptake is plotted vs. concentration of BA in the culture media (mM), 
and the two calculated values from the present work are denoted by vertical red lines.  
The two concentrations fall in the stimulatory range (2 to 3X increase) BA had on the 
mRNA uptake of human placental cells.  This could be an indicator that the BA released 
from the scaffolds may be having a positive effect on the nearby tissue.  The increase in 
the mRNA with the human placental cells was described as similar to the effect of a 
growth factor would have on the cells, so the presence of BA in the tissue adjacent the 
scaffold could have enhanced growth characteristics.   
Based on these simple calculations and information from the literature, it is likely 
that boron released from a scaffold could be expected to have a positive impact on the 
surrounding tissue.  The hypothesis of a positive interaction between the boron released 
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from the 93B3 scaffolds and the soft tissue is confirmed by the histology in Figs 11 to 16.  
Soft tissue had filled the open pores of the 93B3 scaffolds, tissue had bonded with the 
reacted fibers, and blood vessels were growing not only in the open pores, but also inside 
the hollow cores of many of the reacted fibers.   
In conclusion, scaffolds composed of randomly oriented, bioactive 93B3 fibers 
reacted with the body fluids in rat subcutaneous tissue to form a nanocrystalline 
carbonated HA.  The interconnected and open pores in the scaffolds nearly filled with 
soft tissue after four weeks in-vivo.  The initially solid glass fibers reacted in such a way 
that they became hollow.  Soft tissue as well as blood vessels infiltrated the hollow core 
of the reacted fibers and the blood vessels tended to be oriented along the fiber axis.  
Scaffolds composed of bioactive borate glass fibers could have uses for future 
applications as tissue guides for blood vessels, bone, or other tissues.  
Comparing published in-vitro data for the effect of BA on human placental cells 
with calculations from the present work on the estimated concentrations of BA in nearby 
tissue, the BA released from the 93B3 scaffolds falls in the range that was found to 
stimulate mRNA uptake in human placental cells.  The calculated concentration of boron 
released from the 93B3 scaffolds is low compared to most published work studying the 
effects of BA concentration on biological interaction. The effects of BA concentrations in 
the range of those calculated (1 to 6mM) are still relatively unstudied, but could prove 
stimulatory and essential for biological functions. 
Both the PAS and VVG stains positively stained vessels from the 93B3 scaffolds. 
The PAS stain appeared to be more useful as the colors of the vessel and the connective 
tissue were sufficiently different for vessel verification; but the color scheme of the PAS 
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was easier to interpret than the VVG.  The PAS stain also positively stained macrophages 
which is important to make sure the foreign material is not causing an immune reaction.    
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Table 1 -Nominal Bioactive Glass Compositions (wt0/o) 
Glass 8 i0 2 8203 Na20 CaO MgO K20 P205 
4585 45 0 24.5 24.5 0 0 6 
458581 0 45 24.5 24.5 0 0 6 
13-93 53 0 6 20 5 12 4 




Figure 1 – Optical micrograph of an as-made 93B3 scaffold after heating for 45 minutes 
at 575oC.  The scaffold has a nominal diameter and thickness of 7 ± 0.1mm and 2 ± 





Figure 2 – Schematic showing scaffold implantation sites on the back of a rat.  
Implantation sites were approximately 15mm wide by 15mm long.  The red line indicates 







Figure 3 – Image showing the implantation of a 93B3 scaffold in the subcutaneous tissue.  
The hair was removed, and the skin has been cleaned and disinfected.  The orange color 





Figure 4 – Optical image of a 93B3 scaffold prior to removal from rat subcutaneous 
tissue.  The skeletal muscle (SM) and subcutaneous tissue (ST) are labeled as well as 
vessels (black arrows) growing in the adjacent tissue.  The scaffold was soft to the touch 




Figure 5 – SEMBSE micrograph of a cross section of a 93B3 scaffold after four weeks in 
the subcutaneous site in a rat.  Soft tissue (dark gray) surrounds the reacted fibers (light 




Figure 6 – A series of higher magnification SEM micrographs of reacted 93B3 fibers 
after four weeks in the subcutaneous site in a rat.  Figure 6A shows the cross section of a 
reacted fiber having a hollow inner core.  Figure 6B is a magnified view of the hollow 
core of the reacted 93B3 fiber in Fig 6A.  Figure 6C is a magnified view of the nodules.  






Figure 7 – XRD pattern for a 93B3 scaffold after four weeks in-vivo.  The pattern 
matches hydroxyapatite, PDF card# 72-1243 (vertical lines).  The peaks are relatively 


























Figure 8 – Optical image of a 93B3 fiber reacted in rat subcutaneous tissue for four 
weeks, mounted in PMMA, and cross sectioned.  The outer perimeter of the fiber is 
denoted by a dashed line, and the center and outer edge are labeled as indicated.  The four 







Figure 9 – Micro raman spectra for a 93B3 fiber that was implanted in rat subcutaneous 
tissue for four weeks.  The peaks associated with HA are indicated by the dashed lines at 
(431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 1076cm-1 
PO43- v3) and the solid lines are for the mounting medium PMMA.  At the top of Fig 9, 
the spectrum for PMMA mounting medium is shown.  The spectrum for the outer edge of 




Figure 10 – Optical micrograph of the cross-section of an as-made 93B3 scaffold. The 
darker gray circular or ellipsoidal shapes are self-bonded, solid and unreacted, glass 






Figure 11 – Optical micrograph of an H&E stained section of a 93B3 scaffold that was 
implanted in rat subcutaneous tissue for four weeks.  The 93B3 fibers have reacted with 
the rat body fluids and become hollow.  Soft tissue (purple) has infiltrated nearly all of 
the open porosity within the scaffold, and several of the hollow fibers have soft tissue in 











Figure 12 – Optical micrographs of H&E stained sections from a 93B3 scaffold 
implanted in the subcutaneous site in a rat for four weeks.  Cell nuclei are blue, 
cytoplasm connective tissue and extra cellular matrix (ECM) are purple or red and red 
blood cells (RBC) are bright red.  Figure 12A shows a section with multiple hollow fibers 
(F), some of which contain soft tissue (purple).  There is also an organized line of red 
blood cells as pointed out by the arrows indicating a small blood vessel.  Figure 12B 
shows a section with a larger vessel in the center of the image as indicated by the white 
arrows.  There is a large amount of red blood cells (pink dots) in the vessel.  The fibers 





Figure 13 – Optical micrographs of H&E stained sections from a 93B3 scaffold 
implanted in a subcutaneous tissue for four weeks.  Cell nuclei are blue, cytoplasm 
connective tissue and extra cellular matrix (ECM) are purple or red and red blood cells 
(RBC) are bright red.  Figure 13A shows a reacted 93B3 fiber which has been cut parallel 
to the longitudinal fiber direction, and the sides of the fiber have been labeled with (F).  
There is soft tissue (purple) and red blood cells (white arrow) inside the hollow cavity of 
the fiber.  Figure 13B has a fiber that has been cut perpendicular to the longitudinal fiber 
direction, and inside the fiber is soft tissue and red blood cells (arrows) indicating blood 




Figure 14 – Optical micrographs of VVG stained sections from a 93B3 scaffold 
implanted in a subcutaneous site for four weeks.  Cell nuclei are brown to black, 
connective tissue is pink to red, and red blood cells (RBC) are yellow, and elastin is 
black.  Several fibers, denoted by (F), are shown in Fig 14A; but much of the HA 
debonded during staining.  There is a vessel in the center of the image (black arrow) as 
the elastin in the vessel is black, and there are several red blood cells in the center of the 
vessel (yellow).  Figure 14B shows a hollow fiber (F) at the center of the image with a 
vessel in its hollow core (white arrow).  There is a second vessel below, indicated by a 




Figure 15 – Optical micrographs of PAS stained sections from a 93B3 scaffold implanted 
in a subcutaneous tissue for four weeks.  Connective tissue is light green, and red blood 
cells (RBC) are bright green, vessel lining is blue, hydroxyapatite is purple, and 
macrophages are brown.  Figure 15A has stained positive for several blood vessels 
(arrows) as the blue rings are surrounding bright green RBC.  There are several 
macrophages throughout the tissue, circled; however they are not congregating around 
the scaffold material (F).  Figure 15B has a hollow fiber (F) in the center of the image 
(dashed circle) with a vessel inside the void (arrow).   
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Figure 16 – Optical micrographs of PAS stained sections from a 93B3 scaffold implanted 
in a subcutaneous tissue for four weeks.  Connective tissue is light green, and red blood 
cells (RBC) are bright green, vessel lining is blue, hydroxyapatite is purple, and 
macrophages are brown.  Figure 16A shows has several fibers denoted by (F), however 
much of the HA washed off during staining.  The hollow fiber in the center of the image 
has a vessel that grew 700 to 800µm down the hollow void of the reacted 93B3 fiber.  
Figure 16B shows a magnified view of the vessel, and the lining has been indicated by a 
series of arrows.  The vessel has a significant number of red blood cells (RBC) present 




Figure 17 - Effect of mRNA uptake compared to boric acid concentration for human 
placental cells compared to the estimated boric acid concentrations from a reacting 93B3 
scaffold in a sleeping (0.1ml/min*g) and active rats (0.4ml/min*g).  According to the 
estimated boric acid concentrations from the scaffolds, and the effect seen from in-vitro 
cell culture experiments 39, there could be a stimulatory growth effect similar to a growth 
factor from the reacting 93B3 scaffolds. 
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2.1 ABSTRACT 
 The potential toxicity of a bioactive borate glass was evaluated using in-vivo 
animal models in soft tissue and bone and from in-vitro cell culture experiments using 
MLOA5 late osteoblast/early osteocytes cells.  No toxicity was found between bioactive 
borate glass and subcutaneous tissue, in the liver, and nothing beyond normal incidental 
changes in rat kidney.  Bone growth across porous scaffolds composed randomly oriented 
borate glass fibers was significantly higher than for a scaffold composed of a borosilicate 
glass or a silicate bioactive glass (13-93) fibers after 12 weeks in-vivo, p<0.05.  In-vitro 
cell culture testing of bioactive glasses showed that under static culture conditions, borate 
glass disks tended to inhibit the growth of MLOA5 late osteoblast/early osteocyte cells, 
but when the disks were pre-reacted (in culture medium or a dilute phosphate solution) 
the cell proliferation is significantly increased to levels similar to 45S5 bioactive glass.  
The present work, along with data from the literature, show that bioactive borate glasses 
are biocompatible in-vivo and are not toxic to adjacent hard or soft tissues, or internal 
systemic organs such as the kidney and liver, were unaffected at the relatively high, 
estimated concentrations tested (<~126mg/kg/day).  Based on the present results and 
 59 
literature data, boron released from the borate glasses in the form of boric acid was not 
toxic in a dynamic environment such as the body and should be considered for use in 
humans and other mammals for soft and hard tissue engineering applications.         
 
2.2 INTRODUCTION  
Silicate based bioactive glasses such as 45S5 (Table 1) have been known to bond 
to bone and soft tissue for almost 40 years [1].  Bioactive silicate glasses are useful 
materials for tissue engineering due to their high degree of biocompatibility in the body.  
The rate at which silicate bioactive glasses convert to hydroxyapatite (HA) is relatively 
slow, on the order of months to years depending upon the size of the bioactive glass 
particle and its composition [2].  Due to this slow reaction rate, bioactive glasses 
containing boron have been developed which react significantly faster with body fluids 
than silicate glasses [3].   
The effect of boron on cells and animals has been studied in-vitro and in-vivo to 
determine its physiological role [4].  Boron has not been linked to any specific biological 
function, but there is evidence that the absence of boron changes growth patterns in 
animals and stimulates cell growth in-vitro [4, 5].  Determining the effect that a bioactive 
borate glass has on cells and living tissue is a controversial issue due to the difference in 
the experimental parameters.  Typically, in-vitro cell cultures are static systems in which 
cells are seeded, covered with culture medium, and depending on the experiment, not 
disturbed for several days.  The human body is a dynamic system where heavily buffered 
fluids, relatively constant pH, are constantly moving and being replenished.    
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Using a static culture environment to determine in-vivo biocompatibility for a 
non-reactive material is trivial.  As long as the material is un-reactive, the pH remains 
relatively constant, and nothing changed in the system by the material, so the material 
does not directly affect cell attachment and growth.  When the material of interest is 
reactive, differences between the static culture environment and in-vivo (dynamic) 
become apparent.  With a reactive material, the solution pH, the composition of the 
media, and the material being studied may all be changing, and, thereby affect cell 
attachment and growth.  In a static environment, especially in regions adjacent to the 
reactive material, there are no means of equilibration.  Therefore, comparisons between 
the static culture and in-vivo environments may not be representative.     
The schematic in Fig 1 shows the conditions that have been used to evaluate 
potential toxicity of a borate glass in-vitro and in-vivo.  The in-vitro method has been 
used mostly with static culture, but dynamic culture (continual or repetitious agitation) 
has yielded some interesting improvements in cell proliferation [6].  Marion et al found 
that pre-reaction of a bioactive borate glass also increased the in-vitro culture of cells [7].   
In-vivo studies of the biocompatibility of borate based bioactive glasses are 
limited, but animal studies where the potential toxicity of boric acid (BA) has been 
studied are also relevant.  Soft and hard tissues and internal organs of mice, rats, and 
rabbits dosed with BA have been studied and the maximum limits to avoid toxicity in 
adult and fetal animals have been determined [8].  It should be noted that there is a 
relatively wide range of minimum toxicity limits between different animal species, so for 
simplification, hereafter, the lowest toxicity level of a given group will be the assumed 
toxic level for the entire group. 
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The BA levels acceptable for ingestion by animals or added to cell culture are 
shown in Fig 2 and the data and sources are listed in Table 2 [5, 6, 8-12].  The data in Fig 
2 is labeled as non-toxic (green), if inhibition or toxicity is reported in animals (fade from 
green to red), and red where extreme inhibition or cell death occurred.  The static culture 
of the cells had the lowest level of BA toxicity at 62mg/kg/day, or 1mM [6].  The 
conversion from 1mM to mg/kg was made using 62g/mole for boric acid (H3BO3), and 
dividing by 1000 to get 62mg/mM.  An aqueous solution of boric acid is mostly water, 
and one liter of water weighs 1kg, therefore, a 1mM solution of boric acid is equivalent to 
62mg/kg.  
One reason why static cell culture on reactive materials, such as bioactive borate 
glasses, may not be the best method of determining in-vivo performance is illustrated by 
the schematic in Fig 3.  Three different conditions are simulated, in-vitro static, in-vitro 
dynamic or pre-reacted, and in-vivo dynamic.  The in-vitro dynamic or pre-reacted 
conditions were grouped together because the toxicity gradients from each are thought to 
be similar (i.e. a smaller potentially toxic region).  As indicated by the dashed circle and 
the color gradient, the area of cell inhibition in a static culture is in the liquid immediately 
surrounding the material, for this example a glass disk (G).  The majority of the culture 
medium could be only minimally affected by the reaction of the glass with the culture 
media.   
In the dynamic in-vitro condition, the material dissolving from the glass becomes 
diluted and is ideally distributed throughout the culture medium.  This solution reduced 
the potential toxicity of the reactive material and its effect on proliferation.  The final 
condition, in-vivo dynamic, shows a minimal gradient as the leached ions are transported 
 62 
from the glass surface by the fluids in the adjacent tissue and the blood flow.  The BA is 
removed from the body and high concentrations do not build up locally in the tissue 
adjacent to the glass. 
Borate glasses of the composition used in the present work react quickly, within a 
few hours, with an aqueous solution like a phosphate solution or cell culture medium.  
Weight loss data for a soda lime borate glass of is shown in Fig 4 [7].  Initially, the glass 
loses almost 25wt% in the first 24 hours, but the rate decreases by a factor of four 
between 30 and 120 hours due to the formation of calcium phosphate on the glass 
surface.  The weight loss in the first day is primarily due to the dissolution of sodium and 
boron from the glass.  This explains why pre-reaction of a bioactive borate glass for just a 
few hours prior to a cell culture experiment can improve cell growth.  Eliminating the 
initially large influx of alkali and boron in the culture media and forming a calcium 
phosphate layer on the glass surface helps to better simulate how cells might interact 
during the more representative condition of the cells growing on a calcium phosphate 
coated glass. 
The objective in the present work was to evaluate the potential toxicity of 
bioactive borate glass fiber scaffolds in-vivo.  Like almost anything, toxicity has to do 
with the amount or quantity of something ingested or the overall concentration that leads 
to a negative outcome.  Therefore, bioactive borate glass fiber scaffolds were implanted 
in-vivo in soft and hard tissue of rats followed by a comprehensive histological analysis.  
As a reference, comparisons with well known silicate based bioactive glasses were 
included when appropriate.  
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2.3.  MATERIALS AND METHODS 
2.3.1  Scaffold and Disk Preparation 
 Reagent grade chemicals of SiO2, H3BO3, CaCO3, K2CO3, MgCO3, P2O5, and 
Na2CO3 were used to prepare the bioactive glasses (Table 1).  The raw materials were 
weighed (±0.01), thoroughly dry mixed, and melted in a platinum crucible at 
temperatures ranging from 1050 to 1400oC for one to two hours depending on the 
composition.  The glass was stirred with a silica rod several times to achieve a chemically 
homogeneous melt.   
 Rods of 45S5, 13-93, 13-93B1, and 13-93B3 glass (Table 1) were cast into 
graphite molds with an internal diameter of 10mm and annealed at temperatures between 
450 and 550oC for two hours before slow cooling to room temperature.  The rods were 
cut into 1mm thick disks with a slow speed saw which were used for cell culture 
experiments.  The disks were rinsed with ethanol and acetone and stored in a dessicator 
until used.     
Fibers 100 to 300µm in diameter were hand pulled from the melt and broken into 
2 to 3mm lengths (Fig 5A) which were used to manufacture porous, three dimensional, 
randomly oriented fiber scaffolds.  Seventy milligrams of glass fibers were weighed for 
each scaffold and placed with a random orientation in a 7mm inside diameter ceramic 
(mullite) cylindrical mold (Fig 5B).  The molds were placed in a preheated oven at 
selected temperatures between 575 to 695oC for 45 minutes, depending on the glass 
composition, to allow the fibers to soften and thermally bond.  The molds were then 
removed from the oven and cooled to room temperature.  Once cool, the scaffolds were 
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removed from the molds and stored in an air tight desiccator.  The as-made scaffolds had 
nominal dimensions of 7mm in diameter and 2mm thick, see Fig 5C.   
Prior to implantation or cell culture, the scaffolds and disks were dry heat 
sterilized by placing them in a silica glass vial, covering the vial with aluminum foil, and 
heating the vial to 300oC for four hours in an oven.  The scaffolds or disks were slow 
cooled to room temperature. Once cool the scaffolds or disks were ready for use. 
2.3.2  Growth of MLOA5 Cells on Bioactive Glass Disk 
MLOA5 late osteoblast/early osteocyte cells were cultured on as-cut (unpolished) 
disks of 45S5, 13-93, 13-93B1, and 13-93B3 for 24 hours on un-reacted disks and pre-
reacted disks (four hours in culture media) at 37oC, 5%CO2 atmosphere.  The cells were 
fixed, collected, and counted for comparison with the control (50,000 MLOA5 cells 
cultured on the bottom of a single well of a 24 well plate).  The cell culture experiments 
were completed at the University of Missouri –Kansas City (UMKC) School of Dentistry 
Department of Bone Biology [13].   
2.3.3  Subcutaneous Scaffold Implantation 
 The schematic in Fig 7 shows the four implant sites in which a scaffold was 
implanted in a Sprague Dawley rat above each shoulder and above each hind leg between 
the subcutaneous tissue and the skeletal muscle.  Since the scaffolds were implanted in 
multiples of four, each site contained between one and four scaffolds.  No scaffolds were 





2.3.4  Subcutaneous Scaffold and Organ Removal, Tissue Processing, and 
Histology Slide Preparation 
 
 After four weeks, the scaffolds from the experimental group, a lobe of the liver, 
and the left kidney from each rat were excised, photographed, and fixed in 10% formalin 
for four days.   
2.3.5  Tissue Processing and Histology Slide Preparation 
 After the tissues were fixed, they were dehydrated with a series of ethanol 
solutions ranging from 70 to 100% ethanol [14] and a microwave irradiation technique 
[15].  Each scaffold, kidney, or liver was submerged in a glass vial with 10ml of ethanol 
solution, packed into an ice bath, placed in the microwave (EBSciences H2850 
Microwave Processor) for 2.5 minutes at a power of 65% at 37±4oC, and after removal, 
set at room temperature for at least 15 minutes.  This process was followed for each 
tissue in each ethanol solution. 
 As a control, a 13-93B3 fiber scaffold was embedded in a transparent epoxy and 
cross sectioned to show an un-reacted fiber scaffold without any and is shown in Fig 11.  
The glass fibers are circular or elliptical depending on the fiber orientation.  Several of 
the fibers have bonded together in the plane of the cross section, to form complex 
geometrical shapes.    
  Each kidney, liver, and fiber scaffold was embedded with paraffin for 
histological analysis with a tissue processor (AutoTechnicon Model 2A) filled with 
paraffin mounting wax (Paraplast Tissue Embedding Medium, McCormick Scientific 
LLC) at 45oC for four hours.  The infiltrated tissue was mounted in a wax block with a 
paraffin mounting system (Leica EG 1150H).  Histological sections 18µm thick were cut 
of the recovered scaffold to better keep in tact the reacted fibers with a microtome (Leica 
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RM 2235 microtome) with TBS Shur/sharp blades.  The kidney and liver sections were 
cut 6µm thick to improve the clarity of the sections.  Each section was floated on a water 
bath (Lipshaw Electric Tissue Float, model number 375, Detroit MI) at 40oC prior to 
mounting the section on a glass slide (Fisher Brand Superfrost, St. Louis MO).  Between 
two and four tissue sections were mounted on each slide and dried over night (Fisher 
Scientific slide warmer, St. Louis MO).  Each of the tissues (scaffold, kidney, liver) was 
stained with H&E stain (Phelps Country Regional Medical Center in Rolla MO).  A 
detailed protocol for the H&E staining procedure is available elsewhere [10].  
2.3.6  Tissue Assessment 
 The kidney and liver sections were labeled generically and sent to Charles River 
Research Animal Diagnostic Services Center (Wilmington, MA) for a blinded 
pathological analysis.  The scaffold sections were used to assess tissue infiltration and the 
extent of the fiber reaction.   
2.3.7  Calvaria Implant Experiment 
 Porous scaffolds composed of 13-93B3 fibers, 13-93B1 fibers, 13-93 fibers, and 
particles of 45S5 glass (100 to 200µm in diameter) were implanted in a 4mm rat calvaria 
defect (n=4) for 12 weeks.  The growth of the bone was monitored in-situ with micro-CT 
(computer tomography) analysis. The calvaria implant experiment was conducted at the 
dental school at UMKC.   
2.4.  RESULTS 
2.4.1  In-vitro MLOA5 Cell Culture (As-made and Pre-reacted) 
 Data for the proliferation for MLOA5 cells after culture on as-made 45S5, 13-93, 
13-93B1, 13-93B3, and the control (empty well) is shown in Fig 6 [13].  The control was 
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not significantly different (p<0.05) from 45S5, 13-93, and 13-93B1 disks which means 
there is almost no difference between those glasses in a static culture.  Compared to the 
control, 13-93B3 had ~1/3 the cells and was significantly less (p<0.001) indicating that 
the culture conditions inhibited cell growth when compared to the other glasses.   
   After incubating (pre-reacting) the as-made discs in the culture media for four 
hours and then transferring the discs to fresh culture media, a similar proliferation 
analysis was completed at 24 hours as shown in Fig 6 [13].  The number of MLOA5 cells 
on the pre-reacted disks of each glass was higher than the as-made disks, but the cell 
count on the 13-93B3 disks was noticeably higher.   
2.4.2  13-93B3 Scaffold and Tissue Removal 
2.4.2.1 Assessment of Scaffold after Four Weeks In-Vivo 
 Figure 8 shows a representative image of the 13-93B3 scaffolds during removal 
from the subcutaneous tissue.  Numerous blood vessels were visible at the outer edge 
(perimeter) of several of the scaffolds as indicated by the arrows.  All of the 160 scaffolds 
implanted in the 16 rats were recovered.  The particular rat in Fig 8 had a total of 12 
scaffolds implanted, thus the site in Fig 8 has three scaffolds (S) present.  The scaffolds 
have soft tissue completely surrounding them and blood vessels are present at the 
perimeter of the scaffolds (arrows).  There was no inflammation or infection detected in 
the vicinity of the scaffolds which indicated biological compatibility.  The scaffolds had 
lost their original rigidity indicating that they had reacted with body fluids.  There was no 
detectable change in the size or volume of the scaffolds after four weeks in-vivo.   
A representative image of the reacted scaffolds stained with H&E is shown in Fig 
12.  The H&E stained section of a 13-93B3 scaffold reacted for four weeks in 
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subcutaneous tissue is shown in Fig 12A.  The scaffold is >90% filled with soft tissue and 
the fibers that once looked like those in Fig 11 are now reacted.  Magnified views of two 
portions of the scaffold, box B at the center and box C at the outer edge in Figs 12B and 
12C show the fibers were fully reacted throughout the scaffold.   
2.4.2.2 Assessment of Kidney and Liver 
A representative image of a liver and kidney from rats with zero to 16 scaffolds 
implanted is shown in Figs 9 and 10, respectively.  Each liver and kidney is labeled with 
the number of scaffolds that were implanted in the rat.  There were no noticeable 
difference in the size or color between the control and livers from rats implanted with 13-
93B3 scaffolds (Fig 9), and no spots or other differences were seen at the surface of the 
organs.  No hardening or texture differences were noticeable in the livers.  There was no 
difference in size or color, and no spots or other noticeable differences on any kind were 
noticed between the kidneys from animals implanted with up to sixteen 13-93B3 
scaffolds and the control as shown by the images in Fig 10.   
 No pathological differences were reported between the control rats (no scaffolds) 
and the rats implanted with up to sixteen 13-93B3 scaffolds (Table 3).  An example of a 
liver section from each condition (number of scaffolds) is shown in Fig 15.    
 The pathological report on the kidneys (Table 3) showed that 13 of 16 of the 
scaffold implanted animals and 3 of 4 control animals showed at least one of the 
following findings: tubular degeneration, protein casts, and nephrocalcinosis.  All of 
these findings were graded as minimal severity and the findings were described as normal 
incidental changes not uncommon for adult rats.  The tubular degeneration described 
included one or more of the following changes; decreased epithelial eosinophilia, 
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minimally dilated tubules, gold/brown pigment in tubules, and minimal infiltrates of 
mononucleated inflammatory cells.  These minor changes were not observed in the 
control tissues, but the changes were described as minor.  The nephrocalcinosis and 
protein casts are considered frequent histological occurrences in rats as three of four of 
the control animals had protein casts present.  The findings described were either focal, 
present in one spot, or multi focal, present in a few spots.  None of the findings were 
described as diffuse, (present throughout the much of the section), which is the most 
severe gradation for a specific findings occurrence.  An example of a kidney section with 
no pathological abnormalities is shown in Fig 16.  Examples of the observed pathological 
changes are preserved in the appendix.  
2.5.  DISCUSSION 
2.5.1  In-vivo Analysis of Potential Boron Toxicity from Bioactive Borate Glass 
Scaffolds 
 From the present work, no boron toxicity was observed in rat subcutaneous tissue, 
or in systemic organs such as the kidney and liver at or below the estimated BA 
concentration of ~126mg/kg/day.  The estimated BA concentration was based on all the 
boron being released as BA from sixteen scaffolds (70mg each) at a constant rate over a 
28 day period.  Conservatively speaking, the reaction was assumed to be finished in 
approximately four weeks, but if the 13-93B3 scaffolds reacted in two weeks, the BA 
concentration in the rats would have been ~250mg/kg/day.  Regardless of the length of 
time required for the scaffolds to fully react, the fact that there was no toxicity observed 
in the liver, kidney, or in the subcutaneous tissue at the implant sites in the rats with up to 
sixteen 13-93B3 scaffolds is the most significant point.   
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As shown in Fig 17, the 13-93B3 bioactive borate glass scaffold implanted in rat 
calvaria for 12 weeks supported significantly more bone growth (p<0.05) than silicate 
based bioactive glass 13-93.  The amount of bone growth into a scaffold is not a direct 
measure of toxicity, but in-directly, the increase in bone growth in borate glass scaffolds 
over well studied and clinically used silicate bioactive glasses would not be expected if 
the scaffold was measurably toxic. A histomorphometry analysis of the bone tissue 
surrounding the 13-93B3 scaffolds showed no evidence of an immune reaction (increased 
presence of macrophages or immune cells) or necrotic tissues [16]. 
2.5.2 Subcutaneous Scaffold Removal 
 The scaffolds removed from the subcutaneous tissue looked similar to those 
described by Jung et al in a previous experiment when 13-93B3 fiber scaffolds were 
implanted in subcutaneous tissue for four weeks [10].  The scaffolds were infiltrated with 
subcutaneous tissue and blood vessels were present in the surrounding and adjacent 
tissues.  The scaffolds lost their original rigidity and had reacted to form carbonated 
hydroxyapatite (HCA) [10].  
2.5.3 Histological Analysis of Tissues 
 The absence of any negative findings in the liver sections was not unexpected.  
The importance of the liver to the functions of the body warranted the analysis, but, 
Janku et al found no histological differences in borocaptate dosed animals when 
compared to the control [17].  Heindel et al gave rats upwards of 330mg/kg/day of BA, 
which is almost three times the estimated dose given in the present work, and no 
histological changes were reported [8]. 
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 The kidney was found to have incidental changes that are common in adult rats.  
These changes occurred in the rats with 16 scaffolds and in the control rats indicating that 
the boron released from the 13-93B3 glass, at the levels administered, had no immediate 
effects on the kidneys.  Heindel et al dosed rats with 330mg/kg/day and found that after a 
histological analysis of the tissues there was no correlation between nephropathy and BA 
dose [8].  Only a few of the animals showed signs of minimal histological changes from 
the control and were considered normal changes [8].      
The kidney was the organ that was originally considered to be at the highest risk 
since >90% of BA is removed from the body through urine [18, 19].  No long term 
effects would be expected since BA is removed from the body almost entirely after 96 
hours of ingestion [18, 19].  A study of borax workers exposed to airborne borax found 
that over the course of a single work week that boron was removed from the body daily 
through urination and there was no progressive daily increase of boron concentration in 
blood or urine [9].  Therefore, once the 13-93B3 glass has fully reacted, the boron 
concentration of the body should decrease to normal levels within a few days.  
2.5.4  Bone Response to Bioactive Glasses in Rat Calvaria 
In the rat calvaria, the 13-93B3 scaffolds performed statistically better (p<0.05) 
than the 13-93 or 13-93B1 glasses at promoting bone growth.  Since about 50% more 
new bone grew on the 13-93B3 glass scaffold as compared to 13-93 scaffold, the 13-
93B3 glass had a stimulatory effect on bone growth.  It was not surprising to find that the 
13-93B3 glass scaffold promoted bone growth statistically as well in rat calvaria as 45S5 
and better than 13-93.  Richard found previously that particles of the borate analog of 
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45S5 (denoted 45S5-3B) also promoted bone growth as well as the 45S5 glass at 30 and 
60 days in rat tibia [12].   
2.5.5  In-vitro Analysis of Potential Boron Toxicity from Bioactive Borate Glass 
Disks 
 Comparing the results of the as-made disks and the pre-reacted disks (Fig 6), it is 
apparent that the reactivity of the glass disk and the ionic concentration adjacent to the 
seeded cells affect the cell proliferation in-vitro.  By leaching some of the alkali and 
boron from the 13-93B3 disks prior to seeding the cells, the glass went from the lowest 
number of cells after 24 hours to the highest, a 4-fold increase in cell number.  Based on 
weight loss data, the 13-93 is the slowest reacting glass followed by 13-93B1 and 45S5 
which are about the same, and then the 13-93B3 glass which is the most reactive.  
Increasing the pre-reaction time may continue to improve the proliferation rates of the 
13-93B3 glass, but at some point the benefit will likely stop.  Marion et al showed that 
pre-reacting a soda lime borate glass improved cell proliferation of human mesenchymal 
stem cells over the as-made glass, but complete reaction to HA did not promote cell 
growth as much as the partially reacted glass [7].  It was found that the release of some 
ions from the glass improved cell proliferation [7].  
Three glasses, the well known 45S5, the borate analog of 45S5 known as 45S5-
3B (Table 1), and a pre-reacted 45S5-3B glass were all cultured under static conditions 
for four days.  As shown in Fig 18, the 45S5 glass disk had the most cells (as measured 
by total DNA), and the as-made 45S5-3B glass had significantly less cells present after 
four days, p<0.01.  In contrast, the pre-reacted 45S5-3B glass disks supported cell growth 
almost as well as the less reactive 45S5 glass [6].   
 73 
In another experiment, a static culture was compared to dynamic culture for 45S5 
and three borate containing glasses (45S5-1B, 45S5-2B, and 45S5-3B, Table 1).  As 
shown in Fig 19 the greatest difference between the static and dynamic conditions was 
seen for the borate glass (45S5-3B) [6].  The static cell growth for the borate containing 
glasses (1B, 2B, and 3B) decreases as the boron level and reaction rate increases.  An 
interesting result for the dynamic condition was the dramatic improvement in cell growth 
(DNA) for all of the borate containing glasses.  Only the borate glass (3B) was 
statistically lower than the 45S5 glass after four days [6].  The two experiments (Figs 18 
and 19) show how the experimental conditions (static vs. dynamic) can influence cell 
culture data when bioactive glasses are being measured, especially higher reactive glasses 
such as the borate glasses.  
 In Table 2, the 0.002M BA concentration caused a 40% decrease in cell number 
according to Brown et al, but Richard reported an increase in cell proliferation.  The 
experiments conducted by Brown were static as were those by Richard, but Richard 
counted cells every day for four days.  The movement of the fluids that likely occurred 
during the cell counting procedure by Richard may explain why the data disagree.  The 
dynamic environment in the culture dish while counting cells may have been enough to 
significantly modify the proliferation of the cells.    
2.5.6  Correlation between the Sprague Dawley (SD) Rat Model and Humans 
 Heindel et al found that of the SD rat, Swiss CD-1 mouse, and New Zealand 
rabbit, the SD rat had the lowest tolerance for BA ingestion [8] and is therefore 
determined to be the best of the three mammalian models for human comparison.  The 
fact that SD rats dosed with 16 scaffolds (1.12g of  13-93B3 glass, or 1.05g BA in body 
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fluids assuming all boron from glass becomes BA) had no negative histological changes 
in the kidney or liver when compared to the control indicates that bioactive borate glass 
13-93B3 is not toxic to most mammals at or below estimated concentration 
(126mg/kg/day) of BA.  Using the estimated levels of BA administered to the SD rat and 
assuming humans have equal tolerance to the 13-93B3 glass, the graph in Fig 20 was 
made to show the amount of 13-93B3 glass a human could have implanted and be at the 
same concentrations as in the rat experiment.  The weight percent of glass used in the 
calculations, determined by the 4, 8, 12, or 16 scaffolds per rat, was 0.09, 0.19, 0.28, and 
0.37%, respectively, by assuming the weight of each scaffold was 70mg the weight of the 
rat was fixed at 300g.   
 From the graph in Fig 20, ~170 grams (~1/3 pound) of 13-93B3 glass would need 
to be implanted in a 100 pound person to reach the same BA concentration in their body 
as the 300g SD rat containing 1.12 grams of 13-93B3 glass (16 scaffolds).  For a person 
weighing 200 pounds, the person could have almost 340g (~3/4 pound) of 13-93B3 glass 
implanted (Fig 20) without exceeding the BA concentration of ~126mg/kg/day 
(concentration equal to 16 scaffolds in a SD rat).  The amount of bioactive glass used for 
treatment in bone or periodontal defects is typically less than 10 grams which is ~15 to 30 
times less than the levels described here.       
 Young children and developing new born babies may be more susceptible to 
potential boron toxicity.  Animal experiments have reported decreased weights in unborn 
SD rats when the mother was given a BA dose exceeding 78mg/kg/day [8].  There is no 
work to the author’s knowledge of BA doses given to developing animals that were 
healthy when born to determine if the no adverse effect level (NOAEL) changes from 
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prenatal to postnatal.  In-vitro cell cultures (static) also begin to become inhibited cell 
growth at 1mM concentration [6] (~62mg/kg/day of BA).  Assuming a new born could 
consume ~62mg/kg/day, (equivalent to 8 scaffolds in a 300g SD rat), an eight pound 
baby could have ~6.7g of 13-93B3 glass implanted, which is approximately what an adult 
might expect for most periodontal applications [20].   
 
2.6.  CONCLUSIONS 
Boron toxicity has been analyzed from multiple in-vitro cell culture conditions 
and compared with animal toxicity reports.  The present experiments were conducted to 
determine what levels of boron are acceptable or potentially toxic.  In-vitro data were 
found to be highly dependent on the culture environment, static or dynamic, and the 
condition of the glass (as-made or pre-reacted) and the glass composition.  Therefore it is 
suggested that in-vitro cell culture experiments be conducted in a dynamic or semi-
dynamic system where the culture media is circulated similar to conditions in-vivo, 
especially when working with highly reactive materials such as bioactive borate glasses. 
In-vivo experiments with Sprague Dawley rats with up to 16 bioactive borate 
glass 13-93B3 fiber scaffolds (70mg each) implanted for four weeks in subcutaneous 
tissue fully reacted and the boron released caused no detectable histological changes in 
the kidney or liver.  Each SD rat remained healthy and no signs of inflammation or 
infection were seen at the implant sites after four weeks.  There were no negative 
histological findings in the liver and only minor changes which were noted as incidental 
changes normal for an adult rat, were noted in the kidneys.  The open interconnected 
pores of the 13-93B3 scaffolds were filled with soft tissue and there was no inflammation 
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in the tissue adjacent to the scaffolds during the scaffold removal.  Blood vessels had 
grown next to the outer surface of the scaffolds and were seen in the adjacent tissue 
during scaffold removal. 
Scaffolds composed of 13-93B3, 13-93B1, 13-93 glass fibers, and loose particles 
of 45S5 in rat calvaria for 12 weeks produced no adverse reactions.  The rats were 
monitored regularly, and no rats became sick or died due to the implantation of the 
scaffolds.  The 13-93B3 scaffold was found to have statistically more bone (p<0.05) than 
both the 13-93 and 13-93B1 scaffolds by histomorphometry analysis and the bone 
adjacent the reacted 13-93B3 scaffolds showed no signs of immune response or necrotic 
tissue after 12 weeks.  Therefore, bioactive borate glasses such as 13-93B3 should be 
strongly considered for use in humans for hard and soft tissue engineering applications. 
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Green – non toxic 
Yellow – no change in cell number or minimum toxicity in-vivo 
Red – cell death 
* Static Cell Culture 














































Table 3 - Histological Results for Sprague Dawley Rats Implanted with 13-9383 bioactive 
Glass Fiber Scaffolds (70mg) for Four Weeks 
#of Scaffolds t>er Animal 16 16 16 16 12 12 12 12 8 8 
Tissue Findin~ 
Kidney + + + + + + + + 
D eqeneration, tubular 1M 1M 1M 
Protein casts, tubular 1M 1M 1M 1M 1M 1M 
Nephrocalcinosis 1M 1F 1M 1F 
Liver -
#of Scaffolds t>er Animal 8 8 4 4 4 4 Control Control Control Contro l 
Tissue Finding 
Kidnev - + + + + + + + + 
D eaeneration tubular - - 1M 1M 
Protein casts tubular - 1M 1M 1M 1M 1M 1M 1M 1M 
Nephrocalcinosis -
Liver - -
.. Key: - -negatiVe/no s1gn1ficant findmg; +- pos1t1ve/find1ng present; 1 - m1n1mal seventy; 2- m1ld seventy; 3 =moderate seventy; 4-




























Figure 2 – In-vitro and in-vivo data for boric acid toxicity in mg/kg/day.  The green 
regions represent no toxicity, the green to red fade regions show where inhibition begins, 















Figure 3 – Schematic showing how toxic conditions could develop (pH, B concentration, 
etc) and affect the immediate surroundings of a highly reactive material during in-vitro 
static conditions, in-vitro dynamic or pre-reacted conditions, or in-vivo.  The circle 















Figure 4 – Weight loss data for a soda lime borate glass showing the initial fast weight 
loss (24 hrs), followed by a decreasing weight loss which was attributed to the 

























Figure 5 – Steps in manufacturing a scaffold composed of randomly oriented glass fibers.  
The as-made fibers (100 to 300µm diameter, 2 to 3mm long) are shown in (A).  The mold 
used for holding the fibers (70mg) during the heat treatment (575oC to 690oC depending 
on glass composition, for 45 minutes) is shown in (B).  An as-made scaffold (nominal 
dimensions of 7mm diameter, 2mm thick) composed of self bonded randomly oriented 





Figure 6 – Proliferation of MLOA5 cells after 24 hours at 37oC on unpolished as-cut 
bioactive glass disks and pre-reacted bioactive glass disks. [13]. * p<0.001 when 


















































Figure 7 – Schematic showing the implant sites located on the back of a rat.  The red 
lines are sites where the skin was cut (15mm) and the dotted line represent the 
approximate implant site (20mm long).  Up to 16 borate glass fiber scaffolds, four per 
















Figure 8– Appearance of a subcutaneous site containing three 13-93B3 scaffolds after 
four weeks in subcutaneous tissue.  The scaffolds are labeled with an S and arrows point 

















Figure 9– Representative photographs of the livers recovered from rats implanted with up 
to sixteen 13-93B3 fiber scaffolds (70mg each).  The number at the side of each image 
corresponds to the number of 13-93B3 fiber scaffolds implanted in the rat; control (0), 










Figure 10 – Representative photographs of the kidneys recovered from rats implanted 
with up to sixteen 13-93B3 fiber scaffolds (70mg each).  The number at the side of each 
image corresponds to the number of 13-93B3 fiber scaffolds implanted in the rat; control 


































Figure 11 – Cross section of a glass scaffold composed of randomly oriented bioactive 
glass fibers that have been infiltrated with transparent epoxy which provides a reference 
for the histological images.  The fibers (gray) are circular or elliptical depending on the 
orientation, and the fibers that have bonded to other fibers in the plane of the cross 
section look like complex geometrical shapes.  The epoxy occupies what were initially 













Figure 12 – H&E stained section of a 13-93B3 scaffold implanted in subcutaneous tissue 
for four weeks (A).  The section is >90% filled with soft tissue and the fibers have all 
reacted.  A magnified view of box B, located at the center of the scaffold, is shown in 
(B).  There are two fibers that have reacted as indicated by the arrows pointing to the 
center of the fibers.  Healthy soft tissue has attached to the inner and outer surfaces of the 
fibers.  A magnified view of the scaffold at the outer edge is shown in (C), where two 








Figure 13 – H&E stained section of a control liver and a liver section from a rat with four 
to sixteen 13-93B3 scaffolds (70mg each) implanted in subcutaneous tissue.  The 











Figure 14 – Photomicrograph of an H&E stained section of the renal cortex from a 
control rat (A).  Figure 14B is a magnified view of the renal cortex showing the tubular 
epithelium and a glomerulus (a capillary tuft where blood begins the filtering process to 














Figure 15 – Total bone growth into randomly oriented porous bioactive glass scaffolds 
(S), (45S5 was loose particulate (P) form (100 to 200µm)) after 12 weeks in rat calvaria 
(n=4) as determined by histomorphometry analysis.  The 13-93B3 scaffolds generated 
twice as much bone as the 13-93 or 13-93B1 scaffolds and had statistically more bone 










Figure 16 – Quantitative measurement of DNA produced by MC3T3-E1 cells cultured for 
four days on as-made disks of 45S5 (0B), pre-reacted 45S5-3B, and as-made 45S5-3B 
glass disks after four days of culture.  The pre-reacted 45S5-3B glass contained ~2x the 


























Figure 17 – Quantitative measurement of DNA from MC3T3-E1 cells for 45S5 (0B), 
45S5-1B, 45S5-2B, and 45S5-3B glass disks after four days of culture under static 
(black) and dynamic conditions (gray).  The dynamic condition significantly improved 
the amount of viable cells for all the boron containing glasses after four days of culture as 


















Figure 18 – Estimation of how much 13-93B3 glass could be implanted in a human based 
off of the histological analysis of the kidney and liver from Sprague Dawley rats.  Eight 
to 50 pounds was magnified to make reading the graph at lower weights easier.   
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3.1 ABSTRACT 
 Porous scaffolds composed of randomly oriented bioactive borate glass fibers 
doped with copper, strontium, zinc and iron were implanted in laboratory rats for up to 
six weeks to study the biological and angiogenic response.  No inflammation or infection 
was detected at any of the implant sites with a CuO concentration at or below 0.4wt%.  
Scaffolds made from fibers containing (0.1 to 2wt%) CuO had a marked increase in 
blood vessels surrounding the scaffolds after two and four weeks in-vivo.  After six 
weeks, a blinded histological blood vessel analysis (PAS) of the tissue present in the 
scaffolds showed that 0.4wt% CuO produced a statistically significant increase in blood 
vessel area compared to the un-doped scaffold.  It was also found that seeding the 
scaffolds with mesenchymal stem cells also increased the number of blood vessels 
present in the subcutaneous implants.  In a second experiment, the angiogenic effect of 
strontium, zinc, and iron was evaluated in scaffolds doped with 0.4wt% CuO.  Upon 
retrieval of the scaffolds, significant numbers of blood vessels were present in the 
adjacent tissues and an analysis of the infiltrated tissues showed that the addition of zinc 
to the copper doped bioactive glass produced a significant increase (p<0.05) on the 
number of blood vessels present.  
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3.2.  INTRODUCTION 
Bioactive glasses were first introduced by Hench in 1969 with the well known 
silicate based 45S5 (Table 1) [1].  Since then, several silicate based bioactive glasses such 
as 45S5, 13-93, S53P4 (Table 1), and other compositions have been widely studied for 
bone [1-4] and soft tissue [2, 5] applications.  Some of these applications include 
replacement of bones in the middle ear [6], treatment of periodontal defects [6, 7], and 
periodontal implants [6]. 
In the last 10 years, three dimensional porous scaffolds composed of bioactive 
glass [8-14], calcium phosphates such as hydroxyapatite [15-18], and carbonates such as 
calcium carbonate [17, 18] have been studied for bone augmentation.  Unfortunately, the 
inability to promote vascularization in many of these materials has limited their use [19].  
In-vitro performance of porous scaffolds in a regularly agitated culture dish or in a 
perfusion chamber are not necessarily a good estimate of what may be expected in-vivo 
since the nutrients are constantly being replenished to the cells [19].  The approximate 
diffusion limit for oxygen and most nutrients is 100 to 200µm from a blood capillary 
[19], therefore successful in-vivo performance of a scaffold requires a vascular network 
that can provide an adequate blood supply [19]. 
In general, porous scaffolds for tissue regeneration have not performed as well as 
hoped [19].  Current scaffolds made from materials such as titanium, hydroxyapatite, or 
even bioactive glass such as 45S5 lack the ability to stimulate angiogenesis (blood vessel 
formation), which is the key component required for tissue regeneration [19].  Several 
methods of improving the vascularization of scaffolds have been investigated including 
attaching vascular endothelial growth factor [20], coating scaffolds with copper 
 102 
containing salts [21, 22], in-vitro pre-vascularization [19], and in-vivo pre-vascularization 
[19].   
Unfortunately, all of the previously mentioned methods of promoting 
angiogenesis have drawbacks.  Growth factors are expensive and have limited usefulness 
in treating wounds as several growth factors are required at specific time points for 
enhanced healing, but only a few growth factors are approved by the Food and Drug 
Administration (FDA) for clinical use [23].  In-vitro procedures are time consuming and 
must be planned in advance of the surgery.  In-vivo pre-vascularization requires multiple 
surgeries which increases the possibility of infection and also requires a significant 
amount of planning and time.  The dissolution of copper containing salts, while shown to 
promote blood vessel growth [21], has the potential to dissolve too quickly, especially in 
large scaffolds, and dissipate before the full beneficial effect of copper has occurred. 
Of the previously discussed methods for promoting angiogenesis in scaffolds, the 
release of metal ions such as copper, is effective, relatively inexpensive, and requires a 
single surgical procedure.  The role and requirement of copper ions for angiogenesis has 
been well documented in-vitro and in-vivo.  Hu et al showed that copper ions in the 
concentration of 5 to 500µM promoted the growth and proliferation of human endothelial 
cells in-vitro [24].  The addition of metal ions such as copper and tin to cell culture media 
has been shown to promote endothelial cell migration [25].  Barralet et al increased the 
vascular density inside a calcium phosphate scaffold by releasing copper sulfate.  Copper 
ions released from a hyaluronan based hydrogel promoted blood vessel formation in soft 
tissue [22].  The addition of copper chelators (blockers) has a negative effect on tumors, 
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essentially decreasing the microvascular density and decreasing the amount of copper 
stimulated enzymes available for tumor growth [26]. 
Other trace elements such as zinc, boron, strontium, and iron have been studied 
for specific biological responses and are elements found in human cadaver bone [27].  
Zinc serves as a cofactor responsible for keratinocyte migration during wound healing 
which promotes re-epithelialization and also improves epithelial cell resistance to 
apoptosis [28].  Zinc oxide has also been shown to decrease blood clotting time in-vitro 
[29].  Boron, in the form of boric acid, added in the concentration of 1 to 10mM to 
cultures of human placental cells caused a significant increase in mRNA uptake that was 
described as similar to what would be expected of a growth factor [30].   
Greater than 99% of the strontium in the human body is located in the skeleton 
[31].  Rats given strontium in quantities >4g/l in food and water showed signs of 
disturbed bone mineralization, and it is speculated that this is due to the larger size of 
strontium compared to calcium [31].  Strontium in relatively low doses, <4g/l of food and 
water had increased bone formation rates and increased trabecular bone density [31].  
Iron is a constituent of several enzymes, bone marrow, and red blood cells [32], and a 
deficiency of iron in the body can lead to anemia [32].  Iron oxide may also be useful in 
increasing blood clot formation rates [29].           
In the present work, four of the most abundant minor elements found in human 
bone have been systematically doped into the 13-93B3 glass for the purposes of 
promoting angiogenesis.  With the exception of copper, the amounts of the trace elements 
was based on the relative abundance of the trace elements in human cadaver bone [27].  
The elements were added to the 13-93B3 glass consecutively, copper (C or Cu), copper + 
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strontium (CS), copper + strontium+ zinc (CSZ), and copper + strontium + zinc + iron 
(CSZF).  Fibers of each glass were thermally bonded to form porous scaffolds that were 
implanted in the subcutaneous tissue of rats for six weeks.  The scaffolds were removed 
after durations between two and six weeks and the tissue analyzed for the presence of 
blood vessels.    
 
3.3.  MATERIALS AND METHODS 
3.3.1  Glass Melting and Scaffold Preparation 
The borate glass compositions present in Table 1 were made from homogeneous 
mixtures of reagent grade chemicals which were melted in a platinum crucible at 1065oC 
for one hour.  Fibers, with a diameter ranging from 100 to 300µm, were pulled, by hand, 
from the melt.  These fibers were broken into 2 to 3mm lengths which were used to 
prepare porous scaffold composed of randomly oriented fibers.  
Approximately 70mg of fiber was placed in a cylindrical ceramic mold (mullite) 
with an internal diameter of 7mm.  The molds were placed in an oven at 575oC for 45 
minutes, after which the molds were removed and cooled to room temperature.  Once 
cool, the scaffolds were removed from the molds and were ready for use.  Examples of 
the as-made scaffolds doped with up to 2wt% CuO have the nominal dimensions of 7mm 
in diameter and 2mm thick are shown in Fig 1.   
Prior to implantation of the as-made scaffolds or cell seeding with mesenchymal 
stem cells (MSCs), the scaffolds were dry heat sterilized.  The scaffolds were placed in a 
silica glass vial, covered with a loose fitting aluminum foil top, heated in an oven to 
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300oC for four hours, and cooled to room temperature.  Once cool, the scaffolds were 
ready for either cell seeding with MSCs or implantation.    
3.3.2  Scaffold Seeding with Mesenchymal Stem Cells (MSC) 
Mesenchymal stem cells were recovered from the long bones of sacrificed Fisher 
344 rats.  The cells were cultured in-vitro to separate the stem cells from bone marrow 
prior to seeding the scaffolds.  Half of the scaffolds were seeded with 50,000 MSCs, the 
other half were unseeded.  The cells were cultured on the scaffolds for approximately 12 
hours to allow the cells to attach to the glass fibers prior to the implantation.     
3.3.3  Scaffold Implantation 
Five scaffolds made from each type of glass seeded with MSCs and five unseeded 
as-made scaffolds were implanted in subcutaneous tissue of Fisher 344 rats for six weeks.  
The scaffolds were implanted randomly to remove any bias from a single rat.  Each rat 
had four implant sites, two above the shoulders and two above the back legs, which 
contained a single scaffold for a total of four scaffolds per rat.  The back of each rat was 
shaved with clippers to remove hair from the implant sites and washed with iodine and 
then 70% ethanol to disinfect the rats prior to surgery.  During surgery, the rats were 
anesthetized with isoflourine.   
An incision approximately 20mm in length was made completely through the 
cutaneous tissue perpendicular to the spine with a pair of surgical scissors.  Next, a clamp 
was inserted into the incision and gently opened to form an opening between the 
cutaneous tissue and the skeletal muscle.  The opening was made approximately 15 to 20 
mm long.  The scaffold was then inserted toward the back of the cutaneous opening and 
the skin was closed with superglue.     
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After all four scaffolds were implanted; each rat was injected with 0.2ml of 
penicillin (0.1ml per hind leg).  The ears of each rat were labeled and they were placed on 
a heating pad in a cage with access to fresh air during recovery.  Two rats were caged 
together, had access to food pellets and tap water, and were on a light schedule of 12 
hours light, 12 hours dark.  
3.3.4  Scaffold Removal 
After two, four, or six weeks, respectively, the rats were sacrificed by CO2 
inhalation and the scaffolds were removed for analysis.  The scaffolds were placed in 5ml 
of 10% formalin solution for four days to fix the tissue.  
3.3.5  Tissue Processing 
After the scaffolds were fixed, they were dehydrated with a series of ethanol 
solutions by a microwave dehydration technique (EBSciences H2850 Microwave 
Processor) [33].  The microwave was operated at 70% power, and sample temperature 
was set to 37±4oC, for 2.5 minutes for each solution.  Each scaffold was immersed in 
each ethanol solution for a minimum of 15 minutes including microwave time.  
3.3.6  Histology Slide Preparation  
The dehydrated scaffolds were placed in a tissue processor (AutoTechnicon 
Model 2A) filled with fluid paraffin mounting wax (Paraplast Tissue Embedding 
Medium, McCormick Scientific LLC) at 45oC for four hours for wax infiltration of the 
scaffold and tissue.  Each scaffold was mounted in wax for histological sectioning with a 
paraffin mounting system (Leica EG 1150H).  Sections 18µm thick were cut with a 
histological microtome (Leica RM 2235 microtome) with TBS Shur/sharp blades, 
(Triangle Biomedical Sciences, Durham NC).  The cut sections were floated on a water 
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bath (Lipshaw Electric Tissue Float, model number 375, Detroit MI) (40oC) prior to 
mounting on a glass slide (Fisher Brand Superfrost microscope slides, St. Louis MO).  
Three to four tissue sections were placed on a single glass slide, and dried overnight 
(Fisher Scientific slide warmer, St. Louis MO).  Stained slides were viewed with a 
microscope (Olympus BX50, Olympus Optical Co) at magnifications of 40, 100, and 
400X and imaging software (DP Controller, Olympus Optical Co) was used for image 
capture. 
A scaffold composed of randomly oriented fibers was embedded in poly methyl 
methacrylate (PMMA) for use as a reference for the histology sections.  The plastic 
embedded fiber scaffold was sectioned with a slow speed saw and a diamond coated 
blade and polished with 320, 400, 600, 800, and 1200 grit silicon carbide paper.  An 
image of the polished scaffold section is shown in Fig 6.  The fibers appear round if the 
longitudinal axis of the fiber is perpendicular to the plane of the image and ellipsoidal if 
the fiber is cut at an angle to its longitudinal axis.   
3.3.7  Histological Assessment 
3.3.7.1 Blood Vessel Analysis after Six Weeks In-Vivo – Copper Additions 
Scaffolds of 13-93B3, B3 Cu-1 and B3 Cu-3, seeded with MSCs and implanted 
for six weeks in subcutaneous tissue, were sectioned 18µm thick, and stained with 
hematoxylin and eosin stain (H&E), procedure described in detail elsewhere [34], for a 
blood vessel analysis.  The blood vessels present in each tissue section were counted in 
20 randomly selected spots, which predominantly encompassed soft tissue, to determine 
the number of vessels present and to calculate the average blood vessel diameter.   
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 Blood vessel formation was assessed from a blinded analysis of tissue sections 
from  the seeded (msc) and unseeded 13-93B3, B3 Cu-1, and B3 Cu-3 scaffolds 
implanted in subcutaneous tissue for six weeks.  Each type of scaffold, n=3, was stained 
with Periodic Acid Schiff stain (PAS) and was analyzed as illustrated in Fig 9, where the 
center of the scaffold was examined across its middle (dashed line) with a 200x objective.  
The blood vessels in each track of tissue were counted and each blood vessel diameter 
measured.  The data from each scaffold was compared by the student t test.  An example 
of the PAS stained tissue is shown in Fig 10.     
3.3.7.2 Blood Vessel Analysis – Minor Element Additions (H&E) 
Three scaffolds of each composition (B3 Cu-3, CS, CSZ, CSZF) were stained 
with H&E and the number of blood vessels seen in the soft tissue were counted.  Three 
lines from each histological tissue section (parallel to the thickness (2mm) direction and 
at least 1mm apart) were viewed at 400x magnification and the blood vessels counted.  
An example of one scaffold section and the three tracks of tissue analyzed are shown in 
Fig 11 and the remaining sections are shown in the appendix.   
 
3.4.  RESULTS 
3.4.1  Scaffold Removal 
Photographs of the unseeded, copper containing scaffolds taken as they were 
removed after two weeks in subcutaneous tissue are shown in Fig 2.  It is apparent from 
these pictures that the release of copper from the glasses, especially B3 Cu-3 to B3 Cu-5, 
produced a noticeable increase in the number of blood vessels growing toward and into 
the scaffolds when compared to the copper-free 13-93B3 scaffold.  The B3 Cu-5 scaffold 
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has at least six blood vessels growing toward the scaffold and blood vessels are visible 
inside the scaffold are marked with arrows.  The blue color of the scaffolds containing, 
0.2 to 2wt% CuO is still visible, which indicates that some portion of the copper ions are 
still in the glass fibers.   
 After four weeks in-vivo, there appears to be more blood vessels surrounding the 
scaffolds with 0.1wt% CuO (B3 Cu-1) than the copper free 13-93B3 scaffold, which have 
been circled for easier viewing (Fig 3).  There are a few visible vessels at the surface of 
the 13-93B3 scaffold, but the B3 Cu-1 scaffold had three red areas (arrows) which 
indicate the presence of red blood cells and likely blood vessels.  The B3 Cu-3 scaffold in 
Fig 3 has two areas (dark spots) that are attributed to numerous blood vessels.  The side 
of the B3 Cu-3 scaffold that was attached to the subcutaneous tissue was separated and 
lifted from the tissue, and in doing so, the blood vessels were cut which extended from 
the subcutaneous tissue into the scaffold (arrows), which may account for the dark spots.  
Several blood vessels surround the B3 Cu-4 and B3 Cu-5 scaffolds, and in four weeks, 
fibrous tissue appears to have formed around the scaffolds containing greater than 1wt% 
CuO.        
 Based on the results from the four week scaffolds, four scaffolds (13-93B3 as the 
control, B3 Cu-1, B3 Cu-3, and B3 Cu-5) were chosen for a six week in-vivo experiment.  
Each of these four scaffolds had a set, n=4, that were seeded with 50,000 MSCs and a set, 
n=4, that were unseeded, for a total of 32 scaffolds in eight rats.  The scaffolds were 
randomly implanted so that no rat contained a single set of scaffolds.   
 Representative images of scaffolds after six weeks in-vivo are shown in Fig 4.  
The B3 Cu-3 scaffolds were more red than the 13-93B3 scaffolds indicating more blood 
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vessels, and the MSC seeded scaffolds appeared to have more vessels present than the 
corresponding non-seeded scaffolds.  The fibers in the scaffolds after six weeks in-vivo 
(13-93B3, B3 Cu-1 and B3 Cu-3) had lost their blue color which was present at two and 
four weeks.  This loss in color is considered to indicate that the fibers had fully reacted 
with the body fluids and all of the copper ions originally in the glass fibers had been 
released.  There was also no significant change in diameter or thickness of the scaffolds.      
 After six weeks in-vivo, the B3 Cu-5 scaffolds (2wt% CuO) were not biologically 
compatible.  During removal, the B3 Cu-5 scaffolds were found to be surrounded by 
tissue approximately 15mm in diameter (twice the original diameter of the scaffolds) as 
indicated by the arrow in Fig 12A.  The tissue was cut across the top (oval in Fig 12B), 
and a thick yellow fluid was inside.  Further dissection of the tissue revealed a wall about 
4mm thick that surrounded the B3 Cu-5 scaffold (Fig 12C).  The scaffold was removed, 
Fig 12D, and had decreased in size to about 3mm in diameter.  All eight of the B3 Cu-5 
scaffolds, had the same appearance and reactions with the body as shown in Fig 12.     
3.4.2  Histology 
3.4.2.1 Histology – 4 Weeks (H&E) 
 After four weeks, many of the copper doped scaffolds had not fully reacted as 
previously indicated, but it was possible to cut sections at the outer edge of the 13-93B3, 
B3 Cu-1, and a B3 Cu-5 scaffolds.  The stained section of the unseeded 13-93B3 scaffold 
in Fig 13A shows that the fibers are fully reacted and several contain soft tissue.  Figures 
13B and 13C show two magnified areas of tissue adjacent to reacted 13-93B3 fibers (F) 
with infiltrated soft tissue that contain blood vessels (arrows).   
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A section of B3 Cu-1 scaffold after four weeks in-vivo is shown in Fig 14A.  
There appears to be more blood vessels in the tissue at the outer edge of the scaffold in 
Figs 14B and 14C as indicated by the arrows.  The majority of the fibers toward the 
center of the scaffold were not fully reacted as indicated by the presence of unreacted 
glass fibers.  The B3 Cu-5 scaffold had more vessels present than either the 13-93B3 or 
the B3 Cu-1 scaffolds as shown by the histological section in Fig 15A.  The magnified 
images of the B3 Cu-5 scaffold in Figs 15B and 15C show several blood vessels (V) in 
the soft tissue, and several of the blood vessels contain red blood cells (pink dots).   
3.4.2.2 Blood Vessel Analysis – 6 Weeks (H&E)  
After six weeks in-vivo, the number and diameter of the blood vessels were 
measured in a randomly chosen, seeded section of a 13-93B3, B3 Cu-1 and B3 Cu-3 
scaffold to estimate the blood circulation inside the scaffolds.  The color of the box on the 
tissue H&E stained sections indicates the number of vessels counted, so a green box is 1 
to 2 vessels, yellow 3 to 4, light blue 5 to 6, orange 7 to 8, dark blue 9 to 10, and red 11 to 
12.  Examples of blood vessels in an H&E stained section shown in Fig 8 where each 
blood vessel has an arrow showing its location.  For reference, the image in Fig 8 is from 
spot three in the B3 Cu-3 scaffold (Fig 7C).  The total number of blood vessels found in 
the 20 spots from the 13-93B3, B3 Cu-1 and B3 Cu-3 scaffolds, were 66, 92, and 145, 
respectively (Fig 7).     
3.4.2.3 Histology and Vessel Analysis – 6 Weeks (PAS) 
 The PAS staining technique is useful for a blood vessel analysis because it stains 
tissue light blue that is high in glycogen.  Glycogen is a material that is carried by red 
blood cells and distributed throughout the body for cell metabolism.  It diffuses through 
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the lining of blood vessels; therefore blood vessels tend to be relatively high in glycogen.  
Connective tissue stains light green, red blood cells bright green, blood vessel lining blue, 
and macrophages yellow or brown. 
The results of the statistical analysis for the blinded blood vessel study using the 
PAS staining technique are given in Table 2 and an example of the PAS stained tissue is 
shown in Fig 10.  The blood vessel area was measured as area percent of the entire 
section analyzed.  The data for each scaffold is shown in Fig 16 along with selected 
comparisons which are indicated by the brackets and the p values shown.   
3.4.2.4 Blood Vessel Analysis – Minor Elements Addition (H&E)  
An example of the H&E histology sections used for the blood vessel analysis is 
shown in Fig 11.  Several blood vessels throughout the three tissue sections have been 
identified by arrows to guide the reader.  The average number of blood vessels counted in 
each of the scaffold types (Cu-3, CS, CSZ, and CSZF), n=3, are plotted in Fig 17 and 
were compared by the student t test for statistical significance (Table 3). There was a 
statistically significant increase in the total number of vessels in the zinc containing 
scaffolds (CSZ and CSZF) when compared to the Cu-3 scaffold, see Table 3.  The CS 
scaffold had no statistically significant improvement over the Cu-3 scaffold although the 
average number of blood vessels increased about 30%.  The addition of iron in the CSZF 
scaffold showed no significant increase in blood vessels as compared to the CSZ scaffold.  
The addition of the zinc to the scaffold (0.4wt% CuO) produced the most significant 





3.5.1  Scaffold Removal and In-vivo Biocompatibility 
 During the removal of the scaffolds from the rats, it was apparent that the 
mechanical strength was decreased.  The scaffolds were soft to the touch indicating that 
the fibers had reacted significantly with the animal fluids.  The relatively high number of 
blood vessels present in the soft tissue surrounding the scaffolds and the change in color 
of the fibers were signs that the trace elements released from the scaffolds had an 
angiogenic effect.  Subcutaneous skin tissue has relatively few blood vessels compared to 
other tissues like muscle or bone [35].  
There were no signs of inflammation surrounding the scaffolds, infection at the 
implant site, or rejection of the scaffolds from the rats except the previously mentioned 
B3 Cu-5 scaffolds after six weeks in-vivo, which were doped with 2wt% CuO.  These 
scaffolds are thought to have had the negative biological response due to the release of 
excessive copper to the surrounding tissues.  Bioactive borate glasses not doped with 
CuO have been implanted in hard and soft tissue of rats, and there were no reports of 
necrotic tissue, increases in the presence of macrophages, or inflammation [12, 34, 36-
39].   The systemic internal organs of rats such as the kidney and liver have also been 
screened for lesions and other tissue degeneration after implantation of 13-93B3 borate 
fiber scaffolds [40].  There was no marked difference between the rats implanted with 
sixteen (70mg) scaffolds versus the control rats, and any recorded finding was at the 




3.5.2 Angiogenic Analysis of In-Vivo Scaffolds - Blood Vessel Analysis Six Weeks 
(H&E) and (PAS) 
The diameter of each blood vessel in the three scaffolds described in Fig 7 was 
measured to find the average blood vessel diameter in each scaffold type.  The average 
blood vessel diameter was calculated by measuring the diameter of each vessel at its 
smallest diameter, summing the diameters, and dividing by the total number of blood 
vessels.  The shortest distance across each blood vessel was measured to have a 
conservative and consistent measurement technique for blood vessels that were cut at an 
angle different from perpendicular to the longitudinal axis in the histological sections.   
The total blood vessel area for each scaffold was calculated by assuming the 
blood vessels were circular, so the area of a circle was used.  The average blood vessel 
diameters were used to calculate the average area for the blood vessels for the 13-93B3, 
B3 Cu-1 and B3 Cu-3 scaffolds which were 205, 175, and 283µm2, respectively.  Figure 
18 shows the average blood vessel area (dashed line) plotted vs. the left y-axis and the 
total number of vessels (dash and dot line) plotted vs. the right y-axis.   
After six weeks in-vivo, the number of blood vessels in the B3 Cu-1 scaffold  
(0.1wt% CuO)  increased ~50% over the 13-93B3 scaffold, but the average blood vessel 
diameter decreased by 30µm2 (~15%).  The decrease in blood vessel diameter from the 
13-93B3 to the B3 Cu-1 could be coincidental to the scaffolds analyzed since n=1 for this 
analysis.  Another possibility could be that the copper ions stimulated formation of 
vessels at more locations, but not enough copper was present to recruit significant 
amounts of endothelial cells that were required to increase the average blood vessel 
diameter.      
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The total vascular area was calculated by multiplying the average blood vessel 
area by the total number of vessels per scaffold type. The total vascular areas for the 13-
93B3, B3 Cu-1 and B3 Cu-3 scaffolds, were ~13,000, ~17,000, and ~40,000µm2, 
respectively, as shown in Fig 19.  The addition of 0.4wt% CuO to the B3 Cu-3 scaffold 
increased the vascular area by ~300%, which is assumed to increase the blood flow 
through the scaffold by a similar amount.   
The blinded analysis of the six week in-vivo PAS stained sections of 13-93B3, B3 
Cu-1 and B3 Cu-3 scaffolds, n=3, confirmed the findings of the H&E blood vessel 
analysis that the release of copper from a bioactive glass promoted angiogenesis in the 
surrounding tissues.  The B3 Cu-3 scaffold with and without seeded MSCs had 
significantly more vessels (p<0.05) than the unseeded 13-93B3 scaffold.  Copper is 
known to have a role in blood vessel formation as Harris et al reported copper as a 
requirement for angiogenesis [41], and the addition of copper in various forms to calcium 
phosphate scaffolds [21] and a hyaluronan based hydrogel [22] stimulated blood vessel 
formation.  This however, is the first time that copper had been released from a bioactive 
glass and stimulated an angiogenic response in-vivo.  
The addition of MSCs to the 13-93B3 bioactive borate fiber scaffolds also 
significantly improved the vascular growth (p<0.05) over the unseeded 13-93B3 
scaffolds (Fig 16) without the expense of multiple surgeries or growth factors.  
Mesenchymal stem cells can differentiate into a variety of connective tissues including 
blood vessels, cartilage, and bone given the correct combination of biological signals and 
growth factors [35].  From this analysis, it was apparent that the 13-93B3 scaffolds 
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seeded with MSC’s were in the presence of the correct combination of biological signals 
in-vivo to differentiate into blood vessels.       
As additional evidence that copper released from bioactive glass is angiogenic, 
Brown et al counted the number of blood vessels present in the soft tissue that infiltrated 
porous 13-93 silicate scaffolds, 13-93B3 scaffolds, and B3 Cu-3 scaffold containing 
0.4wt% CuO after two weeks in rat subcutaneous tissue [42].  The scaffolds were not 
fully reacted, particularly the slower reacting 13-93 silicate scaffolds, so the scaffolds 
were mounted in PMMA for sectioning and stained with Sanderson Bone Stain to 
differentiate the blood vessels from the other soft tissue.  Ten random locations were 
analyzed from each scaffold section as shown by the arrows in Fig 20.  Data from each 
scaffold type, n=2, was compared by the student t test to determine any significant 
statistical differences (p<0.05).  There was no statistically significant difference in the 
number of blood vessels found (p<0.6535) in the copper free silicate (13-93) and borate 
(13-93B3) scaffolds, but the difference between B3 Cu-3 scaffold containing 0.4wt% 
CuO and copper free 13-93 was statistically significant as p<0.0021.  After only two 
weeks in-vivo, copper released from borate glass was stimulating vascular growth better 
than a silicate based bioactive glass.   
3.5.3  Blood Vessel Analysis of Scaffolds Doped With Selected Metal Ions 
The bioactive borate scaffolds composed of B3 Cu-3 glass fibers contained a 
larger number of blood vessels when compared to 13-93B3 glass fiber scaffolds.  Since 
copper had such a dramatic effect on vascular growth, copper was added to all of the 
minor element doped scaffolds to see what the effect, if any, occurred by the addition of 
strontium, zinc, or iron.  Both scaffold types containing zinc (CSZ and CSZF) proved to 
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significantly increase the number of blood vessels (p<0.05), when compared to the B3 
Cu-3 scaffold (Table 3).  Having two sets of scaffolds (CSZ and CSZF), both containing 
equal amounts of zinc, and both statistically outperforming the B3 Cu-3 scaffold acts as a 
check and secondary data point confirming that the addition of zinc to the glass promoted 
an increased angiogenic response.  
Zinc is well known to promote soft tissue reactions such as keratinocyte migration during 
wound healing which promotes re-epithelialization [28].  Keratinocytes are the cells that 
make up the majority of the epidermis [35], which includes blood vessels, so assuming 
the release of zinc from the scaffold increased the migration rate of the keratinocytes and 
promoted epithelialization inside the scaffold, the increase in blood vessels may be 
explained by the overall promotion of tissue growth.   
 
3.6.  CONCLUSIONS 
The present work shows that ions important to stimulating angiogenesis can be 
released from bioactive glass to promote the important biological function.  Scaffolds 
composed of bioactive borate glass fibers doped with copper, strontium, zinc, and iron, 
were used to promote angiogenesis in the subcutaneous tissue of rats.  The copper doped 
borate glass (0.4wt% CuO) seeded and unseeded with MSCs produced significantly more 
blood vessels when compared to the copper free 13-93B3 glass fiber scaffold.   
The addition of zinc to bioactive borate scaffolds doped with copper significantly 
increased the number of blood vessels in the subcutaneous tissue of rats when compared 
to bioactive borate scaffolds doped with copper only after six weeks in-vivo.  Of the 
materials added for the promotion of angiogenesis, strontium and iron had little impact, 
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but copper and zinc significantly increased the vascularity in the scaffolds they were 
added.  It was also found that the addition of MSCs to a scaffold further enhanced the in-
vivo angiogenic response.   
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Table 1 -Compositions of Bioactive Glasses (wt%) 
Glass Bp 3 Na20 CaO K20 MgO P20 s Si0 2 CuO SrO ZnO Fe20 3 
45S5 0 24.50 24.50 0 0 6.00 45.00 0 0 0 0 
13-93 0 6.00 20.00 12.00 5.00 4.00 53.00 0 0 0 0 
S53P4 0 21.50 21.50 0 0 4.00 53.00 0 0 0 0 
13-93B3 53.00 6.00 20.00 12.00 5.00 4.00 0 0 0 0 0 
B3 Cu-1 52.95 5.99 19.98 11.99 5.00 4.00 0 0.1 0 0 0 0 
B3 Cu-2 52.89 5.99 19.96 11.98 4.99 3.99 0 0.20 0 0 0 
B3 Cu-3 52.79 5.98 19.92 11.95 4.98 3.98 0 0.40 0 0 0 
B3 Cu-4 52.47 5.94 19.80 11.88 4.95 3.96 0 1.00 0 0 0 
B3 Cu-5 51.94 5.88 19.60 11.76 4.90 3.92 0 2.00 0 0 0 
cs 51.73 5.86 19.52 11.71 4.88 3.90 0 0.40 2.00 0 0 
csz 51.20 5.80 19.32 11.59 4.83 3.86 0 0.40 2.00 1.00 0 





























































Figure 1– Examples of as-made bioactive borate glass scaffolds doped with CuO in 














Figure 2 –Appearance of bioactive borate scaffolds doped with CuO, after two weeks in 









Figure 3 – Bioactive borate scaffolds doped with increasing amounts of CuO, implanted 
in subcutaneous sites in rats (four weeks) for evaluation of vascular growth (unseeded).  








Figure 4 – Appearance of 13-93B3, B3 Cu-1, and B3 Cu-3 borate glass fiber scaffolds 
with and without 50,000 seeded mesenchymal stem cells after a six week implantation in 











Figure 5 – Digital micrographs of borate glass scaffolds (original dimensions – 7mm 
diameter, 2mm thick) doped with 0.40% CuO, 2.0% SrO, 1.0% ZnO, and 0.4% Fe2O3 
(wt%) after six weeks in a subcutaneous site.  The top row of scaffolds was seeded with 






Figure 6 – Optical micrograph of the cross section of an as-made randomly oriented fiber 
scaffold infiltrated with PMMA.  The due to the fiber orientation, many of the fibers look 












Figure 7 – H&E stained sections of the six week subcutaneously implanted 13-93B3 (A), 
B3 Cu-1 (B), and B3 Cu-3 (C) scaffolds seeded with 50,000 mesenchymal stem cells.  
The colored boxes (left) are an indication of the number of blood vessels present in each 




Figure 8 – An example of an H&E stained tissue section with blood vessels marked 
(black arrow), and often have red blood cells inside (red or pink).  Blood vessels have a 














Figure 9 – Schematic showing how the PAS stained tissue sections (CuO doped) were 
analyzed.  The dashed line represents the section of tissue analyzed, typically close to the 
center of the section, used for blood vessel analysis.  As indicated by the schematic, 
reacted fibers (white) were often in the line of tissue analyzed and since the scaffolds 













   
Figure 10 – Optical micrographs of PAS stained tissue section from a B3 Cu-3 bioactive 
glass fiber scaffold implanted six weeks.  The arrows point to blood vessels (purple ring) 














Figure 11 – Example of an H&E section used for the blood vessel analysis (H&E).  The 
dashed lines in the top image show the areas across the scaffold that were analyzed, and 
the total number of vessel for each line of tissue are shown (72, 73, and 32, respectively).  
The individual tissue sections are shown below (A to C) and several of the largest blood 
vessels are pointed out with arrows to guide the reader. Bar = 1mm. 
 136 
 
Figure 12 – Optical images showing a B3 Cu-5 scaffold after six weeks walled off in 
subcutaneous tissue, Fig 12A.  A thick fluid was present inside the site, Figs. 12B and 
12C, and the remainder of the scaffold removed from the site is shown in 12D.  All 











Figure 13 – Optical micrographs of stained sections (H&E) from a 13-93B3 scaffold after 








Figure 14 – Optical micrographs of B3 Cu-1 scaffold sections (H&E) that were removed 
from rat subcutaneous tissue after four weeks in-vivo and stained with H&E stain.  Many 











Figure 15 – Optical micrographs of B3 Cu-5 scaffold sections (H&E) that were removed 
from rat subcutaneous tissue after four weeks in-vivo and stained with H&E stain.  Large 












Figure 16 – Area % of blood vessels measured from PAS stained tissue sections from 
bioactive borate glass scaffolds (doped with CuO) after six weeks in-vivo.  N=3.  









Figure 17 – Total number of blood vessels measured for H&E stained borate glass 
scaffold tissue sections doped with minor elements (Cu of C = copper, S = Strontium, Z = 









Figure 18 – Average area for vessels in 20 randomly selected boxes across an H&E 
stained histology section for the borate glass fiber scaffold, 13-93B3 (no CuO), B3 Cu-1 
(0.1wt% CuO), and B3 Cu-3 (0.4wt% CuO) (left side, red triangle). The total number of 













Figure 19 – Total vascular area calculated from 20 randomly chosen areas in H&E 
stained sections for the 13-93B3 (0wt% CuO), B3 Cu-1 (0.1wt% CuO), and B3 Cu-3 













Figure 20 – Cross section of a 13-93 fiber scaffold that had been implanted in 
subcutaneous tissue of a rat for two weeks.  Ten areas of tissue examined for blood 
vessels are indicated by the arrows.  The section was stained with Sanderson Bone Stain.  








4. BONE GROWTH ON BIOACTIVE BORATE GLASS SCAFFOLDS 
 
Steven B. Jung1, Delbert E. Day1, Roger F. Brown2, and Linda F. Bonewald3 
 
1Graduate Center for Materials Research, Materials Science and Engineering Department, 
Missouri University of Science and Technology, Rolla, MO, 65409-1170 
 
2Department of Biological Sciences, Missouri University of Science and Technology, 
Rolla, MO, 65409-1170 
 
3Department of Oral Biology, School of Dentistry, University of Missouri Kansas City, 
Kansas City, MO 64108-2784 
  
4.1 ABSTRACT:  
Bone growth was investigated on bioactive borate glass fiber scaffolds and was 
assessed by two models, the rat calvaria model for osteoconduction and a subcutaneous 
rat model for osteoinduction.  Porous bioactive glass scaffolds composed of randomly 
oriented fibers and loose particulates (100 to 200µm) were placed in calvaria defects 
(4mm diameter) of rats for 12 weeks to compare borate, borosilicate, and two silicate 
based bioactive glasses (45S5 and 13-93) effect on bone growth.  Micro-CT analysis of 
the scaffolds after 12 weeks showed that on average, n=4, the borate glass scaffold had 
the highest bone coverage of the four glasses tested on both the top and bottom of the 
scaffold.  Histomorphometry analysis of the calvaria implanted scaffolds showed that the 
borate glass scaffold had significantly more bone (p<0.05) than the borosilicate or silicate 
based bioactive glass scaffolds.   
In a separate experiment, borate based bioactive glass scaffolds doped with minor 
elements present in bone (copper, strontium, zinc, and iron) were seeded with 
mesenchymal stem cells and implanted in subcutaneous tissue of rats to determine if the 
scaffolds could foster osteoinductive bone growth.  No inflammation or infection was 
 146 
observed at any of the implant sites.  Upon retrieval of the scaffolds, significant numbers 
of blood vessels were present in the adjacent tissues.  Analysis of the tissue for 
mineralized bone-like material showed that none of the unseeded scaffolds formed 
osteoid or bone-like tissue.  At least one of every type of the MSC seeded scaffolds 
stained positive for mineralized bone-like tissue indicating that the bioactive borate 
scaffolds are osteoinductive.   
 
4.2  INTRODUCTION 
Bioactive glasses such as 45S5 (Table 1) have been known to bond with hard and 
soft tissue since 1969 [1, 2].  Bioactive glasses and glass-ceramics have been used in 
clinical applications including periodontal repair  [3], replacement of bones in the inner 
ear [4], and filler for bone cement [5, 6].  Three dimensional scaffolds composed of 
bioactive glasses in a variety of microstructures have recently been under investigation 
for bone defects for load bearing and non-load bearing applications [7-11].  Silicate based 
bioactive glasses however have been shown to react relatively slowly in-vivo taking 
months to years to fully react to hydroxyapatite (HA) [12].   
Due to the relatively slow reaction of silicate based bioactive glasses, a new 
family of faster reacting bioactive glasses was developed.  Borate based bioactive glasses 
submerged in phosphate solutions convert to HA similar to silicate based bioactive 
glasses [13-15].  For example, an in-vitro study comparing the reaction rate of silicate 
based bioactive glass (45S5) to two borosilicate glasses (1/3 and 2/3 of silica replaced by 
boron) and a borate based bioactive glass (all silica from 45S5 replaced by boron), the 
borate glass converted to HA five times faster than the silicate glass [13, 16].    
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Richard et al was the first to implant particles of a 45S5 borate analog (complete 
exchange of boron for silica) in rat femurs.  The glass converted to HA at a significantly 
accelerated rate and bone grew in and attached to the borate glass particles [17]. No 
negative immune response was reported from the histological analysis of the borate based 
particles.   
Jai et al. [18] made pellets from borate glass particles (<50µm) mixed with 
teicoplanin (4 and 8wt%) for the treatment of osteomyelitis.  In-vitro experiments showed 
that approximately 80% of the teicoplanin was released within 15 days.  The compressive 
strength of the scaffolds decreased from 22 MPa to 12 MPa after being submerged for six 
days in PBS solution.  In-vivo experiments with New Zealand White rabbits confirmed 
the previously described in-vitro work, as the teicoplanin exhibited a controlled release 
and the implants had sufficient load bearing strength.  There was no reported in-vivo 
toxicity in the bone adjacent to the bioactive borate glass as the glass converted to HA 
and supported the growth of new bone in the scaffolds.   
Liu et al. [19] treated osteomyelitis located in the tibia of New Zealand White 
rabbits with a scaffold made of bioactive borate glass particles bonded together with a 
polymer binder loaded with Vancomycin.  After eight weeks in-vivo, the implant sites 
had no observable tissue damage or inhibition of bone growth.  After eight weeks, 
approximately 80% of the osteomyelitis infected tibia tested negative for the infection.  
Vascular growth adjacent to the scaffolds was reported to have been participating in the 
bone regeneration.    
Bioactive glass 13-93B3 (Table 1) was used to make porous scaffolds composed 
of randomly oriented fiber which were implanted in the subcutaneous tissue of Sprague 
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Dawley rats for four weeks [20].  The 13-93B3 fibers fully reacted to carbonated 
hydroxyapatite, and the fibers formed porous tubes [20].  Soft tissue and blood vessels 
were present in the open pores of the scaffold and at the center of many of the reacted 13-
93B3 fibers.  There was no noticeable inflammation due to the implantation of the 
scaffold indicating that the 13-93B3 glass was compatible with rat subcutaneous tissue 
[20].  
In the present work, porous scaffolds made from randomly oriented fibers 
composed of borate glass fibers, borosilicate glass fibers, silicate based bioactive glass 
fibers (13-93) and loose particles of 45S5 glass were implanted in 4mm rat calvaria 
defects to compare bone growth between scaffolds and loose particles, and to determine 
if silicate or borate glasses promote the most bone growth.   Additionally, a series of 
bioactive borate glass scaffolds doped with copper, strontium, zinc, and iron were seeded 
with mesenchymal stem cells (MSC’s) and implanted in subcutaneous tissue to determine 
if the scaffolds were osteoinductive.  The amount of each of the minor elements was 
based off the relative abundance of the trace elements in human bone [21].          
 
4.3  MATERIALS AND METHODS 
4.3.1 Glass Melting, Scaffold Preparation, and Sterilization 
The borate glass compositions present in Table 1 were made from reagent grade 
chemicals and melted in a platinum crucible.  The batch materials were melted at 1050 to 
1400oC for one to two hours depending upon the composition.  Fibers of each glass with 
a diameter ranging from 100 to 300µm were pulled from the melt.  The fibers were 
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broken into 2 to 3mm lengths for the preparation of porous randomly oriented fiber 
scaffolds.  
For the subcutaneous implants, approximately 70mg of fiber was placed in a 
cylindrical ceramic mold with an internal diameter of 7mm.  The molds were placed in an 
oven preheated to 575oC and heated for 45 minutes, after which the molds were removed 
and cooled to room temperature.  Once cool, the scaffolds were removed from the molds 
and were ready for use.  The nominal dimensions of the as-made scaffolds were 7mm in 
diameter and 2mm thick. 
The scaffolds for the calvaria implantation experiment were made using a 
graphite mold (~50mm long) with 4mm diameter holes machined longitudinally.  The 
holes were filled with glass fibers, placed in an oven at room temperature, and heated to 
the bonding temperature of; 575oC, 625oC, and 690oC for the 13-93B3, 13-93B1, and 13-
93, respectively, at a rate of 20oC/min and held for 20 minutes.  After the heat treatment, 
the mold was removed from the oven and cooled to room temperature.  Once cool, the 
scaffolds (~40mm long) were removed from the mold and infiltrated with molten wax.  
Once the wax solidified, the scaffolds were cut with a slow speed saw with a diamond 
wafer blade to a nominal thickness of 1.5mm.  After cutting, the scaffolds were 
submerged in xylene to dissolve the wax and were stored in a desiccator until needed.  
Prior to implantation or seeding with MSCs, the as-made scaffolds were dry heat 
sterilized.  The scaffolds were placed in a glass vial, covered with a loose fitting 
aluminum foil top, heated to 300oC for four hours, and cooled to room temperature.  
Once cool, the scaffolds were ready for seeding with MSCs or implantation.    
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4.3.2 Calvaria Defect Model 
4.3.2.1 Scaffold Porosity  
The interconnected open porosity of the scaffolds used for the calvaria 
implantation experiment was measured by a liquid displacement method.  The equation 
used to calculate the open porosity (Po) is shown as Eqn 1.  The dry weight of the 
scaffolds was measured with a digital scale (Mettler Toledo XS105 ±0.00001g) to obtain 
a dry weight (M1).  The scaffolds were submerged in kerosene and placed under vacuum 
for one hour to fill the open, interconnected, pores and then weighed while suspended in 
kerosene (M2) and while saturated with kerosene in air (M3).  The open porosity (Po) of 








MMPo  (1) 
The average open porosity from an n=12 from eqn 1 for each type of scaffolds was 47 ± 
4%, 47 ± 3%, and 51 ± 2% for the 13-93, 13-93B1, and 13-93B3, scaffolds, respectively. 
4.3.2.2 Scaffold Implantation in Rat Calvaria 
 Fiber scaffolds of 13-93, 13-93B1, and 13-93B3 glasses (see Table 1) and 100 to 
200µm diameter loose particles of 45S5 were implanted in 4mm diameter calvaria 
defects of rats for 12 weeks.  The rats were anesthetized with intravenous drugs prior to 
the surgery.  Two 4mm diameter defects were made with a high speed dental bur and 
placed on each side of the sinus as shown in the schematic in Fig 1.  The fiber scaffolds 
or loose particles of 45S5 were implanted in the defects, and the skin was closed.   The 
calvaria implantation and micro-CT measurements were done at the University of 
Missouri – Kansas City School of Dentistry.  Histomorphometry of the 12 week scaffolds 
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and loose particles for quantization total bone growth was compared by one-way analysis 
of variance (ANOVA). 
4.3.2.3 Micro-CT Analysis of In-Situ Scaffolds 
 After 12 weeks the rats were sacrificed and the bone growth across the top and 
bottom of the implanted scaffolds was determined with micro-CT.  The rats were 
anaesthetized and the implant areas scanned to determine bone growth at the implant 
sites.   
4.3.3 Subcutaneous Model 
4.3.3.1 Scaffold Seeding with Mesenchymal Stem Cells  
Mesenchymal stem cells were recovered from the long bones of sacrificed Fisher 
344 rats.  The cells were cultured in-vitro to separate the stem cells from bone marrow 
prior to seeding the scaffolds.  Half of the scaffolds were seeded with 50,000 MSCs, the 
other half were unseeded.  The cells were cultured on the scaffolds for approximately 12 
hours prior to the implantation to allow the cells to attach to the scaffolds/fibers.     
4.3.3.2 Scaffold Implantation  
Five scaffolds of each type (Cu-3, CS, CSZ, CSZF, Table 1) were seeded with 
MSCs and five were left unseeded.  These scaffolds were implanted in subcutaneous sites 
of Fisher 344 rats for a total of 40 implants in 10 rats.  The scaffolds were implanted 
randomly to remove any bias from a single rat.  A schematic of the implant sites is shown 
in Fig 2.  Each rat had four implant sites, two above the shoulders and two above the back 
legs, where a single scaffold was implanted for a total of four scaffolds per rat.  The back 
of each rat was shaved with clippers and washed with iodine and then 70% ethanol to 
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disinfect the skin prior to the surgery.  During the surgery, the rats were anesthetized with 
isoflourine.   
An incision was made about 20mm in length completely through the cutaneous 
tissue, perpendicular to the spine, with a pair of surgical scissors.  Next, a surgical clamp 
was inserted into the incision and opened to separate the cutaneous tissue from the 
skeletal muscle.  The implant site was made approximately 15 to 20 mm long.  The 
scaffold was then placed at the back of the cutaneous opening and the skin closed.  Any 
air that entered the implantation site was removed by gently pressing the cutaneous tissue 
against the skeletal muscle.   The wound was closed by mechanically bonding the skin 
with super glue.     
After scaffold implantation, the rat was injected with 0.2ml of penicillin (0.1ml 
per hind leg) and placed on a heating pad in a clean cage with access to fresh air to 
recover.  The ears of each rat were marked to differentiate the rats.  Two rats were caged 
together during the length of the experiment and had free access to food pellets and tap 
water and the light schedule was 12 hours light, 12 hours dark.  
4.3.3.3 Scaffold Removal and Tissue Processing 
After six weeks, the rats were sacrificed by CO2 inhalation and the scaffolds were 
removed for analysis.  The scaffolds were placed in 5ml of 10% formalin solution for 
four days to fix the tissue.  Once the tissue attached to the scaffolds was chemically fixed, 
the scaffolds were dehydrated with a series of ethanol solutions by a microwave 
dehydration technique [22].  The microwave used was a microwave tissue processor 
(EBSciences H2850 Microwave Processor).  The microwave was set to 70% power, the 
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sample temperature was set to 37±4oC, and microwave was on for 2.5 minutes for each 
solution.  A scaffold was in each ethanol solution for a minimum of 15 minutes.  
4.3.3.4 Histology Slide Preparation and Histological Assessment  
The dehydrated scaffolds were placed in a tissue processor (AutoTechnicon 
Model 2A) filled with fluid paraffin mounting wax (Paraplast Tissue Embedding 
Medium, McCormick Scientific LLC) at 45oC for four hours for wax infiltration of the 
scaffold and tissue.  Each scaffold was mounted in wax for histological sectioning with a 
paraffin mounting system (Leica EG 1150H).  Sections 18µm thick were cut with a 
histological microtome (Leica RM 2235 microtome) with TBS Shur/sharp blades, 
(Triangle Biomedical Sciences, Durham NC).  The cut sections were floated on a water 
bath (Lipshaw Electric Tissue Float, model number 375, Detroit MI) (40oC) prior to 
mounting on a glass slide (Fisher Brand Superfrost microscope slides, St. Louis MO).  
Three to four tissue sections were placed on a single glass slide, and dried overnight on a 
slide warmer (Fisher Scientific slide warmer, St. Louis MO).  Slides were stained with 
Sanderson Rapid Bone Stain to determine if the scaffolds were osteoinductive.  Stained 
slides were viewed with a microscope (Olympus BX50, Olympus Optical Co) at 
magnifications of 40, 100, and 400X and imaging software (DP Controller, Olympus 
Optical Co) was used for image capture. 
A scaffold composed of randomly oriented and self bonded fibers was embedded 
in PMMA for use as a reference for the fibers present in the cross sectioned histology 
sections.  The plastic embedded randomly oriented fiber scaffold was sectioned with a 
slow speed saw and a diamond coated blade and polished with 320, 400, 600, 800, and 
1200 grit silicon carbide paper.  The polished cross section of a scaffold is shown in Fig 3  
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The fibers appear round if the longitudinal axis of a fiber is perpendicular to the plane of 
the image and ellipsoidal if the fiber is oriented at an angle to the section.   
4.3.3.5 Bone-like Material Analysis  
 Sections from four scaffolds of each type, seeded and unseeded with MSC’s, were 
stained with Sanderson Rapid Bone Stain at 50oC for 60 to 75 seconds.  The sections 
rinsed with DI water and checked under a microscope to ensure the tissue stained to an 
appropriate level.  The sections were counter stained with an acid fuchsin solution (99mL 
DI water, 1mL concentrated acetic acid, 1.0 gram of acid fuchsin) at room temperature 
(22oC) for 30 to 45 seconds.  The sections were viewed under the microscope again to 
check the counterstain.  The sections were then coated with a transparent resin and 
coverslipped.  Each section was viewed at 10X and 40X with an Olympus MI transmitted 
light microscope (Olympus Corporation, Japan).   
4.3.3.6 Scanning Electron Microscopy Analysis (SEM) 
An FEI environmental scanning electron microscope ESEM (FEI, Hillsboro, OR) 
was used for SEM imaging of cross sectioned scaffolds.  Each scaffold was embedded 
with poly methyl methacrylate (PMMA) and sectioned in half with a slow speed diamond 
saw.  The surface imaged by SEM was polished with silicon carbide polishing paper to 
1200 grit, coated with ~100nm of Au/Pd for conduction prior to SEM analysis.  
Backscattered SEM was used to identify areas of mineralized bone-like material.   
4.4 RESULTS 
4.4.1 Calvaria Defect Experiment 
 Micro-CT was used to image the bone that had grown across the top and bottom 
of each scaffold as shown by Fig 4.  The area of scaffold not covered by bone was 
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subtracted from the original defect area to determine the defect closure.  The average 
percent closure for each implant type is shown in Fig 5.  The 13-93B3 glass had the 
highest average percent bone regeneration on top and bottom of the scaffold when 
compared to the other implants.  The 45S5 silicate glass had the least amount of bone 
regeneration on the top and bottom after 12 weeks. 
4.4.2 Bone Growth in Bioactive Glass Scaffolds Implanted in Rat Calvaria (12 
Weeks) 
 Total bone growth in the 12 week calvaria scaffolds was quantified by a 
histomorphometric analysis [23] and the results are shown in Fig 6.  The 13-93B3 borate 
scaffolds contained the most new bone of any of the glasses, about twice as much bone as 
the 13-93 and 13-93B1 scaffolds.  A one-way ANOVA analysis of the histomorphometry 
data concluded that the 13-93B3 scaffolds contained significantly more bone (p<0.05) 
than the 13-93 or 13-93B1 scaffolds.     
4.4.3 Subcutaneous Implantation Experiment – Doped Scaffolds 
4.4.3.1 Scaffold Removal 
 After six weeks in-vivo, each scaffold was removed from the subcutaneous tissue 
of each rat.  None of the rats died during the experiment, and none exhibited any signs of 
sickness or infection.  The images in Fig 7 show the appearance of seeded (MSC’s) and 
unseeded scaffolds, while still attached to the subcutaneous tissue.  Several blood vessels 
were visible in the tissue adjacent each scaffold.  Most scaffolds had what appeared to be 
a red or pink tissue inside the scaffold indicating that blood vessels had grown inside the 




4.4.3.2 Osteoinductivity of Scaffolds (Sanderson Rapid Bone Stain) 
 The ability to foster the differentiation of stem cells to a bone-like material is 
known as osteoinductivity.  Half of the scaffolds implanted in the subcutaneous tissue 
were seeded with 50,000 MSCs recovered from rat femurs.  If MSCs differentiate into a 
bone-like material in the presence of the scaffold that has been implanted away from a 
bone site, then the scaffold may be considered an appropriate device for bone 
regeneration in a bony defect.  Sections stained with Sanderson Rapid Bone Stain (SBS) 
appear as follows: cell nuclei are dark blue for bone and soft tissue, cytoplasm stains a 
light blue, osteoid (bone precursor composed of proteins secreted by osteoblast cells) is 
purple, mineralized bone and hydroxyapatite is pink to red, and soft tissue is dark blue. 
4.4.3.3 Histology of Un-Seeded Scaffolds 
An example of each unseeded scaffold type stained with the Sanderson Rapid 
Bone Stain (SBS) is shown in Fig 8 and the tissue analysis results are present in Table 2.  
All of the scaffolds were filled with soft tissue (dark blue) in the interconnected pore 
space.  No osteoid (bone precursor) or mineralized bone-like material was detected in any 
of the unseeded scaffolds as expected.  The arrows in Fig 8B point to air bubbles that 
formed when the cover slip was glued to the section.  The color of the stained sections 
varied as the sections were stained individually by hand and were not stained as precisely 
as they would have been in an automated system.    
4.4.3.4 Histology of MSC Seeded Scaffolds 
A cross section of a representative Cu-3 scaffold seeded with MSCs, and stained 
with SBS is shown in Fig 9A.  Soft tissue (dark blue) is visible throughout almost the 
entire scaffold, filling the interconnected pores between the reacted Cu-3 fibers (red).  
 157 
The area magnified in Fig 9B was chosen because it shows several reacted fibers (F) with 
purple osteoid tissue (O) that grew adjacent with the surface of the reacted Cu-3 fibers 
(red).  Several blood vessels are indicated with white arrows showing the integration of 
blood vessels within the osteoid.  Figure 9C shows a mixture of bone-like (red) and 
osteoid tissue (purple) next to reacted Cu-3 fibers at the outer edge of the scaffold.   The 
bone-like material was located toward the outer surface of the scaffolds.  Osteoid was 
present throughout the seeded (MSC) scaffolds and was often intermixed with tissue that 
stained positive for bone-like material.  The osteoid material contained blood vessels 
which is important for bone metabolism.   
Figure 10A is the backscattered SEM micrograph of a seeded Cu-3 scaffold after 
six weeks in subcutaneous tissue.  The fibers are significantly reacted as most have 
formed hollow voids toward their center.  The pore space between the fibers appears 
black since the soft tissue filling the interconnected pores has a low average atomic 
number.  The ellipsoidal fibers in the image are due to the random orientation of the 
fibers as previously mentioned.  There is a material surrounding some of the reacted 
fibers as indicated by the arrow in Fig 10A which has been magnified in Fig 10B.  This 
material could be bone matrix (calcium phosphate) as its contrast in the BSE image is 
similar to the HA (calcium phosphate) of the reacted fiber.  The material is not 
recognizable as bone at this point, but the formation of this material could be from the 
differentiation of the seeded MSCs.  
The cross section of an MSC seeded CS scaffold is shown in Fig 11.  There is 
significant soft tissue (dark blue) infiltration of the once empty pores as shown in Fig 
11A.  Figure 11B is a magnified view of the outer portion (box B) of the CS scaffold that 
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has a mixture of bone-like and osteoid tissues (B-O).  The image in Fig 11C is a higher 
magnified view of the bone-like and osteoid tissues adjacent to some reacted CS fibers 
(F) in box C.   
The fibers comprising the seeded CS scaffold in Fig 12 had reacted after six 
weeks as most of the fibers had areas that appeared hollow near or at the center of the 
fibers.  Those fibers marked with an arrow at the bottom left of Fig 12, which were near 
the center of the scaffold, had not fully reacted, but the majority of the fibers are fully 
reacted.  No recognizable bone-like material was found in Fig 12 since there was no 
mineralized material attached to any of the reacted fibers or in the interconnected pore 
space. 
A section from a seeded (MSC) CSZ scaffold, implanted in rat subcutaneous 
tissue for six weeks, and stained with SBS is in Fig 13.  Soft tissue (dark blue) was 
present throughout the scaffold as indicated in Fig 13A.  The material in box B, Fig 13B, 
contained bone-like (red) and osteoid material (purple) next to a reacted CSZ fiber (F) 
that was close to the outer edge of the scaffold.  The bone-like material (B) toward the 
bottom of Fig 13B contains osteocytes (circled purple dots) surrounded by mineralized 
matrix (red).  Another area of the CSZ scaffold, box C, contains a mixture of osteoid and 
bone-like material (B-O) and soft tissue (S) next to reacted CSZ fibers is shown in Fig 
13C.  There are several circular and ellipsoidal shapes indicative of blood vessels 
between the two reacted fibers in Fig 13C (red arrows). The blood vessels adjacent to the 
mixture of bone-like and osteoid tissue indicated that the adjacent tissues had sufficient 
oxygen and nutrient supply needed for cellular metabolism. 
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The backscattered SEM image in Fig 14 shows a MSC seeded CSZ scaffold after 
six weeks in rat subcutaneous tissue.  The outer edge of the scaffold is at the upper right 
corner of the image and the center of the scaffold is located toward the lower left.  Some 
of the CSZ fibers were only partially reacted, as they contained residual glass at the 
center (arrows) of the fiber.  The fibers at the outer edge are reacted, but, did not form 
hollow fibers as was observed for the Cu-3 and the CS fibers.  The center of many of the 
reacted fibers had a calcium rich core (horizontal arrows) that has been described in detail 
elsewhere [24].  There was no detectable bone-like material attached to the reacted fibers.  
 A section from a seeded (MSC) CSZF scaffold, implanted in rat subcutaneous 
tissue for six weeks, and stained with SBS, is shown in Fig 15.  The only section of the 
four seeded CSZF scaffolds to stain positive for a bone-like material when stained with 
SBS is shown in Fig 15A.  Soft tissue was present throughout the scaffold, but the only 
bone-like material was present near the outer surface of the scaffold, boxes B and C.  A 
mixture of osteoid and mineralized bone-like tissue formed along the outer portion of the 
scaffold, and two examples of tissue that stained positive for osteoid and bone-like 
material next to reacted CSZF fibers are shown in Figs 15B and 15C.                
Figure 16 is a SEMBSE micrograph of the reacted cross section of a seeded CSZF 
scaffold implanted in rat subcutaneous tissue for six weeks.  The fibers are all reacted 
since the once homogeneous fibers are now composed of noticeably different layers as 
can be seen in Fig 16.  The reacted CSZF fibers have white cores similar to the CSZ 
fibers in Fig 14.  There was no evidence of any mineralized bone-like material attached to 
the reacted fibers as there was no mineralized material surrounding any of the fibers or 
present in the interconnected pore space.    
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4.5  DISCUSSION 
4.5.1  Calvaria Bone Regeneration 
 The present study is the first to compare similar scaffold microstructures 
composed of borate and silicate glasses.  On the average, the scaffold with the most bone 
regenerated across the scaffold top and bottom surfaces after 12 weeks as measured by 
micro-CT was the 13-93B3, and 13-93B3 the only scaffold type to have bone completely 
cover the bottom side of a scaffold.  The 13-93B3 scaffold had significantly more bone 
than the 13-93 or 13-93B1 scaffolds by histomorphometry analysis (1 way ANOVA).   
 The 45S5 glass was implanted in particulate form because the glass is difficult to 
heat treat and form a porous scaffold without crystallization [9].  The objectives of the 
calvaria experiment were to determine the effect of glass composition on bone growth 
and to determine if a scaffold with interconnected pores was better for bone growth than 
loose particles.  The facts of the experiment are that the borate glass had significantly 
more bone (p<0.05) than the borosilicate or silicate glass scaffolds and the borate scaffold 
had on the average more bone than the 45S5 loose particles (Fig 6).  Porous, three 
dimensional scaffolds are becoming popular for tissue engineering of bone and soft tissue 
because they can be made with a tailorable porosity, pore structure, and some bioactive 
glass scaffolds can withstand considerable load (~140MPa) which loose particles can not 
[25].  
4.5.2 Gene Expression Triggered By Bioactive Glass  
Several researchers have studied the effect of the dissolution products from 45S5 
glass on bone cells in-vitro and in-vivo and found that extracts containing calcium and 
silica promote the up-regulation or activation of seven families of genes associated with 
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the osteoprogenitor cell and these activities lead to enhanced bone growth [26].  The 
families of genes that are activated belong to transcription factors and cell cycle 
regulators, DNA synthesis, repair and recombination, apoptosis regulators, growth factors 
and cytokines, cell surface antigens and receptors, signal transduction molecules, and 
extracellular matrix compounds.  Each of these families of genes contains multiple genes 
that have been reported to be stimulated between 160 and 700% when in the presence of 
the 45S5 dissolution products [26].  
Glasses such as 45S5, 13-93, and the 13-93B1 all contain silica and calcium, 
which has been shown to stimulate genes and promote bone growth [27].  The absence of 
SiO2 in the 13-93B3 glass does not disprove the importance of SiO2 in bone regeneration, 
but in the present work, the borate based 13-93B3 scaffolds promoted bone growth 
statistically better than the silicate containing scaffolds.  This promotion of bone growth 
comes as no surprise because boron has been hypothesized to have several biological 
roles including bone mineralization and development [28].   
Animals fed boron deficient diets had decreased or inhibited bone growth when 
compared to animals fed a normal diet [29].  There has been no study done to prove that 
boron can promote bone growth or activate genes if administered at levels above 
physiological levels.  Boron does not affect the calcium or phosphorus levels in bone, but 
affects the levels of trace elements in bone such as zinc, magnesium, copper and 
potassium [29].  Therefore, boron indirectly affects bone formation by altering the 
physiological levels of other elements that have direct roles in bone formation [29].   
The reaction rate of the 13-93B3 glass is ~10 times faster than 13-93 in-vivo 
based on data from glass fibers reacted in rat subcutaneous tissue [7, 20].  Calcium was 
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also previously mentioned as a gene stimulator, so assuming the boron had no effect on 
bone growth, the increased rate in calcium released from the 13-93B3 scaffold could be 
one reason why more bone grew in the borate scaffold than in the silicate (13-93) glass 
scaffold.   
The 13-93B1 scaffold is an interesting data point because if boron was stimulating 
the bone growth, then the borosilicate glass arguably should have had the most growth 
since it was releasing silica, calcium, and boron.  The 13-93B1 glass and the 13-93 glass 
grew almost identical amounts of bone after 12 weeks (Fig 20).  From in-vitro reaction of 
45S5 glass particles modified with boron [13], the weight loss of the borosilicate glass 
(1/3 replacement of silica with boron) and the silicate glass were almost identical, so a 
similar reaction rate and release of calcium from the 13-93B1 and 13-93 glasses would be 
expected.  This is more evidence that the release of calcium may have been the driving 
force behind the increased bone growth.   
In-vitro testing of MC3T3-E1 pre-osteoblast cells with added calcium ions 
showed that the calcium ions (up to 4.8mM) stimulated DNA synthesis and chemotaxis 
(cellular movement caused by a chemical gradient) of the cells [30].  The local release of 
calcium from a material such as a bioactive glass is thereby hypothesized to stimulate 
migration and proliferation of osteoblasts in-vivo.   
Fast reacting bioactive glasses such as the 13-93B3 glass release calcium at a 
higher rate than 13-93 or 45S5 and increase the chemical gradient of calcium in the 
adjacent tissue.  The increase in chemical gradient could potentially increase cellular 
migration which could increase the rate of bone regeneration.  The increased release of 
calcium due to the faster reaction rate of the silica-free 13-93B3 scaffold is therefore 
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offered as an explanation as to why the 13-93B3 scaffold had more bone present after 12 
weeks than the slower reacting silica containing scaffolds.  
4.5.3 Potential Toxicity of the Boron Containing Glasses  
Borate glasses tested in-vitro have inhibited cell proliferation and decreased cell 
number during static culture [31].  Dynamically cultured cells [31] or pre-reaction of the 
borate glasses [32] have improved the in-vitro proliferation as these techniques have been 
done to more closely mimic the in-vivo environment.   The boron released from the 
borate scaffolds in the rat calvaria caused no increase in macrophages or other 
inflammatory cells in the adjacent tissue, and no necrotic tissue was reported [23].  No 
necrosis was expected in systemic organs such as the kidney and liver since rats with up 
to sixteen 13-93B3 scaffolds (70mg each) were implanted in a single rat and there were 
no pathological differences between the control rats and those implanted with sixteen 
scaffolds.  Any recorded finding was at the lowest level of severity and considered 
normal in adult rats [33].  
4.5.4  Osteoinductive Bone-like Tissue Formation Analysis 
 The SBS sections of the doped scaffolds indicated that at least one of the analyzed 
scaffolds from all four scaffold types seeded with MSCs promoted the differentiation of 
the MSCs to a bone-like material when implanted in rat subcutaneous tissue.  The bone-
like tissue formed at the outer edge of the scaffolds according to the SBS staining.  There 
was no SEMBSE evidence to confirm the presence of a mineralized material except in 
the Cu-3 scaffold.  It is unknown why there was little bone-like tissue formation toward 
the center of the scaffolds, but it may have to do with where the MSC cells attached 
during the initial cell seeding or perhaps there was insufficient supply of nutrients at the 
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center of the scaffolds after the initial implantation to sustain the MSC’s.  The MSC’s 
may also still have been in the process of differentiating, although previous work with 
13-93 fiber scaffolds seeded with MSC’s and implanted in rat subcutaneous tissue had 
bone-like material present after four weeks [34]. 
Blood vessels present next to soft and bone-like tissues, as shown in Figs 9B and 
13C are examples of blood vessels adjacent to the osteoid and or bone-like tissues.  Jung 
et al modified the 13-93B3 glass composition with CuO to release copper ions to the 
surrounding tissue similar to copper salts, but in a controlled manner [35].  The addition 
of 0.4wt% of CuO to the 13-93B3 glass increased the amount of vessels present in rat 
soft tissue that had infiltrated the open pores of the scaffolds [35].  It took the scaffolds 
approximately six weeks to fully react in the subcutaneous tissue of the rats and there was 
no negative immune response in any of the glasses containing 0.4wt% CuO or less [35]. 
 
4.6  CONCLUSIONS 
Borate glass 13-93B3 scaffolds promoted bone growth in rat calvaria significantly 
better than scaffolds with a similar microstructure composed of the silicate based 13-93 
bioactive glass scaffolds after 12 weeks in-vivo.  The explanation offered as to why the 
borate scaffold had more bone present is because of the faster reaction of the borate glass 
which increased the release rate of calcium, which is known to promote osteoblastic 
migration and proliferation.   
Borate based bioactive glass fiber scaffolds doped with small amounts of copper, 
strontium, zinc, and iron, each of which is present in human bone, were seeded with 
mesenchymal stem cells and incubated in a soft tissue site to allow for the differentiation 
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of a bone-like material.  Each of the types of doped scaffolds had at least one scaffold 
that stained positive for bone-like material.  Blood vessels were seen throughout the 
infiltrated soft tissue, but it is unclear if the doped glasses promoted the differentiation of 
mesenchymal stem cells into osteoblastic type cells able to make bone-like material. 
All rats remained healthy during the course of their given experiment; there were 
no signs of sickness in the rats, infection at the implant sites (bony or subcutaneous), or 
increase in macrophages or other inflammatory cells in the rat calvaria.  These favorable 
results make borate based bioactive glasses and scaffolds important for future 
development of biomaterials for hard and soft tissue applications.    
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Figure 1 – Schematic showing the scaffold placement in the calvaria of a rat.  The 
scaffolds implanted measured 4mm in diameter and 1.5mm thick as shown in Fig 1.  
Each scaffold was placed between the surrounding sutures and the sinus was avoided to 






Figure 2 – Schematic showing the subcutaneous scaffold implant sites located on the 
back of a rat.  A scaffold was placed above each of the front shoulders and above both 
hind legs as indicated.  The incision (red line) made in the skin was approximately 20mm 
wide and the pocket made under the skin (dotted line) is about 20mm long.  The dashed 









Figure 3 – Optical micrograph of a cross sectioned randomly oriented bioactive glass 
fiber scaffold.  The fibers are gray and look like circular or elliptical depending on the 




Figure 4 – Micro-CT images of the top and bottom of porous randomly oriented fiber 
scaffolds composed of bioactive glass fibers (13-93, 13-93B1, 13-93B3) and 45S5 
particulates (100 to 200µm) after 12 weeks in 4mm rat calvaria defects.  The scaffold and 
bone are labeled for the 13-93 scaffold for the top, bottom, and cross sectioned views.  
Note that the 13-93B3 scaffold is not visible in the bottom image (left).  Bone had 




Figure 5 – Average bone growth across the top and bottom of the implanted scaffolds or 
particulates (45S5) after 12 weeks in rat calvaria (4mm original defect).  Scaffold 














Figure 6 – Total bone growth into porous bioactive glass scaffolds (S), (45S5 was in 
particulate (P) form (100 to 200µm)) after 12 weeks in rat calvaria (n=4) as determined 









Figure 7 – Bioactive borate glass scaffolds doped with minor elements after six weeks in 
rat subcutaneous tissue.  The top row shows scaffolds seeded with 50,000 MSCs, and the 









Figure 8 – Histological sections from a Cu-3 (A), CS (B), CSZ (C), and CSZF (D) 
unseeded scaffold after six weeks in subcutaneous tissue, stained with Sanderson Rapid 
Bone Stain and counterstained with acid fuchsin.  The arrows in Fig 7B indicate the 













Figure 9 – Fig 9A is a representative image of a Cu-3 scaffold, seeded with 50,000 
MSCs, after six weeks in subcutaneous tissue, stained with Sanderson Rapid Bone Stain 




Figure 10 - SEMBSE image of the cross section of a seeded Cu-3 fiber scaffold (Fig 




Figure 11 – Fig 11A is a representative image of the cross section of a seeded CS scaffold 
after six weeks in subcutaneous tissue, stained with Sanderson Rapid Bone Stain and 
counterstained with acid fuchsin.   
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Figure 12 - SEMBSE image of a cross section of a seeded CS fiber scaffold and 





Figure 13 – Fig 13A is a representative image of a CSZ scaffold, seeded with 50,000 
MSCs, after six weeks in subcutaneous tissue, stained with Sanderson Rapid Bone Stain 
and counterstained with acid fuchsin.  Box B shows osteoid mixed with bone-like 
material (B-O) next to a reacted fiber (F).  The two circles in Fig 13B are surrounding 
osteocytes that have become completely surrounded by mineralized matrix.  The (B-O) 
mixture in Fig 13C shows bone-like material in the presence of reacted fibers (F) and soft 
tissue (S).  
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Figure 14 - SEMBSE image of a cross section of a seeded CSZ fiber scaffold that was 
implanted subcutaneously in the back of a rat for six weeks.   
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Figure 15 – Fig 15A is a representative image of a seeded CSZ scaffold after six weeks in 
subcutaneous tissue, stained with Sanderson Rapid Bone Stain and counterstained with 




Figure 16 - SEMBSE image of a cross sectioned CSZF fiber scaffold that was seeded 
with 50,000 mesenchymal stem cells (MSC) and implanted subcutaneously in the back of 
a rat for six weeks.  The majority of the fibers have fully reacted and formed a 
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5.1 ABSTRACT  
 The in-vivo reaction of three dimensional scaffolds composed of randomly 
oriented, borate glass fibers doped with copper, strontium, zinc, and iron were 
investigated after being implanted in a subcutaneous site in laboratory rats for up to six 
weeks.  No inflammation or infection was observed at any of the implant sites.  Upon 
retrieval of the scaffolds, blood vessels were observed adjacent to new tissue.  Evidence 
of the minor elements in the scaffolds after six weeks was confirmed by XRF.  The minor 
elements were either present in the adjacent tissues or in the reacted fibers.  Analysis of 
the reacted fibers by scanning electron microscopy (SEM) and x-ray diffraction (XRD) 
showed that the majority of the un-doped fibers were fully converted to hydroxyapatite 
(HA) after four weeks.  The addition of the minor elements slowed the conversion of the 
bioactive glass fibers to HA.  The scaffold containing copper doped fibers converted to 
HA, but at a slower rate than the un-doped glass.  The addition of copper and strontium to 
the glass significantly decreased the PO43- peak intensities associated with HA as 
determined by micro-raman measurements, but still had broad peaks for HA according to 
XRD.  The addition of zinc to the copper and strontium caused the formation of calcium 
carbonate in the form of calcite at the middle of the reacted fibers.  Iron added to the 
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fibers doped with copper, strontium, and zinc further decreased the amount of HA formed 
in the fiber and increased the size of the calcite core in the reacted fibers.  This is 
believed the first instance where calcium containing bioactive glasses transformed in-vivo 
into materials (calcite) other than HA. 
 
5.2.  INTRODUCTION 
Bioactive glasses such as 45S5 (Table 1) have been known to bond to hard and 
soft tissues for more then four decades [1, 2] and have been used in clinical applications 
for periodontal repair [3], repair of bones in the inner ear [4], and fillers for bone cement 
[5, 6].  Bioactive glasses convert to the mineral known as hydroxyapatite (HA), whose 
stoichiometric composition is Ca10(PO4)6(OH)2, when in contact with body fluids.  
Carbonated hydroxyapatite (HCA), whose composition is Ca10(PO4,CO3)6(OH)2, is the 
same mineral that is present in the inorganic part of bone, and bone will strongly bond to 
synthetic HA or HCA.  Three dimensional porous scaffolds composed of bioactive 
glasses have recently been under investigation by several researchers to repair large bone 
defects [7-11].  Silicate based bioactive glasses, however, have been shown to react 
relatively slowly in-vivo, requiring several months to fully react [12].   
Typically, calcium containing borate glasses submerged in phosphate solutions 
convert to HA in a manner similar to silicate based bioactive glasses [13-15].  An in-vitro 
study of the reaction rate of a bioactive silicate 45S5 glass, two borosilicate glasses, and a 
bioactive borate glass, showed they all converted to HA, but at different rates [13, 16].    
Richard et al implanted particles (300 to 355µm) of a 45S5 borate analog 
(complete exchange of boron for silica) in rat femurs and the glass converted to HA at a 
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significantly higher rate and bone grew around and attached to the glass particles [17].  
Jai et al [18] made pellets of borate glass particles (<50µm) mixed with teicoplanin (4 
and 8wt%) for the purpose of treating the bone disease osteomyelitis.  The bioactive 
borate glass converted to HA in-vivo and supported the growth of new bone.   
A bioactive borate glass, designated 13-93B3 in Table 1, was used to construct 
porous scaffolds composed of randomly oriented fibers which were placed in the 
subcutaneous tissue of laboratory rats [19].  After four weeks, the 13-93B3 fibers had 
fully reacted to form porous tubes composed of HCA which were filled with soft tissue 
and blood vessels [19].  
In the present work, four of the most abundant minor elements found in human 
cadaver bone that have positive effects on bone formation were systematically added to 
the 13-93B3 glass for subcutaneous implantation for the purpose of determining their 
effect on the formation of HA in-vivo.  The concentration of the minor elements selected 
were chosen from the amount of copper found to have a stimulatory effect on blood 
vessel formation from previous work [20] and the relative abundance of trace elements in 
human cadaver bone [21].  The elements were added to the 13-93B3 glass in the order, 
copper (C), copper + strontium (CS), copper + strontium+ zinc (CSZ), and copper + 
strontium + zinc + iron (CSZF).  After six weeks, the scaffolds were removed from the 






5.3  MATERIALS AND METHODS 
5.3.1  Glass Melting and Scaffold Preparation 
Bioactive borate glasses, whose compositions are given in Table 1, were made 
from reagent grade chemicals and melted in a platinum crucible.  The melts were heated 
to 1065oC for one hour in a furnace.  Fibers of each glass, with a diameter ranging from 
100 to 300µm, were hand pulled from the melt.  The un-annealed fibers were broken into 
2 to 3mm lengths which were used to prepare porous scaffolds composed of randomly 
oriented fibers.  
Approximately 70mg of fiber (Fig 1A) was placed in a cylindrical ceramic 
(mullite) mold (Fig 1B) with an internal diameter of 7mm.  The mold was placed in an 
oven preheated to 575oC for 45 minutes, after which the mold was removed and cooled to 
room temperature.  Once cool, the scaffold was removed from the mold and was ready 
for sterilization.   
An example of an as-made 13-93B3 and Cu-3 scaffold are shown in Figs. 1C and 
1D, respectively.  The scaffolds had nominal dimensions of 7mm in diameter and 2mm 
thick.  The doped scaffolds such as Cu-3 are blue due to the addition of CuO to the glass.  
The three dimensional scaffold composed of randomly oriented and self bonded fibers 
had an open, interconnected porosity of 50±2% [22].  
Prior to implantation the scaffolds were dry heat sterilized.  The scaffolds were 
placed in a silica glass vial, covered with a loose fitting aluminum foil top, heated in an 
oven to 300oC for four hours, and cooled to room temperature.  Once cool, the scaffolds 
were ready for implantation.     
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5.3.2  Scaffold Implantation 
Each type of bioactive borate scaffold (five types total) was implanted in 
subcutaneous tissue of Fisher 344 rats, n=5, for either four or six weeks.  The scaffolds 
were implanted randomly to remove any bias from a single rat.  A schematic of the 
implant sites is shown in Fig 2.  Each rat had four implant sites, two above the shoulders 
and two above the back legs, where a single scaffold was implanted in each site, for a 
total of four scaffolds per rat.  The back of each rat was shaved with clippers and washed 
with iodine and then 70% ethanol to disinfect the skin prior to surgical work.  During the 
surgery, the rats were anesthetized with isoflourine.   
An incision 20mm in length was made through the cutaneous tissue perpendicular 
to the spine with a pair of surgical scissors.  The cutaneous tissue was separated from the 
skeletal muscle by inserting a clamp and gently opening it to make an opening ~20 mm 
long.  A scaffold was inserted at the back of the cutaneous opening of the skin and closed 
with super glue.  Once all four scaffolds were implanted; the rat was injected with 0.2ml 
of penicillin (0.1ml per hind leg) prior to complete recovery.  The rats had free access to 
food pellets and tap water and were on a light schedule of 12 hours light, 12 hours dark.  
5.3.3  Scaffold Removal 
After either four or six weeks, the rats were sacrificed by CO2 inhalation and the 
scaffolds were removed for analysis.  The scaffolds were placed in 5ml of 10% formalin 
solution for four days to fix the tissue.  
5.3.4  Scaffold Processing 
Once the scaffolds were fixed, they were dehydrated with ethanol solutions by a 
microwave dehydration technique [23].  A microwave tissue processor (EBSciences 
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H2850 Microwave Processor) was set to 70% power, the sample temperature was set to 
37±4oC, and microwave was on for 2.5 minutes for each solution.  Each scaffold was in 
each ethanol solution for at least 15 minutes.   
The recovered scaffolds were embedded in poly methyl methacrylate (PMMA) by 
first submerging them in methyl methacrylate (MMA) monomer for 24 hours which was 
stirred with a magnetic stir bar.  Next, the scaffolds were infiltrated with MMA 
containing 50% of the polymerizing agent Perkodox 15 for 24 hours.  The final 
infiltration with MMA containing all of the required polymerizer, and was stirred for four 
hours.  The scaffolds were removed from the MMA, placed on a pre-polymerized bed of 
PMMA, and covered with the final solution of MMA.  The MMA was polymerized at 
low temperature, ~4oC until solid. 
An unreacted as-made scaffold composed of randomly oriented fibers was 
embedded in PMMA for use as a reference for the fibers present in the cross sectioned 
histology sections.  The PMMA embedded scaffold was sectioned with a slow speed saw 
with a diamond coated blade and polished with silicon carbide paper from 320 to 1200 
grit.  The fibers appear round or ellipsoidal depending on the fiber orientation.   
5.3.5  X-Ray Diffraction (XRD) 
X-ray diffraction patterns of the recovered scaffolds after four or six weeks in-
vivo were obtained with a PANalytical X’Pert Multipurpose diffractometer.  Cu Kα 
radiation (0.15418 nm) was used with a counting time of 150 seconds and a step size of 
0.0263 degrees.  The scaffolds were placed in the diffractometer after dehydration and x-
rayed in their as-recovered form rather than being ground to a powder.   
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5.3.6  Scanning Electron Microscopy Analysis (SEM) 
An environmental scanning electron microscope (ESEM) (FEI, Hillsboro, OR) 
was used for SEM imaging of cross sectioned scaffolds.  The 13-93B3 scaffold implanted 
for four weeks was not embedded with polymer or wax but was instead sectioned with a 
razor blade.  Each scaffold doped with the selected metal ions was embedded with 
PMMA and sectioned in half with a slow speed diamond saw.  The surface examined by 
SEM was polished with silicon carbide polishing paper to 1200 grit, and coated with 
~100nm of Au/Pd to SEM analysis.  Backscattered SEM, SEMBSE, energy dispersive 
spectroscopy (EDS), and SEM phase mapping were used to the characterize the scaffolds.   
5.3.7  Micro-Raman Analysis 
Micro Raman spectroscopy was used to analyze fibers that had been in-vivo for 
six weeks, LabRAM ARAMIS (Horiba Jobin Yvon).  A 50x objective was used to view 
the fibers and the LABSpec5 software was used to capture the image and analyze the 
spectra.  A diode laser (785nm) was used with and the collection time was five seconds.   
5.3.8  X-ray Fluorescence (XRF) 
 X-ray fluorescence spectra of as-made glass and scaffolds implanted for six 
weeks were obtained with a SPECTRO XEPOS XRF (Spectro Analytical Instruments, 
Germany).  The scaffolds were ground to a fine powder and pressed into a 30mm tablet.  
Spectra were collected for 300 seconds from 6.0 to 10.5 E/kV using a molybdenum target 
at 40kV and 0.88mA.  Spectra between 13.0 and 17.0 E/kV were collected using an 
aluminum target at 49.5kV, 0.70mA for 300 seconds.  The XRF software used for peak 
analysis was X-LAB Pro software.   
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5.4  RESULTS 
5.4.1  Sectioned As-Made Scaffold Composed of Randomly Oriented Fibers for 
SEM Reference  
 
A scaffold composed of randomly oriented glass fibers embedded in PMMA is 
shown in Fig 3.  The fibers are dark gray and the PMMA is light gray.  Depending on the 
fiber orientation, the fibers are circular (longitudinal axis perpendicular to the plane of the 
image) or ellipsoidal (not perpendicular to the plane of the image) shapes.  During the 
heat treatment at 575oC the glass fibers, soften and fuse (bond) together forming a three 
dimensional scaffold of self bonded randomly oriented fibers.  This is evident from Fig 3 
as there are several instances where multiple fibers have bonded.  The light gray area 
between the fibers is the interconnected open porosity.  This cross section of an unreacted 
as-made scaffold serves as a guide for the changes that occurred to both the glass fibers 
and the interconnected pore space during the in-vivo experiment.            
5.4.2  Evaluation of Scaffolds As Recovered from Subcutaneous Tissue 
 None of the rats died during four or six week experiments, nor did any exhibit 
signs of sickness or infection.  The images in Fig 4 show the appearance of each scaffold 
type while it was still attached to the subcutaneous tissue.  Several blood vessels are 
visible in the tissue adjacent to each scaffold.  The scaffolds containing the copper were 
blue prior to implantation (Fig 1D), so the darker color of the reacted scaffolds could be 
due to some un-reacted glass or an increase in the number of blood vessels.  Most of the 
scaffolds had what appeared to be red or pink tissue inside the scaffold indicating that 




5.4.3  X-ray Diffraction (XRD) 
The XRD patterns obtained from the scaffolds implanted in rat subcutaneous 
tissue for four to six weeks are shown in Fig 5.  The patterns for the 13-93B3, Cu-3 and 
CS scaffolds contained identifiable peaks for HA (powder diffraction file (PDF) 72-
1243), but, the peaks were broad and diffuse, most likely due to the nanocrystalline HA 
[19].  The HA peak heights decreased in the Cu-3 and CS scaffold patterns.  The CSZ 
scaffold had broad peaks attributed to HA and much smaller peaks associated with 
calcium carbonate in the form of calcite (pdf card 05-0586).  The XRD pattern for the 
CSZF scaffold contained stronger peaks for calcite only, and no peaks for HA were 
detectable.  A second CSZ and CSZF scaffolds was x-rayed and the presence of calcite 
was confirmed in both scaffolds (patterns not shown).   
5.4.4  Microstructure Analysis of Reacted 13-93B3 Fibers (Four weeks In-Vivo) 
An SEMBSE image in Fig 6 shows the cross section of a 13-93B3 scaffold after 
four weeks in-vivo.  The soft tissue that had grown into the scaffold is dark gray, while 
the reacted fibers are a lighter gray.  Several of the reacted fibers were broken into 
smaller pieces during the sectioning procedure; but many of the fibers remained intact.   
The center portion of a fully reacted 13-93B3 fiber is shown in Fig 7.  The image 
in Fig 7A shows the inside surface of the exposed end of a reacted fiber.  The center of 
the fiber has a relatively rough surface and no original glass is detectable.  Figure 7B is a 
magnified view of the interior surface of the hollow fiber where nodules can be seen 
covering the inside surface of what is believed to be HA (from XRD pattern in Fig 5).  
The magnified view of the nodules in Fig 7C, shows that the nodules are composed of a 
porous network of nanocrystals, which are magnified in Fig 7D.  The needle-like 
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structure of the crystals is consistent with that of HA.  The crystals are ~50nm in length, 
and the microstructure of the crystals is highly porous. 
Figure 8 shows another area of the cross section of a reacted 13-93B3 scaffold.  
Many of these fibers have a hollow core as was found for the fibers in Fig 7.  The two 
fibers in the box in Fig 8, marked with arrows, were magnified to examine their cross 
sections in more detail.  The reacted fiber in Fig 9A, overall diameter of ~170µm, is 
surrounded by soft tissue (dark material) and has a layered structure that is especially 
prevalent close to the center.  The magnified view of the layered structure in Fig 9B 
shows ~50 layers in the ~40µm of fiber perpendicular to the hollow center.  Ten to 
twelve layers are magnified in Fig 9C, and it is apparent that the layers are composed of a 
nanocrystalline material.  The box in Fig 9C is magnified in Fig 9D, and the individual 
layers, ~500nm thick) have a system of struts ~20nm in diameter (arrows) that are 
oriented perpendicular to the layers that connect the entire nanostructure.   
A magnified view of the smaller fiber (~100µm) in the box in Fig 8 shown in Fig 
10 reveals a layered microstructure that is different from that of the fiber in Fig 9.  The 
layers are thicker and fewer are present.  As shown in the magnified view in Fig 11A, the 
layers are ~1µm thick and the distance between is ~1µm.  Each layer is connected by a 
series of struts (~1µm thick) oriented perpendicular to the layer orientation as indicated 
by the arrow in Fig 11A.  A single layer is magnified in Fig 11B and the crystals look 
similar to those seen in the reacted fiber in Fig 7D.  
5.4.5  Chemical Analysis of Reacted Scaffolds (Four or Six Weeks In-Vivo) 
 The cross section of reacted scaffolds shown in Fig 12 is the backscattered SEM 
micrograph of the Cu-3 scaffold after six weeks in subcutaneous tissue.  The fibers are 
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significantly reacted and many appear partially hollow at the center.  The ellipsoidal 
fibers in the image are due to the random orientation of the fibers.   
The fibers composing the CS scaffold in Fig 13 had reacted significantly after six 
weeks.  Some of the fibers in the bottom left corner of the image in Fig 13, (white 
arrows) had a reacted surface that surrounded unreacted glass (gray center), but the 
majority of the fibers were fully reacted.  Most of the CS fibers had voids at their center 
similar to the Cu-3 fibers in Fig 8.   
A randomly selected fiber located at the outer edge of the CS scaffold is 
magnified in Fig 14.  The fiber has reacted with body fluids and has a relatively dense 
outer surface, but a less dense center where a layered structure similar to an onion skin or 
spider web is visible.  The three spots (numbered) in Fig 14 were analyzed by SEM EDS.  
Calcium and phosphorus were formed at each spot and the calcium to phosphorus (Ca/P) 
ratio for spot 1, 2 and 3 is 1.86, 2.00, and 1.71, respectively (Fig 14).  These Ca/P ratios 
are reasonably close to that for stoichiometric HA (1.67). 
 The backscattered SEM image in Fig 15 shows a CSZ scaffold after six weeks in-
vivo.  The outer edge of the scaffold is on the right side of the image, and the center of the 
scaffold is located toward the lower left.  The CSZ fibers at the outer edge of the scaffold 
are significantly reacted as there is no detectable glass remaining, but they did not form 
partially hollow fibers as did the Cu-3 and the CS fibers.  There is a distinct white 
material located at the center of many of the CSZ fibers.  The CSZ fibers toward the 
center of the scaffold (lower left of Fig 15) are not fully reacted, consist of a reacted 
surface layer surrounding a solid glass core (black arrows).   
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One of the partially reacted CSZ fibers with three distinctly different regions was 
chosen (see box in Fig 15) for further analysis (Fig 16).  The outer surface of the fiber is 
solid (light gray), then there is a relatively thick region that is more porous and has some 
layers present (darker gray and layered).  The center of the fiber contains a white 
material.  The Ca/P ratios for the spots 1, 2, 3, and 4 were 27, 2.67, 3.00, and 1.56, 
respectively (Fig 16).  Spot 4 was the only spot where the Ca/P ratio (1.56) was similar to 
that for HA (1.67).     
The CSZF fibers shown in Fig 17 were all significantly reacted since the fibers 
contained a white material at their center similar to the CSZ fibers.  There appears to be 
more of the white material in the CSZF fibers, Fig 17, than in the CSZ fibers, Fig 15.  
The fiber in the box in Fig 17 was arbitrarily selected for further analysis and a EDS 
phase map for calcium, phosphorus, potassium, magnesium, and strontium is shown in 
Fig 18.  Calcium is present in a thin layer on the outer surface of the fiber, but the 
strongest calcium signal is at the center of the fiber.  The phosphorus map shows a 
similar strong ring close to the outer edge of the fiber, but decreases toward the center, 
which contains noticeably less phosphorus.   
The elements mapped were magnesium, potassium, and strontium, but none of 
these elements were present in detectable amounts.  The CSZF fibers only contained 
2wt% SrO, so the strontium concentration may have been too low to detect.  However, 
the absence of the much larger amounts of sodium, potassium, and magnesium in the 
CSZF fibers is attributed to their being leached from the fibers while in-vivo. 
The fiber in the box in Fig 17 was analyzed by EDS at four spots.  The Ca/P ratios 
for spots 1, 2, 3, and 4 were 29, 1.60, 1.40, and 1.28, respectively.  Spot 2 was in the 
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range of Ca/P ratio for HA found in the body (~1.5 to 1.7), but spots 1 was mostly 
calcium, and spots 3 and 4 were similar to the Ca/P ratio for octacalcium phosphate 
(OCP), Ca8H2(PO4)6-5(H2O), which is 1.33.  
5.4.6  Micro-Raman of In-Vivo Reacted Fibers 
A 13-93B3 fiber that had been reacted four weeks in-vivo was analyzed at four 
points by micro raman across the cross section of the fiber diameter as shown in Fig 20.  
A dashed line has been added to outline the perimeter of the fiber to guide the reader. The 
micro-raman spectra for the four spots are shown in Fig 21.  Spot 1 is at the outer edge of 
the fiber and spot 4 is at the center of the reacted fiber.  Since the scaffold was mounted 
in PMMA, many of the peaks, denoted by the solid vertical lines, are from PMMA [24], 
but peaks reported for HA were also present [25].  The peaks associated with HA 
(431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 1076cm-1 
PO43- v3) [24] are denoted by dashed lines.   
 Spots 3 and 4 located near the center of the reacted 13-93B3 fiber in Fig 20 have 
the highest intensity for the phosphate and carbonate peaks of the four spots analyzed.  
Spot 1 was intended to measure the edge of the fiber, but the measured spot may have 
been partially off the fiber (on the PMMA) which would have decreased the intensity of 
the peaks associated with the fiber and magnified the intensity of the PMMA peaks.  The 
presence of a carbonate peak at 1065 to 1070cm-1 (CO32- v1) indicates that the fibers are 
carbonated, similar to the HA in natural bone. 
 The Cu-3 fiber (six weeks in-vivo) shown in Fig 22 was analyzed by micro-raman 
at seven spots across the fiber cross section.  As shown by the spectra in Fig 23, the 
intensity of the HA peaks in spectra 1 to 5 are almost identical indicating no significant 
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change in the material from the outer edge to the center.  The phosphate peaks in spectra 
6 and 7 are noticeably smaller than the other peaks in spectra 1 to 5, which is likely due 
to the measurements being made in the partially hollow center of the fiber.  There was 
also an increase in the intensity of the PMMA peak at 600cm-1 in spectra 6 and 7 further 
providing evidence that the beam was in contact with more of the PMMA than the fiber 
itself.  The presence of CO32- peaks in the spectra indicate that the HA is carbonated 
similar to natural bone. 
 As shown in Fig 24 the CS fiber was analyzed by micro-raman at five spots 
across the fiber.  The spectra in Fig 25 may have low intensity peaks for HA located at 
428cm-1 (PO43- v2) and the broad peak at 1065-1080 which encompasses 1065 and 
1070cm-1 (CO32- v1), and 1076cm-1 (PO43- v3), but the 965cm-1 (PO43- v1) peak for HA 
was not present in any of the spectra. 
 The CSZ fiber was measured in ten spots as indicated in Fig 26 and the spectra 
are in Fig 27.  Spectra 1 to 5 are from the outer edge to the interface between the porous 
calcium phosphate and the calcium rich center had no detectable peaks associated with 
HA present in the micro-raman spectra.  Two new peaks are present in spectra 6 to 10, at 
711cm-1 and 1085cm-1.   These peaks are associated with CO32- in calcium carbonate in 
the form of calcite [26].   
 The CSZF fiber was analyzed at six spots by micro-raman (Fig 28) and the 
spectra are shown in Fig 29.  Again, no peaks associated with HA were observed in the 
spectra.  The peaks for calcite at 711cm-1 and 1085cm-1 were detected at the points inside 
the calcium rich center (spots 4 to 6). 
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5.4.7  X-ray Fluorescence (XRF) of Fibers After In-Vivo Reaction 
 The as-made glass fibers were analyzed with XRF to verify the presence of the 
minor elements (copper, strontium, zinc, and iron).  The spectra for the four as-made 
glasses verify the presence of iron, copper, and zinc (Fig 30A) and strontium (Fig 30B).  
The amount of copper was almost identical for all four glasses as expected.  Iron was 
only added to the CSZF glass, but it was detected in each glass due to impurities in the 
batch materials.  The spectra for zinc in the CSZ and CSZF glasses overlap as shown in 
Fig 30A.  The amount of strontium present in the three glasses it was added overlap in 
Fig 30B.  The peak at 7.4E/kV, marked with an arrow, was due to the organic binder in 
which the samples were pressed. 
 The XRF spectra for the six week implanted scaffolds are shown in Figs 31A and 
31B.  Copper, strontium, zinc and iron were all detected in the scaffolds in which they 
were originally added after six weeks in-vivo.  The Cu-3 scaffold, which contained small 
amounts of strontium, zinc, and iron as impurities (Fig 30), contained similar 
concentrations for each impurity after six weeks in-vivo.  Copper was almost completely 
absent from the Cu-3 scaffold reacted in-vivo (Fig 31A), the copper concentration had 
decreased by over 90% of the original concentration (Fig 30A). 
  The as-made CS scaffolds contained low concentrations of zinc or iron as 
impurities in the as-made scaffolds as shown green lines in the XRF spectra in Fig 30.  
After six weeks in-vivo, the copper and strontium concentrations in the CS scaffold 
decreased by ~90% (blue lines in Fig 31) while the zinc and iron (impurities) remained 
similar to the original concentrations.   
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 Prior to implantation, the as-made CSZ scaffolds contained a low concentration of 
iron as an impurity which did not change after the six weeks in-vivo.  The concentration 
of copper and strontium decreased by 75%, and the zinc concentration decreased by only 
~20% from the as-made scaffolds.   
 The as-made CSZF scaffold had nearly identical concentrations of copper, 
strontium, and zinc when compared to the as-made CSZ scaffold, but the iron 
concentration (red lines in Figs 30 and 31) was significantly higher than the impurity 
levels from the other three scaffolds (Fig 30).  After six weeks in-vivo, the metal ion 
concentration in the CSZF scaffolds had decreased ~80% for copper, ~75% for strontium, 
and ~5% for zinc.  The iron concentration was nearly the same in the as-made glass.  The 
release of metal ions (copper, strontium, and zinc) from the CSZF and the CSZ scaffolds 
were similar in comparison. 
5.5  DISCUSSION 
5.5.1  Scaffold Evaluation and Tissue Analysis during Scaffold Removal 
 During the removal of the scaffolds from the rats, it was apparent that the 
mechanical strength had decreased.  The originally rigid scaffolds were soft to the touch 
indicating that the fibers had reacted with the body fluids and became pliable.  There 
were no signs of inflammation or infection at the implant site, or rejection of the scaffolds 
from the rats.   
Previously, bioactive borate glasses have been studied in-vitro with osteoblasts 
for cell proliferation, and the number of cells decreased with increasing time [27].  The 
most toxic environment for the cells was observed in static in-vitro cultures.  A dynamic 
culture of MC3T3-E1 osteoblast cells on disks of bioactive borate glass showed a much 
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milder effect on cell proliferation which is thought to be more similar to the in-vivo 
environment [27].   
Experiments with bioactive borate glasses in-vivo have shown excellent 
integration of bone into defects filled with particles of bioactive borate glass [17, 18, 28, 
29].  Scaffolds composed of the 13-93B3 glass fibers had significantly more bone 
(p<0.05) after 12 weeks in rat calvaria defects than scaffolds with the similar 
microstructure and interconnected porosity composed of 13-93 bioactive glass fibers 
(Table 1) [22, 30]. No necrotic tissue or increase in macrophages or other inflammatory 
cells was reported in the bone tissue encasing the reacted bioactive borate glass fibers 
[22, 30].  Systemic toxicity of the kidney and liver has also been studied by in-vivo by 
implantation of up to sixteen (70mg each) 13-93B3 fiber scaffolds in Sprague Dawley 
rats.  No pathological changes were reported in the liver when compared to the control, 
and only incidental changes normal in adult rats were reported in the kidney [31].   
The relatively high number of blood vessels present in the soft tissue surrounding 
the scaffolds upon removal after six weeks in-vivo (Fig 4) can be explained by the release 
of copper and zinc from the metal ion containing scaffolds.  Jung et al. showed that 
scaffolds doped with copper and zinc significantly increased the number of blood vessels 
in tissue adjacent to bioactive borate glass fiber scaffolds implanted in the soft tissue of 
rats for six weeks [20].  
5.5.2. Reaction of Metal Ion Doped Borate Scaffolds In-Vivo 
 This is believed to be the first time that bioactive glasses containing calcium have 
been found to convert to a material other than a calcium phosphate such as HA when 
reacted in-vivo.  Conzone and White reacted rare earth containing borate glasses in-vivo 
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and formed rare earth phosphate materials, but those glasses contained no calcium [29, 
32].  The XRD patterns of the reacted scaffolds in Fig 5 show a progressive change from 
HA to calcite as the strontium, zinc, and iron were added to the bioactive borate glass.  
The minor elements having the largest negative effect on the conversion of the glass to 
HA were zinc and iron.  The first XRD peaks for calcite appeared with the addition of 
zinc in the CSZ scaffold.  With the addition of 0.4wt% Fe2O3, there were no detectable 
peaks for HA in the XRD pattern for the CSZF scaffold, Fig 5.  The only detectable 
crystalline material present was calcium carbonate (calcite). 
 Calcite is a polymorph of calcium carbonate that can be found in nature in both 
seashells and coral [33].  Degradable scaffolds composed of calcite have been shown to 
promote bone marrow induced osteogenesis better than a comparable hydroxyapatite 
scaffold [33].  Calcite has been reported to remodel at a faster rate than natural or 
synthetic HA [34] and tricalcium phosphate [35] through in-vitro osteoclast excavation 
experiments.  Bone cement filled with calcite powder has also been made for biomedical 
use [36].   The presence of calcite in the reacted CSZ and CSZF fibers is therefore 
thought in general to be good for tissue engineering of bone and other tissues.  
The copper addition to 13-93B3, Cu-3 glass, increased the time required to fully 
convert a scaffold of similar size and microstructure from four weeks to six weeks, but 
the micro-raman spectra for the Cu-3 glass showed carbonate and phosphate peaks 
indicative of HCA [25].  The increase in time required for the conversion of the glass 
may be explained by previous work by Madsen where copper was found to slow the 
formation of calcium phosphates in-vitro [37].  The addition of strontium to the CS glass 
completely eliminated the 965cm-1 (PO43- v1) raman peak (Fig 28) indicating that the 
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formation of calcium phosphate was being inhibited.  The addition of zinc eliminated the 
remaining phosphate peaks in the CSZ fiber.  Instead of becoming partially hollow like 
the Cu-3 and CS fibers, the CSZ fibers formed a calcite center.  This change in reaction 
may be explained by the strong inhibition zinc has on HA formation [38].  The CSZ glass 
contained copper which likely caused the decreased formation of calcium phosphate 
initially, and the addition of strontium and zinc further inhibited HA formation (Fig 5).  
The combination of these three elements (Cu, Sr, Zn) could also have enhanced the 
inhibition of HA formation due to multiple mechanisms of inhibition working together.  
The CSZF fibers contained more calcite present in their center than the CSZ fibers. This 
is likely due to the addition of a fourth known calcium phosphate inhibiting element Fe2+ 
and/or Fe3+ [38]. 
The formation of calcium carbonate at the center of the CSZ and CSZF fibers is 
not surprising if there are free calcium ions that are not bonded to phosphorus.  There are 
carbonates in body fluids [39], and in aqueous solutions, calcium carbonate is sparingly 
soluble (6.6mg/L) in aqueous solutions like body fluids [40].  Hydroxyapatite has a 
solubility of ~5mg/L at pH = 7.3, and there are no other calcium compounds with a 
calcium solubility between HA and calcite [40].   
The pH that is present in the fluids inside the reacted fibers is not known, but as 
with calcium phosphate crystallization, pH is a factor in the material formed (example, 
calcium carbonate) or the phase of the material (example, calcite, aragonite, or vaterite).  
Calcite and aragonite have the same reported aqueous solubility (6.6mg/L) [40] but 
calcite is the favored phase at pH 7.3.  Vaterite has a solubility of 11mg/L [40], and 
therefore is a less preferable phase for precipitation than either calcite or aragonite.  
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The scaffolds that converted to a mixture of HA and calcite (CSZ and CSZF) 
retained most of the metal ions in either the soft tissue or the reacted fibers as determined 
by XRF.  The EDS spectra for calcium rich portion of the CSZ and CSZF fibers (not 
shown) had small peaks for strontium.  A solid solution of strontium calcium carbonate 
does exist, and has its highest intensity XRD peak is at 29.879 degrees 2θ (PDF card 84-
0591) as opposed to 29.430 degrees 2θ for calcite (PDF card 05-0586).  A slight shift in 
the XRD pattern of the CSZ and CSZF patterns would be difficult to interpret since the 
patterns were relatively low in intensity and the peaks were broad (Fig 5).  Therefore, 
strontium may have been substituting in the calcium sites in the calcite structure and 
forming a solid solution.   
The release of the elements into the surrounding soft tissue would be an important 
finding as the doped glasses could be used to promote healing of wounds by controlled 
ion release.  Evidence that the ions were released from the glass and promoted a positive 
biological response in the surrounding tissue is shown by the vascular growth adjacent to 
and inside the minor element doped scaffolds (Fig 4).   
5.5.3  Microstructure Analysis of Reacted Bioactive Borate Glass Fibers (Layered 
Microstructure) 
 
After four weeks in-vivo, the 13-93B3 fibers were fully reacted and converted to a 
carbonated HA.  The reaction of the fibers is interesting in that the microstructure of the 
calcium phosphate changes from forming a thick monolayer of HA to a multilayered 
structure.  The thickness and periodicity in the layered structure also appear to be linked 
to the original fiber diameter.  The larger the fiber diameter (~170µm) had about 50 
layers (500nm thick) with a ~500nm periodicity (Fig 9).  The smaller diameter fiber 
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(~100µm) had only about seven to eight layers with a layer thickness of ~1µm with a 
~1µm distance between the layers (Fig 10). 
The microstructure similar to those in Figs 8 to 11 and Fig 14 has been seen in 
reacted bioactive borate glasses in-vivo [17, 19, 29] and in-vitro [29, 41].  Conzone [29] 
suggested the formation of the layered structure could result from convection currents of 
fluids at the glass to dysprosium phosphate (DyP) layer interface.  After ~ 3 to 5µm of 
layer formation, the glass core was hypothesized to detach from the DyP layer and start 
the layer forming process again.   
A reaction similar to that reported by Conzone [29] occurred in the fiber shown in 
Fig 9, but the layer thickness was only ~500nm and there are struts connecting the layers 
which contradict the shell formation by convection current model.  The layers in Fig 10 
are also connected, but with larger struts than in Fig 9.  The well defined thickness of the 
nanocrystalline layers and the almost fixed distance between the layers could be due to 
the deposit of an amorphous calcium phosphate gel that, in the process of crystallizing, 
shrinks in size while the next layer of calcium phosphate gel has already started forming.  
The formation of the struts could be due to epitaxial growth of crystals from the 
crystallized layer to the amorphous gel layer since the surface of the crystallized layer 
could promote crystal growth from its surface.  The strut could also act as a seed crystal 
for the crystallization of the next layer.   
The process of deposition and precipitation through a porous material should 
remain similar as the body fluids flow and could be an explanation for the layered 
microstructure.  The difference in the layer thickness for different diameter fibers could 
be due to the differences in diffusion of phosphate from the body fluids through the fiber.  
 207 
As the fiber diameter increases, thinner layers might be expected if the phosphate had to 
diffuse a longer distance.  The smaller diameter fibers would have more phosphate 
available in a shorter distance, hence form fewer and thicker layers.      
Both the Cu-3 and CS fibers reacted to form microstructures similar to 13-93B3 
in-vivo.  Evidence that a change had occurred in the reaction of the minor element doped 
glass fibers was first noticed in the microstructure of the CSZ fibers.  The distinctly 
different material at the center of the fiber as shown by the SEMBSE image in Fig 15 and 
the diffuse calcium phosphate layers surrounding it was different from any reacted 
bioactive glass microstructure seen before.    
The reacted CSZF fiber in Fig 32 had a similar structure to the CSZ fiber in Fig 
15 in that it first formed a surface layer of calcium phosphate, but only about 2µm thick, 
and then began forming a highly porous and low density calcium phosphate that 
eventually changed to a porous layered structure.  This porous layered structure is 
significantly different from the relatively thick mono layer at the surface of the 13-93B3 
fiber (Fig 10).  The layered structure started in the porous HA region of the fiber and 
continued into the calcium rich center.  The thicknesses of the calcium rich layers in the 
CSZF fiber (Fig 35) were noticeably thicker than the calcium phosphate layers adjacent.  
The varied thickness of the layers could be due to differences in the precipitation of HA 
versus the calcite.   
5.5.4 Reaction of Metal Ion Doped Bioactive Glasses 
 There is little published work in the area of bioactive glasses doped with metal 
ions.  Glasses such as the well known 45S5 have been doped with up to 20wt% zinc [42] 
and after 30 days in simulated body fluid, two phases in separate calcium phosphate 
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layers were discovered, a normal HA layer, and a zinc containing calcium phosphate 
phase CaZn2(PO4)2-2H2O [43].  Tape cast 45S5 bioactive glass soaked with a silver 
containing solution formed HA [44].  Pan et al found that adding strontium to borosilicate 
glass significantly reduced the cytotoxic effects of the glasses in-vitro, and the glasses 
converted to HA.  Fluorine has been added to silicate based bioactive glass but HA was 
formed [45].  Boron has been added as a minor constituent (3wt%) to silicate based 
bioactive glasses [2], as a glass former in a borosilicate bioactive glass [13, 46], and as 
the major glass former in borate based bioactive glasses [13, 15, 19, 46], and all 
converted to HA.  
5.5.5 Role of Metal Ions in Calcium Phosphate Formation 
Madsen studied the influence foreign metal ions had on the conversion of brushite 
(CaHPO4-2H2O) to OCP and to HA.  He found that several transition metal ions decrease 
the conversion rate or significantly poison the reaction [38].  Both Cu2+ and Zn2+ were 
found to be strong inhibitors to HA crystal growth.  Sr2+, Fe2+, and Fe3+ were described as 
intermediate as opposed to strong, but nonetheless act as inhibitors during HA 
crystallization [38].  Bigi et al. found that Mg2+ and Sr2+ are important in determining 
what calcium phosphate phase is formed as pH varies in a simulated aqueous solution 
[47].  TenHuisen et al studied the effect Mg2+ on HA formation in-vitro, and found that 
concentrations of Mg2+ below 1mM had no effect on HA crystallization [48].  
Concentrations of Mg2+ between 1mM and 2.5mM changed the shape of the HA crystals 
formed but not the kinetics, and concentrations greater than 2.5mM slowed the overall 
reaction kinetics [48].  Madsen found that Cu2+  ions initially inhibit calcium phosphate 
precipitation on a brushite substrate in dilute phosphate solution by surface adsorption 
 209 
[37].  The Cu2+ coated surface layer eventually diffuses into the interior of the brushite 
crystal clearing the surface to nucleate and grow calcium phosphate [37].   
Not all metal ions inhibit the growth of HA.  Nickel and lead have been found to 
promote HA formation in-vitro [38].  The Ni2+ and Pb2+ ions can substitute for calcium 
ions in calcium phosphates and act as nucleating agents, however, Ni2+ ions have been 
reported to promote the growth of irregular crystals [38].  Chromium ions (Cr3+) have 
been suggested as both a strong inhibitor [38] and a strong promoter [49] of calcium 
phosphate growth, but, the two experiments were completed at different pH values and 
chromium concentrations. 
To better understand why certain ions inhibit or promote HA formation, the ionic 
radius of several ions (6 - coordinated) [50] were plotted against an arbitrary scale of 0 to 
5 in Fig 33, where 0 represents no HA inhibition, and 5 represent severe HA inhibition as 
reported in the literature [38].  The inhibition of HA appears to trend with decreasing 
atomic radius as compared to the radius of calcium.  This helps to explain why 
aluminum, which has a small radius (0.53 Å) has been reported as a poison to HA 
formation in bioactive glass [2], and why the CSZ and CSZF glasses from the present 
work, which have zinc (0.75Å) and iron (0.61Å for Fe2+and 0.65Å for Fe3+) stopped 
forming HA and formed another calcium compound, calcite.      
5.6  CONCLUSIONS 
Scaffolds composed of randomly oriented bioactive borate glass fibers, some 
doped with copper, strontium, zinc and iron were implanted in subcutaneous tissue of rats 
fully and reacted with body fluids for four to six weeks.  Each rat remained healthy 
during the course of the experiment; there were no signs of sickness in the rats or 
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infection at the implant sites.  The metal ions in the doped scaffolds were released to the 
surrounding tissues and/or incorporated into the calcium containing reaction products as 
the glasses reacted with body fluids.   
For the first time, a calcium containing bioactive glass converted to a non-calcium 
phosphate when implanted in-vivo.  Calcium carbonate in the form of calcite was 
deposited at the center of the CSZ and CSZF bioactive glass fibers.  The calcite formation 
was likely due to inhibition of calcium to bond with phosphorus caused by the addition of 
the metal ions.  The formation of calcite could be an improvement in scaffold resorption 
as osteoblasts can remodel calcite faster that HA into new bone.   
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Table 1 - Bioactive Glass Compositions (wt%) 
Glass B z03 Nap CaO KzO MgO Si0 2 PzOs CuO SrO ZnO Fe20 3 
4585 0 24.50 24.50 0 0 45.00 6.00 0 0 0 0 
13-93 0 6.00 20.00 12.00 5.00 53.00 4. 00 0 0 0 0 
13-9383 53.00 6.00 20.00 12.00 5.00 0 4. 00 0 0 0 0 
Cu-3 52.79 5.98 19.92 11.95 4.98 0 3.98 0.40 0 0 0 
cs 51.73 5.86 19.52 11.71 4.88 0 3.90 0.40 2.00 0 0 
csz 51.20 5.80 19.32 11.59 4.83 0 3.86 0.40 2.00 1.00 0 







Figure 1 – Figure 1A shows some chopped fiber 2 to 3mm in length, 100 to 300µm in 
diameter, used for making scaffolds.  Figure 1B shows a ceramic mold used to hold the 
fibers during the heat treatment.  Figures 1C and 1D are examples of an as-made 13-93B3 
and Cu-3 scaffolds that weighs 70mg and has dimensions of 7mm in diameter and 2mm 









Figure 2 – Schematic showing the four subcutaneous scaffold implant sites located on the 









Figure 3 – Bioactive borate glass scaffolds doped with minor elements after implantation 
in rat subcutaneous tissue.  The images show a representative scaffold after six weeks in 
subcutaneous tissue for the Cu-3, CS, CSZ, and CSZF scaffolds and a 13-93B3 scaffold 





Figure 4 – Optical micrograph of a cross sectioned randomly oriented bioactive glass 
fiber scaffold.  The fibers are gray and look like circular or elliptical depending on the 
fiber orientation.  The scaffold was impregnated with PMMA as indicated to support the 










Figure 5 – XRD patterns for randomly oriented borate bioactive glass fiber scaffolds with 
added minor elements implanted in rat subcutaneous tissue for six weeks (13-93B3 was 
implanted four weeks).  Scaffolds had an original mass of 70mg and were 7mm in 












Figure 6 – SEMBSE micrograph of a cross sectioned 13-93B3 scaffold after four weeks 
in the subcutaneous tissue of a rat.  The soft tissue (dark gray) is surrounding reacted 





Figure 7 – High magnification SEM micrographs of reacted 13-93B3 fibers after four 
weeks in the subcutaneous tissue of a rat.  Figure 7A of a sectioned fiber showing the 
hollow center and the wall of the reacted fiber.  Figure 7B is a magnified view of the 
surface of the hollow reacted 13-93B3 fiber in Fig 7A.  Figure 7C is a magnified view of 
the nodules in Fig 7B.  Each nodule consists of a porous nanocrystalline structure as 










Figure 8 – SEM micrograph of a 13-93B3 scaffold cross section after four weeks in-vivo.  













Figure 9 – SEM micrographs of a reacted 13-93B3 fiber in rat subcutaneous tissue for 
four weeks.   
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Figure 10 – Appearance of the cross section of the smaller reacted 13-93B3 fiber (four 













Figure 11 – SEM micrographs of the layered microstructure present at the center of the 
reacted 13-93B3 fiber in Fig 10.  Figure 11A shows several layers, but here a thick strut 
(arrow) is present connecting the layers.  The image in Fig 11B is of a single layer, and it 
is apparent that the layers are polycrystalline and composed of nanocrystals.  
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Figure 12 - SEMBSE image of a cross sectioned Cu-3 fiber scaffold that had been 













Figure 13 - SEMBSE image of a cross sectioned CS fiber scaffold implanted 
subcutaneously in a rat for six weeks.  A majority of the fibers are excavated (partially 












Figure 14 - SEMBSE image of a CS fiber implanted subcutaneously in the back of a rat 














Figure 15 - SEMBSE image of a cross sectioned CSZ fiber scaffold that was implanted 








Figure 16 - SEMBSE image of a CSZ fiber implanted subcutaneously in the back of a rat 





Figure 17 – SEMBSE image of the cross section of a CSZF fiber scaffold that was 












Figure 18 - EDS phase map of CSZF reacted fiber after six weeks in rat subcutaneous 




Figure 19 - SEMBSE image of a CSZF fiber implanted subcutaneously in a rat for six 








Figure 20 – Optical image of a 13-93B3 fiber reacted in rat subcutaneous tissue for four 
weeks, mounted in PMMA, and cross sectioned.  The outer perimeter of the fiber is 
denoted by a dashed line, and the center and outer edge of the fiber are labeled as 
indicated.  The four spots inside the fiber were analyzed by micro raman and the spectra 









Figure 21 – Micro raman spectra for a 13-93B3 fiber that was implanted in rat 
subcutaneous tissue for four weeks.  The peaks associated with HA are indicated by the 
dashed lines at (431cm-1 (PO43- v2), 965cm-1 (PO43- v1), 1065 to 1070cm-1 (CO32- v1) and 









Figure 22 – Micro-raman analysis of a Cu-3 fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The spot size of the laser was 2µm, and is 








Figure 23 – Micro-raman analysis of a Cu-3 fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The light gray lines represent peaks associated with 
PMMA, and the pattern for PMMA is at the top of the figure.   
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Figure 24 – Micro-raman analysis of a CS fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The fiber was measured at five spots from the outer 
edge (1) to the center (5) and the spectra are shown in Fig 25.  The red line through the 
image has no meaning and was an artifact of the micro-raman software.  The spot size of 







Figure 25 – Micro-raman analysis of a CS fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The light gray lines represent peaks associated with 




Figure 26 – Micro-raman analysis of a CSZ fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The spot size of the laser was 2µm, and is 




Figure 27 – Micro-raman analysis of a CSZ fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The micro-raman spectra for each of the 10 spots are 
shown above, outer edge (1 E) to the center (10 C).  The peaks associated with calcite, 





Figure 28 – Micro-raman analysis of a CSZF fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The fiber was measured at six spots from the outer 
edge (1) to the center (6).  The red line through the image has no meaning and was an 
artifact of the micro-raman software.  The spot size of the laser was 2µm, and is 






Figure 29 – Micro-raman analysis of a CSZF fiber that reacted while in contact with rat 
subcutaneous tissue for six weeks.  The micro-raman spectra for spots one to six are 
shown above, outer edge (1 E) to the center (6 C).  Calcite had peaks present in spectra 




Figure 30 – XRF spectra for the as-made bioactive borate glasses doped with minor 
elements.  Copper (Cu or C), strontium (Sr or S), zinc (Zn or Z), iron (Fe or F).  The 
arrow in Fig 30A is indicating a peak associated with the polymer binder used to mount 
XRF sample.  It is noted that the CS, CSZ, and CSZF patterns for Sr overlap in Fig 30B.  
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Figure 31 – XRF spectra for each type of bioactive borate glass scaffold doped with 
minor elements that were implanted in subcutaneous tissue of rats for six weeks.  Copper 
(Cu or C), strontium (Sr or S), zinc (Zn or Z), iron (Fe or F).  The arrow in Fig 31A is 
indicating a peak associated with the polymer binder used to mount XRF sample. 
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Figure 32- High magnification SEMBSE image of the reacted CSZF fiber (six weeks in-





Figure 33 – Schematic relating how hydroxyapatite formation is inhibited by the presence 
of six coordinated ions in aqueous environments 37-38,50.   
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A pad of micron and submicron borate glass fibers was used to treat 15mm full 
thickness cutaneous wounds of rats and by 15 days the wound area decreased by 85 to 
90% of its original size.  The dermal, epidermal, and subcutaneous tissues in all four of 
the 93B3 fiber filled wounds were significantly regenerated by day 22 while only three 
out of four wounds from the control group (untreated wound) regenerated the 
subcutaneous tissue.  There were no signs of infection present in either the control or 
93B3 fiber filled wounds.  The wound contraction, the thickness of the granulation tissue 
and the gap present in the subcutaneous tissue layer after 22 days were all measured and 
compared via the student t test.  There were no statistically significant differences 
between the control and 93B3 fiber filled wounds.  No 93B3 fibers were identifiable in 
the histological sections at 22 days, but there was evidence of 93B3 microspheres that 
had reacted with the body fluids and formed hydroxyapatite (HA).  Blood vessels were 
seen adjacent to many of the reacted 93B3 microspheres indicating that the boron 
released (dissolved) from the microspheres could be promoting an angiogenic effect that 
is important to wound management and healing.  
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The advantages of using the 93B3 glass fibers for wound healing are as follows:  
• The 93B3 fibers are biocompatible and biodegradable 
• The boron released from the glass is potentially angiogenic 
• The release of lithium and sodium from alkali borate glasses has been shown to be 
anti-bacterial  
• The 93B3 glass reacts quickly with body fluids releasing calcium that has been 
linked to regulating healing in skin 
• There were no signs of inflammation surrounding any of the reacted 93B3 glass 
fibers or microspheres   
 
6.2.  INTRODUCTION 
  For decades bioactive glasses have been known to bond with both hard and soft 
tissue 1.  The majority of the research on bioactive glasses has been directed at the 
regeneration of bone, but recently, there has been interest in the effects that bioactive 
glasses may have on soft tissue.  The promotion of soft tissue growth such as blood 
vessels in the presence of bioactive glass has recently sparked interest in using bioactive 
glass to regenerate soft tissue.  Leach et al coated a polymer based, vascular endothelial 
growth factor releasing scaffold with bioactive glass particles and successfully promoted 
blood vessels growth in-vitro 2.   
Soft tissue interactions with bioactive glass have been studied for soft tissue 
augmentation and for understanding how bioactive glass interactions at the bone to soft 
tissue interface.  Fibers of a 13-93 glass, a silicate based bioactive glass, coated with 
chitosan were implanted in rabbit soft tissue for up to 24 weeks 3.  The immune response 
was described as generally mild, and soft tissue was present throughout the bioactive 
glass implants.  Fu et al implanted mesenchymal stem cell seeded 13-93 bioactive glass 
scaffolds in subcutaneous sites of rats for the purposes of bone growth, however, 
significant vascular growth adjacent to the outer surfaces of the scaffolds was noted on 
removal.  Histological assessment from rats showed that significant soft tissue filled the 
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inside of the open pores in the scaffold 4.  Scaffolds composed of randomly oriented 
fibers and scaffolds with a microstructure similar to trabecular bone composed of 13-93 
glass implanted in rat soft tissue were reported to have significant soft tissue growth 
inside the open pores at six weeks.  No significant immune reaction was noted upon 
removal of the scaffolds, and vascular growth adjacent to the outer surface of the 
scaffolds was also noted 5.  
 Calcium, a significant component in most bioactive glasses has been reported to 
be an important factor in the wound healing of skin 6.  It is suspected that calcium is 
required for the migration of epidermal cells and also plays an important role in the late 
stages of healing 6.  The presence of calcium in the immediate vicinity of an open wound 
could help the body to regulate wound healing processes more effectively, especially in 
open wounds.  Human keratinocytes (main type of cells of the epidermis also known as 
basal cells) require <0.5mM calcium to proliferate, but fibroblasts (cells that synthesize 
extracellular matix and collagen) need a concentration >1.4mM.  At higher calcium 
concentrations, keratinocyte proliferation is suppressed, but other biological markers for 
cell differentiation required for wound healing are promoted 6.    
 The use of growth factors for treating wounds has not been very successful 7.  The 
body needs growth factors at certain time intervals to be effective in faster healing, but it 
is difficult to time the release effectively during treatment.  The most effective treatment 
for wounds has been covering the wound and allowing the body to naturally support the 
delivery of growth factors or other required nutrients 7. 
 In an in-vitro study, borate glasses were found to have beneficial antibacterial 
effects 8.  Lithium borate glasses when placed in culture with several harmful bacteria 
 251 
such as escherichia coli (ecoli), salmonella typhimurium (salmonella), and 
stapphylococcus aureus (staph), have all been shown to kill the bacteria due to the local 
increase of pH from the release of alkali (Li) to the immediate surroundings 8.  The 
ability to reduce or eliminate bacterial growth at the site of an open wound would be 
advantageous, especially without the need for antibiotics.  
Traditionally, bioactive glasses have been silicate based and react relatively 
slowly with the body fluids over a period of several months 3,9,10.  Bioactive glasses 
containing boron as the glass former have been shown to react with simulated body fluids 
up to five times faster than silicate glasses in certain in-vitro experiments 11,12.  Fibers (up 
to 300µm in diameter) of the bioactive borate glass 93B3 have been shown to fully react 
in four weeks in rat subcutaneous tissue with no noticeable immune reaction.  Soft tissue 
and blood vessels were present inside many of the reacted fibers.  
Due to the faster reaction of the borate glass when in contact with body fluids, its 
biological compatibility, its release of calcium in the immediate wound site, and its 
potential antibacterial effect, an investigation of a bioactive glass in the form of 
submicron fibers was undertaken.  Borate glass fibers (300nm to 2µm diameter) were 
made and used as a bandage material to treat full thickness cutaneous wounds.  After 22 
days, the rate of wound closure was similar between the treated and untreated wounds, 
but there may be advantages in terms of wound quality (growth and functionality of 





6.3.   MATERIALS AND METHODS 
6.3.1 Preparation and Sterilization of Bioactive Glass Fibers 
 The glass fibers used as the wound dressing were made from a borate glass with a 
nominal composition of 53 B2O3, 20 CaO, 12 K2O, 6 Na2O, 5MgO, 4 P2O5 (wt%) 
denoted as 93B3.  The glass was melted in a platinum crucible for one hour at 1050oC 
and stirred every ten minutes prior to casting the melt on a cold copper plate.  The 93B3 
fibers (shown in Figs 1 and 2) were made by a proprietary process (Mo-Sci Corporation, 
Rolla, MO).  The bioactive 93B3 glass fibers were sterilized by placing ~150mg of fiber 
in a silica glass vial with an aluminum foil top, heating the vial to 300oC in an oven (Ney 
Vulcan 3-130) for four hours, and cooling the oven overnight to room temperature 
whereupon the sterile fibers were ready for use. 
6.3.2  Animals 
 Four male Sprague Dawley rats supplied by Fisher Scientific (St. Louis MO) were 
used in the experiment.  The rats were approximately four months old, and weighed about 
250 grams each.  The rats had free access to tap water and food pellets and were caged 
individually. 
6.3.3 Surgical Procedure 
 Each rat was shaved to remove the hair at the surgical site (Fig 3) and disinfected 
with iodine and 70% ethanol solution prior to the surgical procedure.  Two full thickness 
cutaneous defects, 15mm in diameter, were made in the skin, one on each side of the 
spine above the shoulders, see Fig 3.  One defect was covered with a dry pad of bioactive 
93B3 glass fibers (150mg) while the other defect was used as a control and left empty, 
see Fig 4.   
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The wound covered with the glass fibers was staggered, alternatively between the right 
and left side for successive rats.  After the surgery, bandages were placed over the glass 
fiber pad at the wound sites for four days over the control wounds. 
6.3.4 Cutaneous Wound Recovery, Fixation, and Dehydration 
 After 22 days, the animals were sacrificed by CO2 inhalation.  A section of soft 
tissue ~20mm by 20mm on an edge surrounding the wound was recovered for 
histological assessment.  The tissue was placed in a 10% formalin solution for four days 
and then dehydrated by microwave dehydration with a series of ethanol solutions from 
80% to 100% 13. 
6.3.5  Sample Embedding and Slide Preparation 
 The dehydrated tissue sections were cut in half, one half stored in ethanol, and the 
other half placed in a tissue processor (AutoTechnicon Model 2A) for wax embedding.  
The tissue sample was infiltrated with wax (Paraplast Tissue Embedding Medium, 
McCormick Scientific LLC) for a minimum of four hours at 45oC before being embedded 
in a wax block with a paraffin mounting system (Leica EG 1150H).  The wax block was 
placed in a microtome (Leica RM 2235 microtome) and 18um thick sections were cut 
with TBS Shur/sharp blades, (Triangle Biomedical Sciences, Durham NC).  The sections 
were floated on a warm water bath (Lipshaw Electric Tissue Float, model number 375, 
Detroit MI) (40oC) to improve the flatness of the sections and then mounted on a glass 
slide (Fisher Brand Superfrost microscope slides, St. Louis MO).  The mounted slides 
were placed on a slide drier (Fisher Scientific slide warmer, St. Louis MO) overnight to 
dry the tissue sections.  
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6.3.6 Wound Healing Assessment 
 The dimensions of the open wounds was measured periodically and the area of 
the open wound (unhealed) was calculated as a function of time.  An example of the 
healing progression for a control wound and wound treated with 93B3 glass fiber pad is 
shown in Fig 5.  The wound area as a function of time, the gap in the subcutaneous tissue 
(distance between the sides of the wound) at 22 days, and the average thickness of the 
granulation tissue present at 22 days were measured and compared by the student t test to 
determine statistical differences between the control and wounds treated with the 93B3 
glass fiber pad.  
6.3.7 Histological Staining – Hematoxylin and Eosin (H&E) 
 H&E staining of the histological sections was done with a Leica CV Autostainer 
XL (Phelps Country Regional Medical Center, Rolla MO).  Stained slides were viewed 
with a microscope (Olympus BX50, Olympus Optical Co) at magnifications of 200, and 
400x and imaging software (DP Controller, Olympus Optical Co) was used to capture 
images. 
6.3.8  Scanning Electron Microscopy (SEM) 
 Fibers of the 93B3 glass were imaged with a Hitachi S4700 FESEM (see Fig 2).  
The fibers attached to an aluminum stub with carbon tape and were coated with ~100Å of 
gold palladium prior to examination.  The accelerating voltage was 10kV and the 





6.4.  RESULTS 
6.4.1  Histological Assessment of the Wound Sections (H&E) 
 All four of the H&E stained sections for the control wounds are shown in the 
composite photos in Fig 6.  The dark horizontal line (at the top of the sections) represents 
the area of the wound where the two sides of the wound joined and were in the process of 
healing. In Figs 6A, 6C, and 6D granulation tissue is present at the top of the wound 
(black arrows).  The wound in Fig 6B had healed to the point where the granulation tissue 
had been replaced by dermal and epidermal tissue.  The wound sections in Figs 6A and 
6B have a band of subcutaneous tissue (bright pink) spanning the bottom of the entire 
wound area.  Figure 6C has subcutaneous tissue present on the right hand side of the 
wound (black arrow), but there is no subcutaneous tissue present at the wound interface 
(black line, top of image) or on the entire left side of the section.  The gap in the 
subcutaneous tissue (double ended arrow) in Fig 6C was the longest of any tissue section, 
control or 93B3 glass fiber treated, at 12.7mm.  The section in Fig 6D has a 4mm gap 
(double ended arrow) located at the interface between the two sides of the wound. 
 A composite photo of the sections from the wounds filled with the pad of 93B3 
fibers is shown in Fig 7.  The black horizontal line shows the region were the two sides of 
the wound came together.  Granulation tissue present in Figs 7B, 7C, and 7D, as 
indicated by the arrows.  No granulation tissue was observed in Fig 7A as it had been 
replaced with dermal and epidermal tissue.  A small gap (<2mm) was present in the 
subcutaneous tissue (double ended arrow) in Figs 7A and 7B, a larger gap (~4mm) was 
present in Fig 7C and there was no detectable gap in the subcutaneous tissue in Fig 7D. 
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No evidence was found of the 93B3 fibers in Fig 7, but the small fiber diameter would 
make them difficult to see at the magnifications used for the histological analysis.   
 The 93B3 fiber filled wound in Fig 7A, was selected for histological analysis.  
The entire tissue section and selected magnified areas are shown in Fig 8.  The 
approximate boundary of the original wound is indicated by the horizontal arrow in Fig 
8A.      
Evidence of the original wound is indicated by the presence of the larger, reacted 
93B3 microspheres distributed throughout the subcutaneous tissue, see Figs 8B, 8C, 8D, 
and 8E.  In Fig 8B, the reacted microspheres are at the bottom left of the image, and 
above them there are hair follicles (vertical arrows) and fat deposits (oval) that are 
indications that the tissue has not scarred, but in fact returned to its original function.  The 
microspheres in Fig 8B are magnified in Fig 8C, and adjacent to the top of the reacted 
microsphere is a blood vessel filled with red blood cells (white arrow).  In the unhealed 
portion of the wound in Fig 8A, boxes D and E, more reacted microspheres are present 
along with blood vessels nearby (see Fig 8D and 8E).  The two vertical dashed lines in 
Fig 8A show the region where the subcutaneous tissue has yet to regenerate, but the 
dermal and epidermal layers have completely replaced the granulation tissue.     
6.4.2 Wound Healing Assessment 
 The wound area that remained open during the healing process was calculated as 
a function of time as shown in Fig 9.  The average wound area (n=4) for the control was 
slightly less than that for the wounds treated with the 93B3 fiber pad up to day 11, but, by 
day 15 the fiber treated wounds and the control wounds were almost the same.  After 18 
days, the control and 93B3 fiber filled wounds were >99% closed as shown in Fig 9 and 
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all the wounds were completely closed by day 22.  The wound closure data was 
compared via the student t test, but there was no statistical difference (p<0.05) between 
the control and the wounds treated with the 93B3 fiber pad (see Table 1).   
 The average gap between the subcutaneous tissue and the thickness of the 
granulation tissue was also measured to differentiate any differences in healing between 
the control wounds and the wounds treated with the 93B3 fiber pads.  The average gap in 
the subcutaneous tissue was 4.2±6mm for the control and 1.9±1.6mm for the 93B3 fiber 
filled wounds.  The average thickness of the granulation tissue for the control wounds 
and 93B3 fiber filled wounds was 1.7±1.2mm and 1.7±1.3mm, respectively, see Fig 10.  
There was no statistically significant difference between the control wounds and the 
93B3 fiber filled wounds for the average gap in subcutaneous tissue or the thickness of 
the granulation tissue when compared by the student t test (Table 1).    
6.5. DISCUSSION AND CONCLUSIONS 
 The composition of the bioactive 93B3 glass has already been discussed in some 
detail for why it was chosen for a wound healing application.  Borate glasses, specifically 
lithium borate glasses, have been shown to have antibacterial effects when placed in the 
presence of escherichia coli, salmonella typhimurium, and stapphylococcus aureus 8.  The 
high alkalinity of the aqueous environment was determined to be responsible for killing 
the bacteria.  The 93B3 glass fibers, also a high alkali containing borate glass, would be 
expected to have a similar response on killing bacteria and would do so without the need 
for antibiotics. The possible antibacterial effect, the release and benefits of calcium to 
wound healing, the biological compatibility of the glass, and the fast reaction time all 
were considered important to the performance of the 93B3 glass in wound healing. 
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The 93B3 glass converts to hydroxyapatite (HA), the same material found in the 
inorganic component of bone, when in contact with body fluids.  Hydroxyapatite is a 
compatible material with living mammalian tissues, and HA has considerable use as a 
filler to increase skin thickness 14. 
The micron and sub-micron sized fibers shown in Figs 1 and 2 are compressible 
similar to cotton and are relatively easy to pack into open wounds.  The 93B3 fiber did 
not need to be changed like many traditional wound dressings as it is inorganic and the 
likelihood of bacteria growing in the dressing was low due to the release of alkali from 
the glass 8.   
The presence of a scab-like material formed from the 93B3 fibers and the wound 
secretions likely caused the wound to heal at a slower rate as the skin had moved the 
layer of fibers out of the way to close the wound.  In Fig 5A, the wound (right side) is 
completely covered with a crusty layer composed of 93B3 fibers that reacted with body 
secretions.  The images in Fig 5B and 5C show the layer of fibers (right side) edges 
curled as the wound contracted.  The majority of the 93B3 fibers were removed when the 
layer of fibers was discarded and the wound was already 85-90% closed (between days 
11 and 15).  The fact that the fibers stayed in place for ~90% of the wound closure is 
good since covering the wound is desirable 7.   
The granulation tissue that forms at the wound interface is where new capillaries, 
macrophages, and fibroblasts congregate as soon as four days after the initial damage 7.  
The macrophages secrete growth factors necessary for angiogenesis and promote new 
tissue formation (fibroplasia) while also eliminating bacteria 7.  The fibroblasts build a 
network of extracellular matrix required for endothelial cell migration, and the vascular 
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network supports all of the cells by supplying oxygen and the necessary nutrients needed 
by the cells 7.  As the wound is healed, the granulation tissue is replaced by functional 
tissue, so the size of the granulation tissue is an indicator of how much tissue still needs 
to be regenerated.  The fact that the average granulation tissue thickness between the 
control and the treated wound was not statistically significant suggests that the fiber was 
not inhibiting the re-epithelialization process.  No signs of immune reaction or other 
adverse biological effects attributable to the  93B3 fiber were noticed during the wound 
healing. 
When reviewing the histological control sections, the tissue section of the control 
wound shown in Fig 6C did not have any subcutaneous tissue present starting at the right 
hand side of the granulation tissue all the way to the far left of the section.  The thinned 
dermis at the gap in 6C implies poor-quality scar formation and the dashed arrow on the 
right side of Fig 6C denotes subcutaneous tissue present on the right side of the wound.  
This was the only section from the control or fiber filled wounds that did not regenerate a 
subcutaneous tissue layer.  Sections of all of the 93B3 fiber filled wounds contained 
regenerating subcutaneous tissue, therefore, the 93B3 glass fibers may offer an advantage 
to the wound healing process by bridging the regenerating tissues.  
The wounds treated with the pads of 93B3 glass contained blood vessels close to 
the reacted 93B3 microspheres.  Images from Fig 8B, 8C, 8D, and 8E all had vessels in 
the immediate vicinity of the reacted 93B3 microspheres.  The boron release from the 
reacting fibers may have had a positive effect on the surrounding tissues.  In-vitro work 
by Dzondo-Gadet et. al 15 showed that low concentrations of boric acid in solution with 
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human placental cells promoted the uptake of mRNA and had a stimulatory effect on cell 
activity similar to a growth factor.   
The presence of the 93B3 glass fibers and microspheres may have also acted as a 
scaffold or guide for the new tissue to use to grow across the wound.  After only four 
days, the 93B3 fibers had reacted with secretions from the wound and formed a crusty 
layer that looked similar to a scab.  The presence of a fiber layer served to keep the 
wound moist and keep bacteria and other pathogens from entering the wound.  The 
animals were kept in a relatively clean environment and were injected with penicillin to 
reduce the chances of infection, therefore the benefits of a scab may not have been 
noticeable.   
The data in Table 1 indicate there was no statistically significant difference 
between the healing time of the wounds covered with the 93B3 glass fiber pads and the 
control (empty wound).  The control and the fiber filled wounds healed at approximately 
the same rate and were >99% closed by day 18.  This outcome was not entirely surprising 
as the size of the wounds was not of critical size and much of the wound closure was 
caused by the contraction of the actin fibers in the skin.  In humans, this sort of wound 
closure is only present in young children, whereas, wounds typically close by epithelial 
cells migration across the wound.  Re-epithiliazation of the wound is a better indicator of 
wound healing than just the rate of contraction 7.  For the treatment of wounds in adult 
humans, the most important factor is wound coverage 7.  There are several skin 
substitutes on the market for treating a variety of wound types, but often they are only 
effective for a short period of the wound healing process by stimulating the production of 
cytokines which the body uses in healing the wound 7.     
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The next step with this work would be to alter the glass composition to release 
specific metal ions that have been shown to promote endothelial cell migration in-vitro 16.   
These trace elements-- copper, zinc, manganese, iron, and magnesium, have all been 
identified as essential elements for skin healing at various times in the wound healing 
process 6.  The evidence for wound healing support is strongest for copper and zinc, and 
these will be tried first.   Another step would be to coat the 93B3 glass fibers with a 
material such as a growth factor 17 or peptide 18 that promotes wound healing.  There are 
significant practical hurdles in adding degradable proteins to the glass composition.  As 
discussed previously, the bioactive glasses release ions in a controlled manner over a long 
period of time (days to weeks), which may have benefits in the wound healing process 
compared to a short burst of growth factor 7.  A non-healing model would also be useful 
especially in determining any differences between the control and the glass fiber during 
the endothelial cell migration stage of healing.  
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Table 1. Statistical Significance Between the Control wounds and the 93B3 Filled 
Wounds For Wound Closure, the Gap in Subcutaneous Tissue at 22 Days, and the 

















































































Figure 2 – SEM micrographs of the as-made 93B3 fiber.  The image in Fig 2B is a higher 






















Figure 4 – Photograph of a Sprague Dawley rat showing the full thickness cutaneous 
defects.  Fig 4A shows both freshly formed wounds (15mm diameter) just posterior to the 

















Figure 5 – Progression of wound closure for the full thickness subcutaneous wounds.  
The times shown are (A) 4 days, (B) 7 days, (C) 11 days, (D) 15 days, (E) 18 days, and 
(F) 22 days.  The control is on the left side and the 93B3 fiber filled wound is on the 












Figure 6 – Histological sections of the full thickness cutaneous control wounds after 22 




Figure 7 - Histological sections of the full thickness cutaneous 93B3 bioactive glass filled 
wounds after 22 days (H&E).  The black line at the top of each tissue section denotes 
where there is unhealed tissue.  The double ended arrows show the gap in the 
subcutaneous tissue and the vertical indicate granulation tissue.   
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Figure 8 – Histological assessment of a 93B3 filled full thickness cutaneous wound after 
22 days.   
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Figure 9 – Comparison of the original wound (%) vs. time for the control (blue) and the 













Figure 10 – Average gap in the subcutaneous tissue and average thickness of the 














This section combines and summarizes the main conclusions from each of the six 
manuscripts from the body of the dissertation. 
1. Boron released from 13-93B3 scaffolds at an estimated concentration of 
<126mg/kg/day (sixteen 70mg scaffolds reacting in four weeks) caused no in-
vivo toxicity in adjacent tissue or systemic organs.  The kidney and liver were 
analyzed from sacrificed rats and no pathological changes beyond incidental 
were reported.  When a 13-93B3 scaffold was placed in a bone site, there was 
no increase in macrophages or other inflammatory cells, and there was no 
necrotic tissue in the new bone adjacent the 13-93B3 scaffolds after 12 weeks.  
2. Scaffolds composed of 13-93B3 fibers had significantly more bone after 12 
weeks in rat calvaria (p<0.05) than silicate based 13-93 scaffolds indicating 
the borate glass was a better bone growth promoter.   The reason behind the 
increased bone regeneration in the borate scaffold is thought to be due to the 
faster reaction of the scaffold which increased the rate of calcium release.  
Calcium is known to act as a bone growth stimulator by promoting osteoblast 
migration and proliferation. 
3. Bioactive borate glass was doped with trace elements (copper and zinc) which 
significantly improved angiogenesis (blood vessel formation) in the soft tissue 
inside porous, randomly oriented fiber scaffolds.  Angiogenesis is important in 
sustaining tissue growth in scaffolds, and glasses doped with these elements 
could be an important improvement in increasing the size of tissue 
engineering scaffolds.  
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4. For the first time, bioactive glasses containing calcium were made to form 
non-calcium phosphates when reacted in-vivo.  The conversion of the glass is 
thought to be controlled by the size of the atom added as a trace element to the 
glass.  It is speculated that the smaller the ion, the more profound the effect on 
the inhibition of hydroxyapatite. 
5. Cutaneous soft tissue defects were successfully treated with nano fibers of 13-
93B3 glass, and the quality of the scar was better than the control (untreated 
wound).  Ions such as calcium are known to increase epithelial cell migration 
in-vitro and are hypothesized to have several physiological roles in wound 
healing.  The reaction of the glass and release of ions such as calcium are 
assumed to improve wound healing. 
6. The hollowing of 13-93B3 fibers when reacted in-vivo often had soft tissue 
and blood vessels present inside.  The vessels grew along the length of the 
fiber, so it is thought that bioactive glass fibers could be used as a method of 










4. FUTURE WORK 
1. Continue studies into the potential toxicity of boron in-vivo.  The more data the 
better.  Collection of urine and subsequent measure of boron during the reaction 
of the glass could be a good measure of how the glasses reacted in-vivo.  Little is 
known at this point about how boron is released or if it changes as a function of 
time.  Rats are a good model for boron toxicity since they are more sensitive to 
boron that mice or rabbits. 
2. Understanding more about calcium as the major bone promoter from bioactive 
glass could be important, especially for future use and acceptance of silica free 
bioactive glasses.  In-vitro cell culture work on the migration and proliferation of 
osteoblasts and other tissues in the presence of calcium, or in-vivo work with 
additional silica free glasses with even faster release rates (CaLiB) could be 
interesting for enhanced bone formation. 
3. The angiogenic response of soft tissue with the doped bioactive borate glasses 
(copper and zinc) could be important in improving bone and soft tissue scaffolds 
and wound healing treatments.  Blood vessel guides and treatment of diabetic or 
non-healing ulcers could be made partially or wholly from these glasses and 
significantly improve the treatment options.   
4. The conversion of glasses to non-HA materials is a new area of work that has a lot 
of possibilities.  Calcium compounds such as calcite have been reported to be 
degraded faster than HA by osteoclasts in-vitro.  It may be possible to control the 
calcium phosphate phase that forms and make tricalcium phosphate or brushite in-
vivo.  Calcium free glasses replaced with barium or strontium may have benefits 
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in tissue engineering or other fields of study.  In the past, in-vitro reaction has 
simulated the in-vivo reaction; so much of this work may be possible in-vitro.  In 
addition, other trace elements could be added to the glass, singularly, or in 
combination to see if phases can be shifted by straining the crystal structure and 
how solid solutions affect the formation of new materials.  
5. The change from a mono layer of HA to a layered structure in borate glasses such 
as 13-93B3 is still not understood.  Borate glasses have been reported to form 
these layers for almost 15 years, and several reasons for the formation have been 
suggested, but this phenomenon has never been formally studied.  Controlling or 
at least understanding this microstructural change could be beneficial for making 
new devices for controlled drug release or other new technologies. 
6. Wound healing is potentially a huge new area of study for bioactive glass.  The 
body is compatible with bioactive glass, and the controlled release of ions can be 
achieved that can improve the rate of healing.  The reaction products of bioactive 
glasses also tend to be antimicrobial, so the glasses may be of use in treating 
bacterial infections locally in people that are resistant to penicillin. 
7. One tissue not studied in the present work was the avascular tissue cartilage.  
Cartilage survives by diffusion of nutrients and oxygen to blood vessels that exist 
outside of the tissue.  Cartilage is also slow to heal is damaged and healing could 
be enhanced by the addition of particles of fibers of the angiogenic glasses.  A 
vasculature inside the cartilage scaffold could enhance the rate of diffusion in the 





























Figure 1 - Photomicrograph of an H&E stained section of the renal cortex from a rat that 
contains protein casts and tubular degeneration (Fig 1A).  Figure 1B is a magnified view 
of the renal cortex showing a folded glomerulus as indicated by the vertical arrow, renal 
tubes (horizontal arrows) and mononuclear inflammation characterized as tubular 




Figure 2 - Photomicrograph of an H&E stained section of the renal medulla from a rat 
that contains nephrocalcinosis (arrows) and a large blood vessel on the left of the image 
(Fig 2A).  Figure 2B is a magnified view of the renal medulla showing nephrocalcinosis 





Figure 3 - Photomicrograph of an H&E stained section of the renal cortex from a rat that 
contains protein casts and tubular degeneration (Fig 3A).  Figure 3B is a magnified view 
of the renal cortex showing three protein casts (P), tubular degeneration due to loss of the 
epithelial eosinophilia (dashed circle), and gold/brown pigment indicative of infiltrates of 


































Figure 1 – H&E stained section of a Cu-3 scaffold (1 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 14 (A), 8 (B), and 11(C), respectively.  The original scaffold 





Figure 2 – H&E stained section of a Cu-3 scaffold (2 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 24 (A), 32 (B), and 32(C), respectively.  The original scaffold 




Figure 3 – H&E stained section of a Cu-3 scaffold (3 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 33 (A), 35 (B), and 37(C), respectively.  The original scaffold 





Figure 4 – H&E stained section of a CS scaffold (1 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 32 (A), 27 (B), and 39(C), respectively.  The original scaffold 






Figure 5 – H&E stained section of a CS scaffold (2 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 11 (A), 45 (B), and 21(C), respectively.  The original scaffold 






Figure 6 – H&E stained section of a CS scaffold (3 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 47 (A), 45 (B), and 35(C), respectively.  The original scaffold 




Figure 7 – H&E stained section of a CSZ scaffold (1 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 64 (A), 38 (B), and 33(C), respectively.  The original scaffold 





Figure 8 – H&E stained section of a CSZ scaffold (2 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 72 (A), 73 (B), and 32(C), respectively.  The original scaffold 





Figure 9 – H&E stained section of a CSZ scaffold (3 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 51 (A), 34(B), and 52(C), respectively.  The original scaffold 




Figure 10– H&E stained section of a CSZF scaffold (1 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 58 (A), 45(B), and 45(C), respectively.  The original scaffold 




Figure 11– H&E stained section of a CSZF scaffold (2 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 59 (A), 80(B), and 78(C), respectively.  The original scaffold 




Figure 12– H&E stained section of a CSZF scaffold (3 of 3) used for the blood vessel 
analysis.  The three strips counted in this section are indicated by the dashed lines in the 
whole section and a magnified view of the strips is shown below.  The number of vessels 
from each strip were 37 (A), 51(B), and 52(C), respectively.  The original scaffold 






























BIOACTIVE GLASS SCAFFOLDS FOR SOFT TISSUE REGENERATION 
By 
 
Steven Jung, Missouri University of Science and Technology 
 
ABSTRACT 
 Melt derived fibers of 13-93 glass have been made into three dimensional random 
oriented scaffolds for soft tissue regeneration.  The scaffolds were implanted in the 
subcutaneous tissue of rats from two to twenty eight weeks.  Significant vascularization 
and tissue growth was evident after just two weeks in-vivo.  The 13-93 glass fibers 
reacted with the body fluids at a rate of approximately 3µm a week during the duration of 
the experiment and formed a layer of hydroxyapatite (HA) at the fiber-tissue interface.  
Collagen, the building block of both hard and soft tissue, was also found coating the 
reacted glass fibers indicating that the 13-93 glass fibers may be a useful material for soft 
tissue augmentation and wound dressing.  
  
INTRODUCTION 
 Bioactive glasses have been known to bond to bone since 1969 [1, 2].  Treatment 
of middle ear and periodontal defects led to the first investigations into soft tissue 
bonding of bioactive glass [1, 2].  Wilson showed soft tissue interactions with silicate 
based bioactive glasses were similar to interactions with bone, first forming a silica gel 
layer followed by the precipitation of an amorphous calcium phosphate which then 
crystallized to the crystalline material known as hydroxyapatite (HA) [1, 2].  These first 
studies indicated that bioactive glasses may one day have use in the treatment of damaged 
soft tissue. 
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Like bone, damaged tissues such as skin, muscle, and internal organs need a 
substrate to which they can attach and grow for effective healing.  Scaffolds made of 
degradable and bioactive materials are preferred as they provide a resorbable substrate 
beneficial to tissue growth.  Polymers alone are not bioactive; however, bioactive glasses 
or composites of polymers and bioactive glasses show significant promise for treatment 
of damaged soft tissue.  Leu et. al. incorporated 45S5 bioactive glass into a collagen 
substrate and found that the addition of the glass had a proangiogenic effect[3].  Leach 
made a polymer scaffold with embedded 45S5 bioactive glass, and used it to release 
vascular endothelial growth factor (VEGF) and studied the angiogenic effect for use in 
hard and soft tissue applications [4].  
The maximum distance tissue can survive is approximately 100 to 200µm from a 
blood vessel, so new blood vessel formation is necessary for wounds to heal [5].  Specific 
to placing artificial materials such as bioactive glass scaffolds in the body, tissues cannot 
grow into and fill the scaffold until a network of blood vessels have first penetrated the 
scaffold or at least are promoted to penetrate the scaffold as surrounding tissue infiltrates 
the scaffold.  The importance of vascularization to wound healing is significant and 
should not be ignored [5].  Vascular endothelial growth factor has been isolated as one of 
the most important signals for wound healing.  Several growth factors natural to the body 
have been identified as important to wound healing, however, none are as prevalent or 
have the long-term stimulatory effects for vascular growth as VEGF[6].  
 The well known bioactive glass, 45S5, is difficult to heat treat to form scaffolds or 
to pull into continuous fibers, so, other silicate based glasses have been developed with 
longer working ranges for improved processing [7, 8].  Another bioactive glass known as 
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13-93 has been used successfully to produce scaffolds with a variety of porosities and 
microstructures [9-12].  Three dimensional scaffolds composed of 13-93 have been 
shown to bond to soft tissue, and significant vascularization was observed when these 
scaffolds were placed in a subcutaneous site [9, 11].  
DISCUSSION 
 The present work describes the use of bioactive glass 13-93 (53 SiO2, 20 CaO, 12 
K2O, 6Na2O, 5MgO, 4P2O5 in wt%) as a soft tissue scaffold material.  The scaffolds used 
in the present work were 7mm in diameter, 2mm thick, and weighed approximately 
70mg.  An example of a 13-93 glass fiber scaffold is shown in Figure 1.  These scaffolds 
were studied for soft tissue and vascular growth along with the reaction of the fiber with 
body fluids.  The scaffolds were made by breaking melt derived 13-93 glass fibers into 2 
to 3mm lengths, placing the randomly oriented fibers in a ceramic mold, heating the 
fibers to a temperature sufficient for thermal bonding, followed by cooling the scaffolds 
to room temperature.  The microstructure of a three dimensional glass fiber scaffold is 
shown in Fig. 2a.  During the bonding process, the fibers soften and the edges round.  
The softened fibers stick together forming the three dimensional scaffold as shown in Fig 
2b.  The interconnected porosity of the scaffold is approximately 50%, and its 
compressive strength is approximately 5 MPa.  
 Soft tissue growth into 13-93 fiber scaffolds has been studied extensively for 
scaffolds implanted for times between two and twenty eight weeks in subcutaneous sites 
in laboratory rats.  Typically, four implant sites are used on a single animal as shown in 
Fig 3.  The implant site is just under the skin, and the scaffold is implanted by cutting the 
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skin and sliding the scaffold under the loosely attached tissue.  The picture in the lower 
right hand corner of Fig 3 shows a scaffold being implanted in a subcutaneous site.   
 After two weeks in-vivo, the scaffold looks like the one shown in Fig 4.  The 
tissue at A is the subcutaneous tissue underneath the skin, B is the scaffold, and C is the 
skeletal muscle.  The scaffold has become infiltrated with soft tissue, and the scaffold is 
visibly red from blood vessels that had grown into the scaffold.  Prior to extraction, the 
scaffold had become attached to the subcutaneous tissue indicating the tissue and glass 
were compatible.  There was no measurable change in the overall dimensions of the 
scaffold. 
 Figure 5a is a H&E stained micrograph of the tissue present inside a 13-93 
scaffold after two weeks in-vivo.  The glass fibers are labeled with an ‘F’. The soft tissue 
present between the fibers was healthy and vessels containing red blood cells (pink dots) 
were present throughout the scaffold.  The black vertical arrows denote some of the 
vessels present in the scaffold in Fig 5a.  Soft tissue had grown adjacent to the fibers and 
no negative immune reaction, such as a walling off of the fibers, was observed.  This 
indicates that the 13-93 glass fibers are compatible with soft tissue and that the reaction 
products of the glass fibers are not producing an inhospitable environment.  The reaction 
products may in fact be promoting growth as silica and other elements present in the 
glass have been linked to growth factor release and promotion of tissue growth [13, 14]. 
Figure 5b is a section of the same two week 13-93 scaffold; however, it was 
stained with PAS stain which stains red blood cells green and soft tissue purple.  Tubule 
lining such as in vessels appears as a purple ring or outline depending on the vessel 
orientation.  Examples of the vessel lining are shown by the black horizontal arrows.  The 
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vascularity is more evident in the PAS stained section than the H&E stained section as 
denoted by the large number of vessels (vertical black arrows) throughout Fig 5b.  The 
distance between the vessels in the tissue present in Fig 5b range from ~50 to at most 
~100µm, which is considered a sufficiently vascularized tissue [5].  Vascular growth into 
the scaffold is important because the blood supply is the transportation system for 
supplying nourishment and oxygen and removal of waste and carbon dioxide.  
Insufficient vascular density can hinder tissue growth and slows the healing of wounds 
such as with diabetic ulcers and bed sores.  
 Figure 6 shows the progressive reaction of the 13-93 glass fibers with the body 
fluids for 4, 9, and 28 weeks in-vivo.  After 4 weeks in subcutaneous tissue, the image in 
Fig 6a, which is a SEMBSE (backscattered image) of a 13-93 fiber, shows a reaction 
layer at the outer edge of the fibers.  At higher magnification, three distinct layers are 
present.  Layer A is pointing to the 4µm layer hydroxyapatite, B is a 5 to 6µm thick silica 
gel layer, and C is the unreacted glass.  The total reaction layer is approximately 10 to 
12µm thick.   
Figure 6b is a SEMBSE image of a 13-93 fiber after nine weeks in-vivo.  The 
total reaction layer (HA and silica gel) is up to 30µm thick in some areas, and a non-
uniform reaction layer is becoming evident.  The non-uniform reaction layer has been 
documented previously both in-vivo[11] and in-vitro[15], but no explanation for this 
reaction has been suggested to date.   
The SEMBSE image in Fig 6c shows the cross section of a fractured 13-93 fiber 
after 28 weeks in-vivo.  The fiber has nearly reacted completely with the physiological 
fluids; the outer surface at A is a 30µm thick layer of HA.  The silica gel layer designated 
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by B is approximately 6 to 8µm thick, and the unreacted material at the center (C) is 
composed of SiO2, CaO, and P2O5.  None of the Na2O, K2O, or MgO from the starting 
fibers was detected at 28 weeks indicating that they had diffused out of the glass and 
were removed by body fluids.  An interesting observation from these three fibers is that 
the silica gel layer quickly reached a thickness of approximately 5 to 6µm (within four 
weeks), and even while the HA layer continuously grew thicker; the gel layer thickness 
remained constant.   
 An important observation from the in-vivo experiments using the 13-93 glass 
fiber scaffolds was the formation of collagen on the reacted fibers and potential uses in 
tissue engineering.  The SEMBSE image in Fig 7a shows strands of collagen coating and 
spanning the reacted 13-93 fibers in a scaffold that has been in-vivo for 28 weeks.  A 
magnified view in Fig 7b shows the collagen fibrils clearly, and the 64nm periodicity that 
is unique to collagen molecules [16].  Collagen is the building block of nearly all human 
tissue, hard and soft, so the interaction and compatibility with bioactive glass for tissue 
regeneration is important.  
 Understanding the short and long term benefits of 13-93 bioactive glass scaffolds 
with soft tissue make these scaffolds candidates for use in treating conditions such as 
diabetic ulcers, severe burns, or other traumatized soft tissue.  A material or scaffold that 
promotes vascular growth and tissue guiding while promoting the natural healing 
processes of the body will be an important advancement in the fields of both biomaterials 





 Three dimensional scaffolds composed of randomly oriented fibers of the 
bioactive 13-93 glass are compatible with subcutaneous soft tissue, promote significant 
vascular and soft tissue growth within just two weeks in-vivo, and react to form HA when 
in contact with soft tissue.  The 13-93 fibers reacted at a rate of about 3µm a week during 
the 28 week experiment.  No immune reactions were detected during the histological 
examination of the implanted scaffolds, and collagen, the building block of hard and soft 
tissue, readily forms on the 13-93 fibers when implanted subcutaneously.  Therefore, 
scaffolds or composites composed of 13-93 bioactive glass are good candidates for future 
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Figure 1 – Image of a 13-93 random fiber scaffold.  The scaffold measures 7mm in 






Figure 2 – SEM micrographs of a 13-93 random oriented fiber scaffold. Figure 2a shows 
the random orientation of the fibers and the rounded end of the fibers due to the heat 




Figure 3 – Schematic showing the scaffold placement in the subcutaneous tissue.  Image 





Figure 4 – Image of a 13-93 scaffold after two weeks in-vivo.  The tissue under A is the 
subcutaneous tissue under the skin, B is the scaffold, and C is the skeletal muscle.  The 




Figure 5 – Histology sections from the 13-93 scaffold implanted two weeks in 
subcutaneous tissue.  Fig 5a is a H&E stained section showing the soft tissue (pink) 
surrounding the glass fibers (white and labeled with an F).  The vertical arrows are 
pointing out blood vessels with red blood cells inside of them (pink dots).  Fig 5b is a 
PAS stained tissue section, and here the soft tissue is purple and the tubules of the vessels 
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is a dark purple (horizontal arrow). The red blood cells are green making the vessels more 




Figure 6 – SEMBSE images of 13-93 glass fibers implanted in a subcutaneous site for 
four, nine, and twenty eight weeks.  Fig 6a shows the reacted edge of the four week 
implanted fiber where A is the hydroxyapatite layer, B is silica gel, and C is unreacted 
glass.  The total reaction layer is 10 to 12µm thick.  Fig 6b is an image of a nine week 
implanted fiber showing a reaction layer of non-uniform thickness of about 30µm.  Fig 6c 
is an image of a fractured fiber that was implanted for 28 weeks.  The total reaction layer 
is approximately 90µm. The surface layer A is the HA, B is a silica gel layer, and C is 








Figure 7 – SEMBSE images of a 13-93 scaffold implanted in subcutaneous tissue for 28 
weeks that is coated with collagen fibrils.  Fig 7a shows a fractured scaffold surface with 
collagen strings coating and connecting the glass fibers.  Fig 7b is a higher magnification 
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Three dimensional assemblies of fibers made from bioactive glass compositions 
were investigated to determine their usefulness as scaffolds for the repair and 
regeneration of hard and soft tissues.  The microstructure, properties and in-vivo 
performance were measured for scaffolds (7mm diameter and 2mm thick) made from an 
interconnected network of discontinuous fibers of bioactive glasses such as 45S5 and 13-
93 that were arranged in a random oriented geometry.  Scaffolds, made from fibers whose 
diameter ranged from approximately 100 up to 300 microns, were implanted 
subcutaneously in laboratory rats for up to four weeks.  Scaffolds comprised of randomly 
oriented fibers seeded with mesenchymal stem cells prior to implantation contained 
significant new bone-like material after four weeks in-vivo.  No bone-like material was 
observed in un-seeded scaffolds as expected, but these scaffolds were completely 
penetrated by new soft tissue with noticeable amounts of new vascularization.        
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Histological staining techniques were used to asses the quality of the infiltrating 
soft tissue and to identify cells and tissues of interest.  Biological staining and scanning 
electron microscopy back scattered imaging (SEM-BSI) showed new bone tissue had 
formed throughout the scaffolds seeded with mesenchymal stem cells.  Scanning electron 
microscopy electron dispersive spectroscopy (SEM-EDS) analysis of the cross-section of 
a 13-93 and 45S5 fiber implanted four weeks was used to measure the compositional 





Bone density, especially in women, has been documented to decrease with age 1.  
Biologically compatible replacement materials of variable strength are needed to deal 
with this problem 2,3. Cortical bone is the strongest type of bone, with a compressive 
strength that ranges from 117 to 167 MPa 2,3.  Cervical vertebrae and lumbar bone, are 
weaker having a range of compressive strength between 5 to 10 MPa 3, while cancellous 
bone, a spongy bone material, has a compressive strength of only 0.2 to 4MPa 2,3.   
One idea for the regeneration of bone has been to use ceramic materials for bone 
scaffolds.  This option has been widely researched in terms of both materials and 
processing techniques 1,4-16.  The end result is often a sintered ceramic three-dimensional 
scaffold with high porosity (70-90%) and relatively low compressive strength (<0.4MPa) 
5,7-8.  Ceramics most often studied for bone scaffold use are stoichiometric hydroxyapatite 
(HA) with the ideal composition of (Ca10(PO4)6(OH)2) 5,7,9,11,15, other crystalline ceramics 
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such as CaSiO3 or CaCO3 3,9,10, bioactive glasses like the silicate based 45S5 or 13-93 
glasses 1,7,11,13,14,17, and glass-ceramics like bioactive glass-ceramic apatite wollastonite 
(A/W) 1.  All of these materials have been shown to promote significant cell attachment 
and tissue growth.   
Glassy materials have unique properties that make them attractive for use as 
biological implants and for three dimensional porous scaffolds.  It has been shown that 
the chemical composition can greatly affect the rate at which a glass either dissolves in 
liquids similar to those found in the body 18-19 or reacts to form HA.  Homogeneous 
nucleation and crystal growth, such as that of bioactive glass 45S5, makes it possible to 
engineer glass-ceramic materials with improved mechanical properties such as bending 
strength, hardness and elastic modulus when properly heat treated 20-24.  Other bioactive 
glasses, such as the silicate based 13-93, have compositions that are more resistant to 
crystallization 13,25.  The decreased tendency for crystallization is due to compositional 
changes that reduce the nucleation and crystal growth rate, which results in a wider 
working range.  This change increases the ability to pull fibers from a melt, which can be 
self-bonded to form bioactive glass scaffolds of a reasonable mechanical strength with a 
significant fraction of interconnected porosity 13,14,25.    
The scaffolds investigated in the present work consisted of a network of randomly 
oriented self-bonded glass fibers.  Scaffold designations are with respect to the weight 
fraction of 13-93 glass fibers in each scaffold, so S100 scaffolds were composed of 100 
wt% 13-93 glass fibers and S30 was 30 wt% 13-93 and 70 wt% 45S5.  The preparation of 
the scaffolds, porosity, compression strength, and in vitro cell growth of MC3T3-E1 pre-
osteoblast cells have been previously described for the present scaffolds 26-27.   
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The main objective of the present research was to compare the in-vivo response of 
the S100 scaffold versus the S30 scaffold by seeding the scaffolds with mesenchymal 
stem cells prior to subcutaneous implantation.  The evaluation of the scaffolds included 
determining the scaffold’s ability to support bone tissue formation and growth from an 
initial mesenchymal stem cell seeding, a visual examination for breakdown of the 
bonding between the fibers to assess the structural capabilities in-vivo, and a comparison 
of reactivity between the different glass fiber types in body fluids.  These aforementioned 
criteria should give useful insight into the suitability of a scaffold composed of randomly 
oriented bioactive glass fibers for the growth and regeneration of bone. 
 
MATERIALS AND EXPERIMENTS 
 
Scaffold Preparation and Physical Properties 
 Continuous fibers (100 to 300 μm in diameter) of the 45S5 and 13-93 bioactive 
glass (Table 1)  were hand pulled from a melt and broken into 3mm lengths.  Fibers for 
each scaffold were individually weighed for a total of 70mg, so S100 scaffolds contain 
70mg 13-93 fiber and S30 contained 49mg 45S5 and 21mg 13-93 fibers.  The bioactive 
glass fibers were placed in a mold consisting of an alumina substrate and a mullite 
cylindrical tube with a 7mm inside diameter.  The molds were then placed inside a box 
furnace that was pre-heated to 720oC.  After 45 minutes of heating, the molds were 
removed from the furnace and cooled to room temperature.  The self bonded scaffolds 
were removed from the molds and were ready for use 27.    
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 The S100 and S30 scaffolds were previously measured for compression strength 
and open porosity 26-27.  The S100 scaffold had a compressive strength of 5.3MPa and an 
average open porosity of approximately 44%, while the S30 scaffold had an average open 
porosity of 63% and compressive strengths of approximately 0.6MPa. 
 
 




Scaffold Sterilization and Seeding with Mesenchymal Stem Cells 
All scaffolds were washed twice with ethyl alcohol and heat sterilized at 250oC 
for 2.5 hours in a small box furnace prior to cell seeding or implantation.  Half of the 
scaffolds were seeded with 150,000 mesenchymal stem cells harvested from Fisher 344 
rats (Fisher Scientific, St. Louis, MO).  The cells were harvested from the femur of 
previously sacrificed rats and cultured for 24 hours in glass dishes with Sigma α-MEM 
0644 media (Sigma Aldrich, St. Louis, MO): (10% fetal calf serum, 1% penicillin/strep 
antibiotic, 50mg/ml ascorbic acid, and 10-8 molar dexamethasone) at 37oC and in 95% 




A total of eight male and female Fisher 344, rats ranging in age from eight to ten 
weeks, were used to assess the biological response of the S100 and S30 scaffolds after 
being implanted for three and four weeks.  The back of each rat was shaved just prior to 
surgery, sterilized with iodine, and then washed with 70% ethanol to ensure a clean and 
sterile working area.  Each rat was anesthetized with a mixture of isoflourine and medical 
grade oxygen.  The implanted scaffolds are hereafter referred to in by the following 
designations; scaffold S100 seeded with mesenchymal stem cells is designated S100+, 
scaffold S100 without mesenchymal stem cells is designated to as S100, scaffold S30 
with mesenchymal stem cells is designated S30+ and scaffold S30 without mesenchymal 
stem cells is designated S30.   
One scaffold of each type, S100, S100+, S30, and S30+ was implanted for a total 
of four scaffolds per animal for a total of 32 scaffolds.  Each scaffold was implanted 
subcutaneously in a pocket that was formed in the back of each rat, one above each 
shoulder and one above each hind leg, between the skin and the muscle as shown in Fig. 
1.  The pockets were approximately 15mm wide and 15mm long to ensure that each 
scaffold was inserted away from the incision site.  The incisions were closed with super 
glue (Krazy® Glue, Elmers Products inc. Columbus, OH).  After implantation, 0.1 mL of 
Penicillin G Procaine was injected into each thigh of the rat to prevent infection.  The rats 
were placed on a heating pad in a cage with fresh air during recovery. 
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Figure 1. Schematic showing implantation sites for subcutaneous implantation of the 
S100 and S30 scaffolds in the back of a rat. 
 
Removal of Scaffold from Rats and Scaffold Dehydration 
After the allotted three or four week period, the rats were sacrificed in a chamber 
of CO2.   Each scaffold was surgically removed from the subcutaneous site of each rat 
and placed in a 10% formalin solution at room temperature (22oC) for 96 hours to fix the 
tissue.  At this point, each scaffold was visually examined as described later. 
Each scaffold was dehydrated with a series of seven ethanol solutions ranging 
from 80 to 100% ethanol using a solution volume ratio of ten times that of the scaffold 
(~5mL solution/scaffold) 28.  Each scaffold was placed in glass vial and submerged in the 
ethanol solution.  The glass vials were placed in a plastic tray, which was packed in ice to 
keep the ethanol solution from over heating, microwave irradiated at 80% power at 37oC 
for two minutes and was continuously submerged in each of the alcohol solutions for a 
 Top of head 




total of fifteen minutes.  After dehydrating, each scaffold was placed in xylene for 24 
hours to make any tissue present transparent.  
 
Impregnating Scaffolds with Polymethyl Methacrylate (PMMA) 
Each scaffold was infiltrated with a series of three solutions for 48 hours each 
(0%, 50%, and 100% polymerizing agent perkodox mixed with methyl methacrylate 
monomer (MMA)) to ensure monomer penetration and controlled polymerization.  Just 
prior to infiltration of the 100% MMA solution, the scaffold was attached to a bed of 
partially polymerized PMMA.  The scaffold was then covered with a layer of MMA and 
slowly polymerized over a four day period at 4oC.  
 
Scaffold Separation, Sectioning, and Polishing 
Each scaffold was sectioned at its center, perpendicular to the 7mm diameter 
using an IsometTM slow speed saw (Model 11-1180, Buehler LTD. Evanston, IL) with a 
LECO® diamond coated blade (LECO® Corporation, St. Joseph, MI) .  The cross section 
of the scaffold was polished with silicon carbide papers ranging from 320 to 1200 grit.  
The polished surface was attached to a glass slide with superglue and polished to a final 
thickness of 50 ±10μm.  
 
Scaffold Cross-section Staining 
The 50μm section of each scaffold was stained using Sanderson’sTM Bone 
Staining method (Surgipath Canada inc, Winnipeg, Manitoba).  The mounted scaffold 
cross sections were dipped in the preheated stain (50oC) for two minutes, rinsed with 
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distilled water, and blotted dry with a paper towel.  The stained sections were then 
counter stained with a solution consisting of one gram of acid fuchsin, 99mL of distilled 
water, and one mL acetic acid for 40 seconds at 22oC to differentiate the soft tissue as 
blue and bone tissue as red.  The cell nuclei of both the soft and bone tissue appear as 
dark blue dots, cytoplasm (a watery substance that fills cells) is light blue, osteoid seam 
(a mixture of proteins which is secreted by osteoblast which when mineralized becomes 
bone) is a purple color, bone matrix material is red, and soft tissue is blue.  Each stained 
section was examined at 10X and 40X magnification using an Olympus MI transmitted 
light microscope (Olympus Corporation, Japan).   
 
SEM Imaging and EDS Compositional Analysis In-vivo Scaffolds  
Scanning electron microscopy backscattered imaging SEM-BSI, (Hitachi S-570 
SEM) was used to determine the compositional change from the center to the outer edge 
of reacted fibers of 13-93 and crystallized 45S5 fibers (45S5c) that had been four weeks 
in-vivo.  Cross sectioned scaffolds were polished with silicon carbide papers to 1200 grit.  
The scaffolds were sputter coated with gold palladium and attached to aluminum stubs 
with carbon tape to eliminate charging.  For standard-less EDS, there is no set error, as it 
depends on the elements analyzed and the accelerating voltage used for generation of the 
EDS spectra.  For this EDS analysis, the data plotted is shown to give a general idea of 
the reaction and leaching of the fibers.  
 
RESULTS AND DISCUSSION 
Scaffolds Prior to Implantation (As-Made) 
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Figure 2 shows a high and low magnification image of the as-made S100 (Figs 2a 
and b) and S30 (Figs 2c and d) scaffolds prior to implantation.  Figures 2a and Fig. 2c 
show the random orientation of the fibers in the as-made scaffolds.  An example of the 
bonding developed between the fibers after heat treatment is shown in Figs. 2b and 2d.  
An important difference in the 13-93 and 45S5 fibers after self-bonding is that the 13-93 
fibers remain glassy and smooth, whereas the 45S5 fibers crystallize and a rough surface 
is formed as shown in Fig. 2d.  Previously, 45S5 glass has been reported to crystallize 
into combeite 7, whose stoichiometric composition is shown in Table 1.  
 
Figure 2. SEM images of the 13-93 fibers in the S100 scaffold (a), and S30 scaffold (c) 
after 45 minutes at 720oC.  The bonding between 13-93 glass fibers in a S100 scaffold is 
shown in (b) and a 13-93 fiber bonded to 45S5c fiber in S30 scaffold in (d). [26]. 
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Evaluation of Scaffolds Implanted in Rats 
Upon removal, the first evaluation was a visual assessment of robustness of the 
scaffold.  Figure 3 shows three scaffolds, (a) an as-made S100 scaffold prior to 
implantation, (b) a S100+ scaffold after four weeks in-vivo, and (c) a S30+ scaffold after 
four weeks in-vivo.  The diameter of the two implanted scaffolds was essentially 
unchanged from the as-made control, and both scaffolds had sufficient strength to remain 
intact after four weeks in-vivo.  
Significant soft tissue had infiltrated both scaffolds after four weeks in-vivo as is 
clearly evident from Figs. 3b and 3c.  Healthy tissue had grown into the scaffolds, and 
there was no evidence of infection or inflammation in the surrounding tissue to suggest 
rejection of the scaffolds.  Another interesting observation was that several blood vessels 
had grown into the S100 and S30 scaffolds; see black circles in Figs. 3b and 3c.  The 
remaining scaffolds, not shown, at three and four weeks, with and without seeded 
mesenchymal stem cells, all looked similar to those in Fig. 3 in terms of tissue infiltration 
and the presence of blood vessels. 
The reaction products of these two bioactive glasses may be causing an 
angiogenic effect, which in this case is positive, as the penetrating blood vessels are 
providing nourishment to the interior of the scaffolds.  Previous work completed by 
others on the angiogenic effect of 45S5 glass found that there may be a link between 
bioactive glasses and angiogenesis in-vitro 29-30.  No one to date has reported on 
proangiogenic effects for 13-93 glass, in-vivo or in-vitro, but this work shows compelling 
evidence that there may be a positive angiogenic effect in-vivo.  
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Figure 3. Appearance of glass fiber scaffolds before and after subcutaneous in vivo 
implantation for four weeks. (a) S100 scaffold prior to implantation, (b) S100+ after four 
weeks in- vivo, (c) S30+ after four weeks in-vivo.  Red circle is 7mm in diameter and 
denote the starting diameter of the scaffolds. 
 
Evidence of Bone Formation in Implanted Scaffolds  
Regions of red tissue in the histology sections were assumed to be bone tissue, 
therefore, the results of the scaffold cross sections stained for bone tissue identification in 
both the S100 and S30 scaffolds are as follows.  None of the non-cell seeded scaffolds 
contained any bone tissue as expected since they had no mesenchymal stem cells seeded 
on them, and were not adjacent to any natural bone tissue.  All of the S100 and S30 
scaffolds seeded with mesenchymal stem cells and implanted for three and four weeks 
had red tissue present after being stained and was assumed to be bone tissue.     
The 13-93 fibers in the non-seeded S100 scaffolds in Fig. 4 are the white elliptical 
regions surrounded by a dark line.  None of the non-seeded S100 scaffolds contained any 
detectable bone tissue (red stained region) after three or four weeks in-vivo, as is evident 
in Figs. 4a and 4b.  However, soft tissue had penetrated the outer portion of the unseeded 
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scaffolds and was often present in the center of the scaffold.  The presence of this tissue 
is an indication of the biocompatibility between the soft tissue and the 13-93 fibers.   
 
Figure 4. Optical micrograph of randomly selected location in the stained cross section of 
scaffolds after three or four weeks in-vivo. Soft tissue (blue) and bone tissue (red) 
formation. (a) S100 three weeks, (b) S100 four weeks, (c) S100+ three weeks, (d) S100+ 
four weeks. 
 
The seeded S100+ scaffolds all contained regions of bone tissue (red regions) 
after three and four weeks in-vivo, as is evident in Figs. 4c and 4d.   There is a mix of 
both soft (blue) and bone (red) tissue present in the three and four week S100+ scaffolds.  
The amount of bone tissue in the week four scaffold, Fig. 4d, appears to be slightly more 
than in the three week scaffold, Fig. 4c.  
 322 
Figure 5 is as enlarged view of Fig. 4d to better show the regions of soft and bone 
tissue after four weeks in-vivo.  The blue dots within the blue matrix are nuclei of soft 
tissue, and the blue dots in the red matrix are nuclei of osteocytes which have 
incorporated into the bony matrix.  In several areas of the scaffold, pockets of bone tissue 
are attached and growing on the 13-93 fibers.  There is a visible reaction layer present on 
the surface of the 13-93 fibers that formed as the 13-93 fibers reacted with the body fluids 
of the rat.  The reaction layer is the darker gray layer that outlines the 13-93 fibers, and 
will be described in more detail later.   
 
Figure 5. Optical micrograph (100X) of the cross-section of a S100+ scaffold seeded with 
mesenchymal stem cells after four weeks in-vivo.  Tissue has been stained where blue 
denotes soft tissue and red denotes bone (hard) tissue. 
 
The boxed area in Fig. 5 labeled (a) is shown at higher magnification in Fig. 6.  
The reacted surface layer on the 13-93 fibers varies in thickness between ~10 to 20μm.  
The dark circles in Fig. 6 encircle osteocytes (blue dots surrounded by a white halo) that 
are incorporated into the newly formed bone tissue.  Only a few examples of the 
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osteocytes in the bony matrix material are shown in Fig. 6, but osteocytes were seen 
throughout the new bone as shown in Fig. 5.  This is important because it shows that the 
MSC cells have differentiated to become mature bone and that the S100 scaffold is 
promoting osteogenesis.  The osteoid seam (purple tissue) represents un-mineralized 
secreted proteins of osteocytes and is the growth front for new bone, as pointed out with 
arrows at both the far right and lower left of Fig. 6.   
 
Figure 6. Optical micrograph (400X) of S100+ scaffold cross-section. S100+ scaffold 
was seeded with mesenchymal stem cells and implanted four weeks subcutaneously in 
the back of a rat and stained for soft (blue) and bone (red) tissue. 
 
Representative examples of the seeded and non-seeded S30 scaffolds after three 
of four weeks in-vivo are shown in Fig. 7.  These cross-sections look significantly 
different than those for the S100 scaffolds, see Fig. 4.  The 45S5c fibers are dark and 
crystallized as opposed to the glassy white 13-93 fibers.  Again, none of the non-seeded 
scaffolds contained any evidence of bone tissue (red), as is evident from Fig. 7a (S30 
three weeks), and Fig. 7b (S30 four weeks).  The soft tissue (blue) in Figs. 7a, 7b, and 7c 
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stained relatively light making it difficult to see, however the cell nuclei stained dark 
blue.  The abundance of nuclei through out the cross-sections indicates significant 
infiltration of soft tissue.  Soft tissue (blue) is visible throughout areas of the scaffold 
cross-section in Fig. 7d, indicating that it had penetrated and survived within the scaffold 
environment provided by the mixture of 13-93 and 45S5c fibers. 
 
Figure 7. Optical micrograph (100X) of the cross-section of S30 scaffolds after three and 
four weeks in-vivo and stained for soft (blue) and bone (red) tissue formation.  (a) S30 
three weeks, (b) S30 four weeks, (c) S30+ three weeks, (d) S30+ four weeks. 
 
Figures 7c and 7d are representative sections of the S30+ scaffolds in which bone 
tissue had formed.  There is a mixture of both soft and bone tissue present in these 
scaffolds, and again the total amount of bone tissue is estimated to be slightly higher after 
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four weeks in-vivo.  In Figure 7d, new bone tissue is seen surrounding both the 13-93 and 
45S5c fibers.  This suggests that both materials are biocompatible and suitable for bone 
growth.  To the author’s knowledge, this is the first time that 13-93 and 45S5c fibers have 
been placed in-vivo in the same site, and from this analysis, both fibers appear to interact 
positively with the living tissue, and there does not appear to be any significant advantage 
from a biological point of view between the two fibers.  
The surface of the 13-93 and 45S5c fibers differs greatly as the 13-93 fibers are 
smooth, while the surface of the 45S5c fibers are noticeably rougher as shown in Fig. 2d.  
The cause of the rough surface is unknown, but one possible explanation is that as the 
45S5 glass crystallized and the crystals began to grow together, a liquid or viscous phase 
surrounding the crystals was pushed out causing the rough surface.  The microstructure in 
Fig. 7 shows bone tissue on both the smooth 13-93 and rough 45S5c surfaces, but a 
determination of which surface is preferred for tissue attachment and growth cannot be 
made from the present work.    
The enlarged view of Fig. 7d shown in Fig. 8, better shows the seeded S30+ 
scaffold after four weeks in-vivo.  The high level of crystallization that occurred in the 
45S5c fibers when they were heated to form a scaffold is evident from the small irregular 
grains that are present throughout the fibers in Fig. 8.  The 45S5c fibers have visible 
reaction regions surrounding them, light gray to white in color, that is attributed to their 
being in contact with the body fluids of the rat.  Two examples of the bonding between 
the 45S5c fibers and a 13-93 fiber are shown on the right hand side of Fig. 8.  Both fibers 
labeled as ‘13-93’ in Fig. 8 are attached to two 45S5c fibers.  The attachment appears to 
be from 13-93 fibers softening and sticking to the 45S5c fibers.  
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Figure 8. Optical micrograph (100X) of S30+ scaffold cross-section after four weeks in-
vivo.  The S30+ scaffold was seeded with mesenchymal stem cells and implanted four 
weeks subcutaneously in the back of a rat and stained for soft (blue) and bone (red) 
tissue.  The darker, textured fibers are crystallized 45S5c fibers, where the glassy 13-93 
fibers are transparent and featureless. 
 
An expanded view of the region inside the box labeled (9) in Fig. 8 is shown in 
Fig. 9. A region of new bone tissue is seen between two 45S5 fibers that are bonded to a 
13-93 fiber.  Osteocytes are visible in the newly formed bone, as observed in the S100+ 
scaffolds.  New bone tissue appears to be attached to both the 13-93 fiber and the 45S5c 
fiber, with no apparent preference for either fiber.  This indicates that both fibers promote 
new bone growth.  Again, as mentioned about the S100 scaffold, the S30 scaffold has 
osteocytes embedded throughout the new bone indicating that the MSC cells have 
differentiated and are forming new bone. 
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Figure 9. Optical micrograph (400X) of cross-section of the box labeled (9) in Fig. 8.  
S30+ scaffold was seeded with mesenchymal stem cells and implanted four weeks 
subcutaneously in the back of a rat and stained for soft (blue) and bone (red) tissue. 
 
The thickness of the reacted region of the 45S5c fiber on the left hand side of Fig. 
9 appears to be ~20 to 30μm, which is thicker than the regions seen surrounding the 13-
93 fibers.  This suggests that the 45S5c fibers react faster than the 13-93 fibers which is 
consistent with the higher alkali and lower silica content of the 45S5 fibers.  
The region, in the box labeled (10), in Fig. 8, is shown as a transmitted light 
image in Fig. 10a and as a SEM-BSI image in Fig. 10b.  Figures 10a and 10b have 45S5c 
fibers on the left and at the top of the image as denoted by the arrows, and a fiber labeled 
13-93 to the right.  The X’s in Figs. 10a and 10b show regions of the fibers that had 
reacted in-vivo. These regions are rich in both calcium and phosphorus.  The Y’s 
correspond to areas of new bone, stained red in Fig. 10a, and the light gray material 
attached to the edge of the fibers in Fig. 10b.  Soft tissue infiltrated with PMMA, labeled 
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Z, corresponds to the blue tissue in Fig 10a, and the darkest portion of the image in 
Fig.10b.  Figures 10a and 10b look slightly different because the section used for Fig. 10a 
was stained for histology and the adjacent section of scaffold was prepared for imaging 
with the SEM.  Subsequent polishing removed material from the surface of the scaffold 
section, which slightly altered the image, but the representative areas of the scaffold are 
still the same as previously described. 
 
Figure 10. Seeded S30+ scaffold after four weeks in-vivo. (a) Optical micrograph (400X) 
of a portion of the cross-section of a S30+ scaffold. (b) SEM-BSI of same area as shown 
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as (10a). The X’s indicate reacted regions on the fibers, the y’s indicate areas of new 
bone, and the Z’s are areas of PMMA infiltrated soft tissue. 
 
The new bone tissue found after three weeks in-vivo in the seeded scaffolds in the 
present work is consistent with prior work10 completed on porous HA and porous calcium 
carbonate constructs seeded with marrow cells and subcutaneously implanted in rats for 
two to six weeks.  In the prior work10, three weeks was the minimum time for new bone 
to become recognizable in the porous HA and porous calcium carbonate constructs.   
 
Analysis of 13-93 and 45S5c Fiber after Four Weeks In-vivo 
A 13-93 fiber after four weeks in-vivo was imaged with SEM-BSI and also 
measured for compositional change with SEM-EDS.  The dotted line in Fig 11a 
illustrates the boundary between the adjacent new bone and the calcium rich layer of the 
13-93 fiber.  The new bone is in direct contact with the outer edge of the 13-93 fiber.  
Figure 11a is an SEM-BSI image of the cross-section of a 13-93 glass fiber that was part 
of a S100+ scaffold after four weeks.  The calculated oxide weight percent, as measured 
by SEM-EDS, present at the three positions (A,B, and C) shown in Fig. 11a is shown 
graphically in Fig. 11b.  The change in gray scale across the fiber cross-section in Fig. 
11a indicates a change in composition from the unreacted glass; position A, to the outer 
edge at position C. The unreacted portion of the fiber at position A has a composition 
close to that of starting 13-93 glass (Table 1).  Position B is a silica rich layer containing 
almost 90 weight percent SiO2, the rest being CaO and P2O5.  The CaO and P2O5 content 
increased significantly at the outer edge (position C), indicating a calcium phosphate 
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layer had formed.  The K2O, MgO, and Na2O content decreased to near zero at position C 




Figure 11. (a) SEM-BSI of a 13-93 glass fiber after four weeks in-vivo.  (b) Composition 
(weight % oxide) obtained from SEM-EDS of a reacted 13-93 fiber at the locations A, B, 
and C.  Composition for 13-93 glass given in Table1. 
 
Stoichiometric HA (Ca10(PO4)6(OH)2) has a Ca/P molar ratio of 1.67, and the 
Ca/P ratio at the outer edge of the 13-93 fiber at position C in Fig. 11b was measured 
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with EDS to be 1.38.  This increase in Ca/P ratio at position C indicates that a calcium 
phosphate material has formed and verifies earlier statements about the formation of a 
calcium phosphate surface layer on 13-93 fibers due to interactions with body fluids.  The 
formation of a calcium phosphate layer was expected as it has been detected by in-vitro 
testing in SBF 1,11,13, 25, 31 and in-vivo in various animal models 1,17. 
A 45S5c fiber, after four weeks in-vivo and seeded with msc cells, was imaged 
with SEM-BSI and also measured for compositional change with SEM-EDS.  Figure 12a 
shows an SEM-BSI image and Fig. 12b shows the corresponding plot of composition 
across a 45S5c fiber after four weeks in-vivo.  This fiber has undergone significant 
reaction after four weeks as is apparent by the thick light gray layer that surrounds an 
easily distinguishable darker core.  The variation in composition across the fiber, as 
determined by EDS, is shown graphically in Fig. 12b.  All of the Na2O has been leached 
from the 45S5c fiber, even from the core.  This leaching of Na2O has been previously 




Figure 12. (a) SEMBSI of 45S5c fiber four weeks in-vivo (from an S30 scaffold seeded 
with msc cells). (b) Compositional analysis (weight % oxide) obtained from SEM-EDS 
of reacted 45S5c fiber as a function of position.  Composition of 45S5 glass is shown in 
Table 1. 
 
The dark core at the center of the fiber in Fig. 12a is greater than 90 weight 
percent SiO2.  The silica core found in reacted 45S5c fibers in the present work has been 
similarly described previously with 45S5 glass particles to make calcium phosphate 
shells in-vitro 32 and reacting 45S5 glass fibers with phosphate solutions in-vitro 18.  The 
previous report on calcium phosphate shells32 stated that all of the SiO2 was eventually 
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released from the 45S5 glass spheres, and lead to a hollow shell of calcium phosphate 32.  
It is unclear from the present work if the SiO2 will be totally dissolved from the center of 
the reacted 45S5c fibers, but it has been shown that it may, given the right physiological 
conditions 32.   
The calcium phosphate rich layer present at position four of the fiber in Fig. 12a, 
contains only 17 weight percent SiO2 while the remaining components are CaO and P2O5 
at ~40 weight percent each.  The Ca/P molar ratio is 1.18 and there are high levels of both 
CaO and P2O5 at position three and four relative to other the other oxides which indicates 
that a relatively thick (25μm) calcium phosphate layer has formed on the outer edge of 
the fiber in only four weeks.  The formation of the calcium phosphate material at the 
outer edge of the 45S5c fiber does verify earlier statements about a calcium phosphate 
reaction region, and should be expected as 45S5 has been documented numerous times to 
form HA both in-vitro with SBF 18,19,23,24, and in-vivo in animal models 1,17.   
CONCLUSIONS 
New bone tissue formed in both the S100 and S30 fiber scaffolds seeded with 
mesenchymal stem cells at both three and four weeks in-vivo.  Soft and bony tissues were 
found in the interior of the cell seeded scaffolds after extraction.  Cell seeded scaffold 
cross-sections showed osteocytes were present in the regions of newly formed bony 
tissue indicating that the MSC cells were differentiating into mature bone.  From this 
analysis, no preference in fiber composition (45S5c or 13-93) was distinguishable for the 
soft or bone tissue to grow.  Therefore, both materials are excellent for tissue engineering 
applications. 
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Several blood vessels which penetrated the scaffolds provided nourishment to the 
tissues inside both the S100 and S30 of scaffolds.  Integration of blood vessels into the 
interior of the scaffolds could be an indicator that the reaction products from 13-93 and 
45S5c fibers could be beneficial in terms of triggering angiogenesis (blood vessel 
formation) in-vivo.  Proangiogenic glasses and porous self-bonded bioactive glass 
scaffolds could be beneficial for new soft tissue repair applications. 
Compositional SEM-EDS analysis of 13-93 and 45S5c fibers after four weeks in-
vivo indicated that calcium phosphate rich layers had formed on the surface of the fibers 
while other glass components had been resorbed in the body fluids of the rats.  The 
reaction layer thickness present on the 45S5c fibers was in the range of 20 to 30μm while 
the 13-93 reaction layer was only 10 to 20μm. 
Neither scaffold type showed signs of mechanical failure or degradation after four 
weeks in-vivo.  Based on these observations and the compressive strength measured 
previously, both S100 and S30 scaffolds are considered sufficiently strong for in-vivo use 
for cancellous bone applications or for soft tissue. Therefore, the present results indicate 
that self bonded bioactive glass fiber scaffolds constructed of 13-93 and 45S5c with 
average porosity measurements between 44 and 63% and compressive strengths between 
0.6 and 5.3 MPa have the ability to function in-vivo, promote bone tissue formation, 
possibly promote angiogenesis, and be biologically converted to calcium phosphate or 
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Bioactive 45S5 glass has been studied extensively both in vivo and in vitro, and it is 
relatively well known that when placed in a phosphate containing solution the glass will 
react to form the bone-like material hydroxyapatite (HA).  In the present work, a kinetic 
analysis of previously measured weight loss data was done to determine reaction rate 
constants for four bioactive glasses; one silicate glass, two borosilicate glasses, and one 
borate glass, via the contracting volume model.  The reaction rate increased with 
increasing B2O3 content, with the borate glass reacting nearly five times faster than the 
silicate 45S5 glass.  The three silica containing glasses all deviated from the contracting 
volume model after approximately 50-70% of the total weight loss; however, when 
compared to the 3-D diffusion model, the normalized data were in good agreement to 
100% of the total weight loss.  The deviation from the contracting volume model to the 
slower 3-D diffusion model indicates a change in conversion model for the silica 
containing glasses and can likely be attributed to the formation of a silica rich layer of a 
certain thickness that began controlling the release of ions from the unreacted glass by 
diffusion.   






Bioactive glass 45S5 was first reported to bond to bone by Hench in 1971.(1)  Ever since, 
45S5 has been used extensively in both research and clinical use for the repair of bone 
and other living tissues.  Silicate based bioactive glasses, such as 45S5, and ceramics 
have served as important biomedical materials because it has the ability to bond to 
surrounding hard and soft tissues and enhance bone formation.(2-9)   
Borate glasses have only recently been explored for use in biomedical 
applications.  Richard was the first to investigate replacing SiO2 with B2O3 in the 45S5 
glass composition.(10)  The borate based 45S5 immersed in a K2HPO4 solution at body 
temperature (37oC) formed a layer of hydroxyapatite (HA), Ca10(PO4)6(OH)2, similar to 
that formed by the silicate based 45S5.(10)  The in vitro formation of HA from the borate 
based 45S5 led to further investigation in vivo.  Particles of the borate based 45S5 glass 
were placed in a rat tibial defect, and not only promoted bone formation, but did so at a 
faster rate than the silicate based 45S5 glass.(10)       
Possible reaction mechanisms have been described by Huang et. al.(11-12) for the 
silicate 45S5 glass and the borate analog of 45S5 (all SiO2 replaced by B2O3).  The borate 
glass fully converted to HA by the glass dissolving, the B2O3 and Na2O going into 
solution, and the CaO reacting with PO43- from the phosphate solution.  The silicate glass 
was described to partially convert to HA, while leaving a sodium depleted core 
surrounded by a silica rich layer.   
According to the results of previous studies(10-12), the borate based glass most 
closely follows a contracting volume type of behavior, where the HA first forms at the 
outside of the glass particle, and then continually reacts inward toward the center until 
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completely reacted.  The silicate glass forms HA at the outer edge of the particle initially; 
however it is not clear how the formation of the silica gel layer affects the movement of 
ions.  Therefore, if the silica gel layer becomes the rate controlling mechanism, the 
weight loss reaction might follow 3-D diffusion kinetic behavior.   
 The main objective of the following work was to determine if there was a 
mechanistic difference in the way silicate, borosilicate, and borate bioactive glasses 
converted to HA.  The relative reaction rates of the silicate, borate, and two borosilicate 
based 45S5 glasses were determined by comparison with the contracting volume model.  
Finally, the normalized weight loss data was compared to the 3-D diffusion model to see 




2.1 Glass Preparation and Weight Loss for the Silicate, Borate, and Borosilicate Based 
45S5 Glasses 
 
 The glasses used were based on the bioactive 45S5 glass composition, and the 
composition of each glass is shown in Table I.  The weight loss data used in this analysis 
and an in-depth experimental procedure was reported by Huang et. al.(11-12) 
2.2 Kinetic Evaluation of the Weight Loss Data 
  In the previous work by Huang(11-12), the weight loss for the glass particles was 
measured for hundreds of hours beyond a measurable change to make sure the 
experiment has indeed ended, and is shown in Fig.1.  The maximum weight losses for the 
0B, 1B, 2B, and 3B were 42%, 35%, 42%, and 57% respectively.  The weight loss data 
reported by Huang et. al(12) were converted to fractional weight change (α) by dividing 
the measured weight loss values by the maximum weight loss value (Fig.2).  The 
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maximum weight loss was determined by the difference of the mass of the starting glass 
and that of the end product. 
The contracting volume model (CVM) is a geometrical model that is used to 
theoretically describe the reaction rate of a solid sphere of some material and a reactant 
(gas or liquid).  In this experiment, the CVM was used to model the weight loss from the 
glass particles suspended and the 0.02M phosphate solution data measured by Huang(11-
12).  The values of α vs. time for the four glasses were fitted using the CVM shown as 
equation (1).(13-14) 
Contracting Volume Model     1-(1-α)1/3 = kt (1) 
 The 3-D diffusion model, equation (2)(14), is a diffusion model that describes the 
diffusion of material through some rate controlling medium in three dimensions.  The 3-
D diffusion model was compared to the normalized weight loss data just as the CVM to 
see if a change in the glass conversion model could be detected from the weight loss for 
any of the four glasses. 
 3-D Diffusion Model     [1-(1-α)1/3]2 = kt            (2) 
 Terms present in equations (1) and (2) are the normalized weight loss (α), which 
is calculated by dividing the measured weight loss by the total weight loss for the 
reaction, rate constant (k), and time (t). 
 
3. Results 
3.1 Weight Loss of Silicate, Borate, and Borosilicate Based 45S5 Glasses 
The weight loss data measured by Huang et. al.(11-12) for the four glasses tested for the 
first 1800 hours of reaction is shown in Fig. 1.  The 0B and 1B glasses reacted at nearly 
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the same rate for the first 200 hours while the 2B and 3B glasses reacted significantly 
faster.  At the time the experiment was stopped, the 0B, 1B, and 2B glasses had stopped 
losing weight, however the measured weight losses were less than the theoretical weight 
losses for the three glasses (Table 1).  Theoretical weight loss for these glasses was 
calculated by assuming the end product would be HA, and all the rest of the components 
(Na2O, B2O3, and SiO2) would be in solution.  Silica rich cores were found at the center 
of the 0B, 1B, and 2B glass particles at the end of the experiment, indicating that the 
silica had not fully dissolved in the phosphate solution.(11)  The final (maximum) weight 
loss of the 3B glass was 57%, which was within 2% of its theoretical limit, and therefore 
assumed to have gone to completion.  
3.2 Isothermal Reaction Kinetics for the Silicate, Borate, and Borosilicate Based 45S5 
Glasses 
 
The accumulated weight loss percent data shown in Fig. 1 were converted to α by 
dividing the measured weight loss by the maximum weight loss for each glass.  The solid 
lines in Fig. 2 show that the normalized weight loss (α) vs. time curves for each glass had 
similar shapes.  The k values used to fit equation (1) to the curves in Fig. 2 are listed in 
Table 1. The k values ranged from as low of 0.0045 for 0B to as high of 0.0220 for the 
3B glass, indicating that the 3B glass reacts approximately five times faster than the 0B 
glass.  The CVM model is a good fit for all four glasses for the first 30 hours of reaction.  
 After about 50 hours, the normalized weight loss deviated from the CVM model.  
The reaction rate of the 0B, 1B, and 2B particles decreased from that initially described 
by the CVM.  After 50 hours, the normalized weight loss data is in good agreement with 
the 3-D diffusion model, indicating a change in reaction model for the three silica 




4.1 Reaction Model of the Glasses with 0.02M Phosphate Solution 
The reaction model for the four glasses was determined by plotting α vs. time along with 
fits of equations (1) and (2) for each glass.  A plot with the normalized weight loss data 
for the four glasses (points) compared to the CVM (solid line) and 3-D diffusion equation 
(dashed line) is shown in Fig. 3.  The first 30 hours of data, for all four glasses, were in 
good agreement with fits of the CVM, indicating that the HA formation was due to 
dissolution of the glass in the phosphate solution.   
 The normalized weight loss data for the 0B, 1B, and 2B glasses deviate from the 
CVM after about 50 hours.  The normalized weight loss after 50 hours fit well fitted by 
the 3-D diffusion model until the end of the reaction (~600 hours).  One explanation for 
this behavior is that the silica gel layer in the silica containing glasses had reached a 
thickness such that the movement of ions was controlled by diffusion through the silica 
gel.  The first glass to change from the CVM to the 3-D diffusion model, in terms of 
normalized weight loss (α), was 0B which contained the most silica, and was followed by 
the 1B and 2B glasses.  It is reasonable to suggest that if the change in model was caused 
by the formation of a silica gel diffusion layer, then the glass containing the most silica 
(0B) would form a silica gel diffusion barrier first and so on as seen with the 1B and 2B 
glasses.   
4.2 Effect of B2O3 Content on the Reaction Rate Constant 
In previous analysis of the 0B, 1B, 2B, and 3B glasses, the general relationship between 
higher B2O3 content and increased reaction rate was identified(11), but no mathematical 
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relationship was determined that related the B2O3 content of the glasses and the rate of 
conversion to HA.  Figure 4 shows the mol% B2O3 plotted versus the rate constant k 
(Table 1) for each of the glasses.  There is a measurable change in k between all four 
glasses, shown by the solid curved line in Fig. 4. This may be a method for accurately 
determining the effect B2O3 is having on the reaction rate constant.   
 The equation shown in Fig. 4 describes the reaction rate constants of the four 
glasses in the 0.02M phosphate solution versus the B2O3 content.  Comparing the 
phosphate concentration of 0.02M to the ~0.001M phosphate concentration in body 
fluids(11), the equation would seem irrelevant for practical use as 0.02M phosphate 
solution is not a standard solution concentration.  The possible importance of the equation 
shown in Fig. 4 comes from finding a relationship between B2O3 content and the reaction 
rate constant k.  A similar experiment between the 45S5 glasses and a solution such as 
simulated body fluid (SBF) could be done to develop a similar equation that is more 
applicable when trying to model a bioactive glass conversion reaction in a real system, 




The conversion of the 0B, 1B, 2B, and 3B glasses was described using both the 
contracting volume model and the 3-D diffusion model.  The CVM fits the data for the 
3B glass over the entire range of α, while the data for the 0B, 1B, and 2B glasses are only 
fitted well by the CVM for the first 30 hours of reaction.  The 0B, 1B, and 2B glasses at 
long times are better fitted by the 3-D diffusion model, probably due to the formation of a 
rate controlling silica gel layer in the glass particles.  The relative reaction of the 3B glass 
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was five times faster than the 0B glass, with k values which range from 0.0045 for 0B to 
0.0220 for 3B. 
 The reaction rate constant of 45S5 type bioactive glasses immersed in 0.02M 
phosphate solution was shown to depend on the B2O3 content, and thus warrants 
additional work to find a similar relationship for a more common solution such as SBF.  
Simulated body fluid would more accurately model the in vivo environment and could be 
used to tailor glass compositions for desired in vivo reaction rates.   
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Figure 1. Accumulated weight loss percent(11-12) for the 0B, 1B, 2B, and 3B glasses 
during the first 1800 hours of reaction in 0.02M K2HPO4 solution at 37oC. The dashed 
horizontal lines denote the maximum weight loss for each glass.  The 0B and 2B glasses 










Figure 3. Normalized weight loss (α) vs. time for the 0B (crosses), 1B (triangles), 2B 
(squares), and 3B (diamonds) glasses compared with the Contracting Volume Model 
(solid lines) and 3-D Diffusion Model (dashed lines).  The CVM is a good fit of the data 
for the first 30 hours for all four glasses, but after 50 hours, the 3-D Diffusion Model is a 
better fit for the slower reacting 0B, 1B, and 2B glasses (dashed lines).  
 349 
 
Figure 4. Reaction Constant (k) vs. Mole % B2O3 for the 0B, 1B, 2B, and 3B glasses 
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